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Aneuploidy and increased cell migration and invasion are hallmarks of aggressive human 
cancers. Aneuploidy derives from an increased rate of perpetual chromosome 
missegregation during mitosis, referred to as chromosomal instability (CIN). CIN contributes 
to the development of genetic heterogeneity and is thought to support rapid adaptation of 
cancer cells. Significantly, late tumor stages, which exhibit metastasis, are not only 
characterized by increased cancer cell migration and invasion, but also by high levels of CIN, 
both of which correlate with poor patient prognosis. Therefore, I aimed to investigate a 
potential link between CIN and increased cell migration and invasion in aggressive human 
cancer cells. 
In this study, I found that CIN per se is not sufficient to trigger increased cancer cell migration 
and invasion. However, a hyperactive TRIO-Rac1-Arp2/3 pathway acts as a shared trigger 
for both, the development of CIN and cancer cell migration and invasion. Hyperactivation of 
TRIO, Rac1 and the Arp2/3 complex depends on increased microtubule plus-end assembly 
rates and on the localization of the Rac1-GEF TRIO to microtubule plus-ends via the 
microtubule end-binding protein EB1. In mitosis, microtubule dependent hyperactivation of 
the pathway causes spindle positioning defects leading to erroneous microtubule-kinetochore 
attachments and the generation of lagging chromosomes, which constitute a common cause 
for chromosome missegregation and CIN. Inhibition of TRIO, Rac1 or the Arp2/3 complex 
suppressed these phenotypes and prevented the development of aneuploidy in 
chromosomally instable colon cancer cells. In interphase, the hyperactivity of TRIO, Rac1 
and the Arp2/3 complex resulted in highly enhanced cancer cell migration and invasion. 
Analogous to the situation in mitosis, restoration of proper microtubule dynamics in 
interphase suppressed the migratory and invasive phenotype in invasive colorectal cancer 
and melanoma cells. Thus, these results demonstrate a mechanistic link between the 
regulation of the actin and the microtubule cytoskeleton important for the development of CIN 
as well as for triggering cancer cell migration and invasion. 
As one important trigger that can cause increase of microtubule plus-end assembly rates in 
both, mitosis and in interphase I identified a concomitant loss of the transcription factors p53 
and p73. In fact, my studies suggest that p53 and p73 cooperate in maintaining 
chromosomal stability and suppressing cancer cell migration and invasion. 




1.1 The Eukaryotic Cell Cycle 
The cell cycle enables the generation of two daughter cells that are accurate copies of the 
parental cell. This process is divided into two main phases: mitosis and interphase. Mitosis 
again is subdivided into a successive series of phases: prophase, prometaphase, 
metaphase, anaphase and telophase, whereas interphase is subdivided into G1-, S- and G2-
phase (Fig. 1.1). Each phase of the cell cycle is characterized by the time-dependent 
activation and inactivation of enzymatic cascades, that are regulated through various protein 
complexes (Nigg 2001).  
 
 
Figure 1.1: The eukaryotic cell cycle. The eukaryotic cell cycle is divided into interphase with its 
sub-phases G1-, S- and G2-phase and mitosis with its sub-phases prophase, prometaphase, 
metaphase, anaphase and telophase. During prophase, the centrosomes separate and the 
chromosomes starts to condense. The nuclear envelope breaks down in prometaphase and the 
mitotic spindle assembles. When all chromosomes are attached to spindle microtubules emanating 
from the opposing spindle poles and fully aligned on the cell equator, the cell is said to be in 
metaphase. During anaphase the chromosomes are separated and pulled towards the opposing 
spindle poles. A new nuclear envelope is build in telophase and the chromosomes decondense. 
 
 
During G1-phase (gap-phase 1), the cell grows in size and many genes required for cell 
division are switched off. In case of poor nutrient supply or during differentiation, the cell is 
able to exit the cell cycle to enter the resting phase G0. But upon proliferative environmental 
stimuli, the cell overcomes the restriction point, whereupon genes required for the transition 
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into S-phase (DNA synthesis phase) are transactivated. The transition from G1- to S-phase 
needs to be tightly regulated, since the misregulation promotes oncogenesis (Bertoli et al. 
2013). During S-phase, the centrosomes, which are the main microtubule organizing centers 
in mammals, are duplicated and the DNA is replicated. As a result, two sister chromatids 
exist, which are linked by the cohesin protein complex (Losada et al. 1998; Sumara et al. 
2000). This complex is important for a symmetrical segregation of the sister chromatids 
during mitosis (Michaelis et al. 1997). The G2-phase is characterized by the accumulation 
and activation of enzymes, which trigger mitotic entry when reaching a critical threshold.  
During the following mitosis, the replicated DNA is segregated equally onto two daughter 
cells. Chromosome condensation, movement of centrosomes towards the opposing spindle 
poles (Nigg 2001) and the formation of the mitotic spindle (Nigg & Stearns 2011) starts in 
prophase. During prometaphase, the nuclear envelope breaks down and the mitotic spindle 
is further established. Moreover, the kinetochores assemble at the centromeric region of the 
sister chromatids, thereby generating binding sites for the microtubules (Cheeseman & Desai 
2008). First, the chromosomes become randomly attached by microtubules emanating from 
the spindle poles in a process termed "search and capture" (Kirschner & Mitchison 1986). 
Then they are aligned at the metaphase plate in an accurate manner. Once all chromosomes 
are properly attached to spindle microtubules and fully aligned, the cell is said to be in 
metaphase. During anaphase A, cohesin protein complexes, which link the sister chromatids, 
are cleaved by the enzyme separase (Nakajima et al. 2007), the sister chromatids are 
separated and move towards the spindle poles due to microtubule shortening, while in 
anaphase B the two spindle poles themselves move apart (Rieder & Salmon 1994). In 
telophase, the chromatids reach the spindle poles thereby forming the new daughter nuclei. 
The separation of the daughter cells is completed by cytokinesis. 
 
1.2 Cell Cycle Regulation And Checkpoints 
The cell cycle needs to be highly regulated to avoid the formation of abnormal daughter cells. 
The timely ordered progression of cells through the cell cycle is mediated by the oscillating 
activation and inactivation of cyclin-dependent kinases (CDKs) (Arellano & Moreno 1997). 
The catalytic activity of CDKs requires the binding of regulatory subunits known as cyclins 
(Malumbres & Barbacid 2005). The cell cycle dependent synthesis and degradation of 
cyclins regulate CDK activity in a timely manner (Malumbres & Barbacid 2009). However, 
binding of cyclins to CDKs is not sufficient to fully activate the complex. CDK activity is also 
regulated by activating and inhibitory phosphorylations and dephosphorylations (Coleman & 
Dunphy 1994; Lolli & Johnson 2005). The kinases Wee1 and Myt1 inhibit CDK-cyclin 
complexes by phosphorylation, whereas the phosphatase Cdc25 removes these inhibitory 
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phosphorylation (Malumbres & Barbacid 2005). Furthermore, an activating phosphorylation 
through the CDK activating kinase (CAK) is required (Lolli & Johnson 2005). Specific CDK-
cyclin complexes control cell cycle progression: D-type cyclins bind to CDK4 and CDK6 
during G1-phase, E-type cyclins preferentially bind to CDK2 at the G1-S-transition, CDK2-
cyclin A is active during S-phase and CDK1-cyclin A and CDK1-cyclin B at the transition to 
mitosis as well as during mitosis (Malumbres & Barbacid 2009) (Fig. 1.2). 
 
               
Figure 1.2: Regulation of the cell cycle by CDK-cyclin complexes. In early mitosis, Cdk1 and 
Cdk2 bound to cyclins A and B are highly active. The G1-S-transition is mediated by Cdk4/6-Cyclin D 
and Cdk2-Cyclin E activity, which also lead to the synthesis of proteins needed for DNA replication in 
S-phase. Cdk2-Cyclin A is active during S-phase until early mitosis. P: prophase, PM: prometaphase, 
M: metaphase, A: anaphase, T: telophase. Modified from Pollard & Earnshaw 2007. 
 
 
Signaling pathways control the progression of the cell during the cell cycle and regulate the 
transition between the different phases by modulating CDK activity. For instance, the DNA-
damage checkpoint is activated upon diverse alterations in the DNA caused by 
environmental or endogenous stress (Bartek et al. 2004). Central checkpoint proteins are 
ATM (ataxia telangiectasia mutated) and ATR (ATM-Rad3-related) and their effectors Chk1 
(Liu et al. 2000), Chk2, BRCA1 (Cortez 1999) and p53 (Banin et al. 1998; Matsuoka et al. 
1998). DNA double strand breaks during G1-phase activate ATM and Chk2, which leads to 
the stabilization of the transcription factor p53 (Banin et al. 1998). This in turn results in the 
induction of the cyclin-dependent kinase inhibitor p21, which binds to CDK-cyclin complexes, 
thereby blocking cell cycle progression into S-phase (Harper et al. 1993; Harper et al. 1995). 
During G2-phase, the activation of Chk1 by ATR leads to a phoshorylation and thereby 
inhibition of Cdc25. As a consequence, Cdc25 is not able to activate CDK1-cyclin B, thus 
preventing mitotic entry in the presence of damaged DNA (Sanchez 1997).  
During mitosis, the spindle assembly checkpoint (SAC) ensures genomic stability by delaying 
chromosome segregation until all kinetochores are properly attached to spindle microtubules. 
During prometaphase, the mitotic checkpoint complex (MCC), consisting of the proteins 
BubR1, Bub3, Cdc20 and Mad2, assembles at unattached kinetochores (Lara-Gonzalez et 
al. 2012). Due to this complex formation, Cdc20 is not able to activate the E3 ubiquitin ligase 
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anaphase-promoting complex/cyclosome (APC/C) (Musacchio & Salmon 2007). When all 
chromosomes are bi-oriented and aligned at the metaphase plate, the SAC is satisfied and 
the generation of the MCC declines. Cdc20 is released from the complex and can activate 
APC/C, which leads to the ubiquitylation of cyclin B and securin and their subsequent 
proteasomal degradation. Proteolysis of securin results in the release of the protease 
separase. In turn, separase cleaves the cohesin complexes that are responsible for sister 
chromatid cohesion, thereby enabling chromosome segregation. On the other hand APC/C-
mediated proteasomal degradation of cyclin B inactivates the cyclin-dependent kinase 1 
(CDK1), thereby promoting mitotic exit (Peters 2006). 
 
1.3 The p53 Tumor Suppressor Family 
The TP53 gene encoding for p53 is among the most frequently altered tumor suppressor 
genes in human cancers. About 50% of human cancers harbor mutations in this gene, 
leading to an overproduction of mutant protein in high concentrations. p53 is a sequence 
specific transcription factor, which is involved in regulating the expression of genes 
controlling cell cycle arrest and apoptosis. p53 is activated upon genotoxic damage or 
metabolic stress and plays a central role in G1 and DNA damage checkpoints. Upon DNA 
damage p53 induces DNA repair proteins with subsequent cell cycle arrest until the 
damaged DNA is repaired. In case of irreparable DNA damage, p53 is also able to induce 
programmed cell death, thus preventing the proliferation of cells with highly damaged DNA 
(Amundson et al. 1998). 
The p53 family members p73 and p63 were found to have a high structural and functional 
similarity to p53 (Yang et al. 1998; Kaghad et al. 1997). They share the hallmark features of 
p53´s structure: an amino-terminal transactivation domain, a highly conserved DNA-binding 
domain and a carboxy-terminal oligomerization domain (Levrero et al. 2000). Therefore, they 
might be able to fulfill redundant functions of p53. Indeed, it was shown, that TA isoforms of 
p73 and p63 can bind to p53-responsive promotor elements of well-known p53 target genes 
like CDKN1A, BAX or MDM2 (Yang & McKeon 2000). In addition, so-called △N isoforms, 
which are truncated at their N-terminus, have been shown to act antagonistically to p53 as 
well as to TAp73 and TAp63 (Yang et al. 1998; Grob et al. 2001). These △N isoforms are still 
capable of DNA-binding and thus might compete with p53, TAp73 and TAp63 for DNA-
binding sites. Because of the conserved oligomerization domain, △N proteins are also able to 
bind to p53, TAp73 and TAp63 leading to sequestration of the proteins and formation of 
inactive hetero-oligomers (Yang & McKeon 2000; Grob et al. 2001). Furthermore, △Np73 is 
highly overexpressed in various tumors (Concin et al. 2004) including ovarian and skin 
cancer. The overexpression is associated with poor patient prognosis and decreased survival 
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(Concin et al. 2005). △Np73 expression can also be found in metastases of skin cancer 
patients (Tuve et al. 2004). Here, △Np73 induces epithelial-mesenchymal-transition (EMT), 
with loss of E-cadherin and induction of N-cadherin (Engelmann et al. 2014). 
A frequent lesion in colorectal cancer is a mutation in TP53 (Muller & Vousden 2013), which 
causes loss of lost wild-type function. Mutant p53 protein exerts a dominant-negative 
regulation towards the remaining wild-type p53 (Petitjean et al. 2006). Mutations can be 
found throughout the TP53 gene but they cluster within the DNA-binding domain. Several hot 
spot mutations were identified, including occurrence at R175, G245, R248 and R273. These 
mutations affect folding of the protein and also alter the DNA-binding ability of p53. Mutant 
p53 still exerts DNA-binding activity, nevertheless, the binding to p53 responsive elements is 
impaired (Muller & Vousden 2013; Thukral et al. 1995). However, mutant p53 can also bind 
to unique DNA-elements, which indicates a gain of function and gives mutant p53 the 
function of an oncogenic transcription factor (Kim & Deppert 2004; Muller & Vousden 2013). 
Transcriptional functions of mutant p53 are also achieved via a direct interaction with other 
transcription factors to prevent or even enhance their function. An inhibitory interaction can 
be found between mutant p53 and p73 as well as p63. Thereby, mutant p53 binds to and 
inhibits the TA isoforms of p73 and p63 (Gaiddon et al. 2001).  
 
1.4 p21 As Mediator Of p53 Tumor Suppressor Activity 
p21 is a member of the Cip and Kip family of CDK inhibitors, which includes p21, p27 and 
p57. The gene encoding for p21 (CDKN1A) is activated upon DNA-damage by p53 and p21 
protein mediates a cell cycle arrest (Deng et al. 1995) by inhibiting CDK2, CDK4 and CDK6 
(Harper et al. 1995). CDK2 activity is required for phosphorylation of the Rb (retinoblastoma) 
protein. Upon phosphorylation, Rb is released from a complex consisting of Rb and the 
transcription factor E2F. This complex disruption leads to E2F-dependent gene expression, 
which is needed to overcome the restriction point. p21 is frequently deregulated in cancers 
and is able to promote proliferation and oncogenesis (Rufini et al. 2011). This deregulated 
expression is often associated with a loss of function of transcriptional regulators such as 
p53 (Abbas & Dutta 2009). Reduced CDKN1A expression is detected in colorectal, cervical, 
head and neck as well as small-cell lung cancers (Ogino et al. 2010). Ahead from p21´s role 
in the DNA damage checkpoint, p21 deficiency was shown to induce mitotic defects (Kreis et 
al., 2014). These defects include prolonged metaphase and anaphase as well as erroneous 
chromosome segregation and cytokinesis, which promote genomic instability. However, the 
underlying mechanisms are unclear. 
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1.5 The Cellular Cytoskeleton 
1.5.1 The Microtubule Cytoskeleton 
The microtubule cytoskeleton is important for a large number of cellular functions. During 
mitosis the most prominent function is the assembly of the mitotic spindle and the precise 
chromosome segregation (Wittmann et al. 2001), whereas during interphase microtubules 
participate in organelle positioning, intracellular transport as well as maintaining cell shape 
and facilitating cellular motility (Goode et al. 2000). Microtubules are assembled of α- and β-
tubulin heterodimers, which form a protofilament. 13 protofilaments form the hollow tube of 
microtubules. Microtubules exhibit a certain polarity with α-tubulin exposed at the minus-end 
and β-tubulin exposed at the plus-end. Assembly and disassembly of tubulin heterodimers 
occurs solely at their ends. Each end switches between growth and shrinkage, whereby 
dissociation of tubulin mainly occurs at the minus-end and association at the plus-end. 
Thereby, microtubules grow and shrink at a steady state, a process termed ´treadmilling´ 
(Margolis & Wilson 1998; Grego et al. 2001).  
    
Figure 1.3: Dynamic instability of microtubules. Microtubules are assembled by α-/β- tubulin 
heterodimers that are incorporated at the microtubule plus-end. The assembly at the plus-end and 
disassembly of heterodimers at the minus-end, without changes in length is termed treadmilling. 
However, microtubules are characterized by dynamic instability. They undergo transition to rapid 
shortening, which is termed catastrophe. This process can be terminated by a rescue event 
whereupon the microtubule grows again. Modified from Pollard & Earnshaw 2007. 
 
 
Microtubule growth is regulated by the incorporation of the tubulin heterodimer into the 
microtubule end and the hydrolysis of β-tubulin bound GTP. GTP hydrolysis occurs with a 
delay, resulting in a so-called GTP-cap at the microtubule tip. The GTP-cap stabilizes the 
microtubule and loss of the cap leads to a catastrophe event with microtubule 
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depolymerization and shrinkage. The switch between growth and shrinkage is known as 
catastrophe, while the switch from shrinkage to growth is termed ´rescue´. Microtubule 
disassembly can be rescued by the presence of GTP-islands on the surface of the 
microtubule lattice, which mimic the GTP-cap (Desai & Mitchison 1997; Akhmanova & 
Steinmetz 2015) (Fig. 1.3). 
The dynamicity of microtubules is regulated by microtubule associated proteins (MAPs) and 
their sub-class of microtubule plus-end tracking proteins (+TIPs) (Schuyler & Pellman 2001). 
Microtubule polymerases, such as ch-TOG (colonic and hepatic tumour-overexpressed 
gene), bind to microtubule plus-ends and promote the incorporation of tubulin heterodimers 
into the growing plus-end (Gard & Kirschner 1987; Brouhard et al. 2008). Microtubule 
depolymerases, such as MCAK (mitotic centromere-associated kinesin), regulate 
microtubule disassembly by removing heterodimers from the microtubule minus-ends 
(Hunter et al. 2003; Burns et al. 2014). Indirectly, also the end-binding proteins (EBs) of 
+TIPs can regulate microtubule polymerization rates. Hundreds of EB proteins like EB1 can 
bind to a growing microtubule tip (Vaughan 2005), thereby serving as a binding platform for  
other proteins like CLIP-170 (cytoplasmic linker protein) (Lansbergen et al. 2004), CLASP1 
and CLASP2 (cytoplasmic linker protein associated proteins 1/2) (Mimori-Kiyosue et al. 
2005) and p150Glued (Ligon et al. 2003; Watson & Stephens 2006). These proteins appear to 
promote rescue events or suppress catastrophe events (Akhmanova & Steinmetz 2015). 
 
1.5.2 The Actin Cytoskeleton 
Actin plays an important role in several cellular processes like cell motility, establishment and 
maintenance of cell shape, cytokinesis and muscle contraction. Actin filaments are 
assembled of actin polymers and a variety of actin-binding proteins (ABPs), which include 
filament crosslinkers, motor proteins as well as nucleation and elongation factors  
(Lee & Dominguez 2010; Mullins & Hansen 2013). 
In the cell, actin is present in a monomeric, globular (G-actin) or polymeric, filamentous (F-
actin) form. G-actin is able to bind ATP, which is hydrolyzed to ADP, when actin is 
incorporated into a growing filament. F-actin forms a double-stranded helix and exhibits a 
certain polarity with a barbed (+) end and a pointed (-) end. Spontaneous addition of ATP-
bound G-actin at the barbed (+) end leads to growing of the actin filament, whereas 
depolymerization of F-actin occurs at the pointed (-) end by dissociation of ADP-bound  
G-actin (Lee & Dominguez 2010) (Fig. 1.4). This so-called actin filament treadmilling is 
regulated by ABPs. Among them, ADF/cofilin and profilin accelerate the dissociation of  
G-actin from the pointed end and the incorporation to the barbed end, respectively. 
ADF/cofilin and profilin are ABPs that bind to G-actin, thereby controlling the pool of 
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unpolymerized actin in the cell (Lee & Dominguez 2010). During actin polymerization, an 
actin/profilin complex is guided to the barbed end of a filament and incorporated into the 
filament by the filament elongation factor Eva/VASP (Lee & Dominguez 2010).  
 
           
Figure 1.4: Actin filament nucleation. Actin filaments form a double-helix and exhibit a barbed (+) 
and a pointed (-) end. Association of ATP-bound actin monomers mainly occurs at the barbed end, 
whereas the pointed end is mainly characterized by dissociation of ADP-bound actin monomers. Actin 
binding proteins (ABPs) regulate actin treadmilling. Profilin promotes incorporation of actin monomers 
at the barbed end, whereas cofilin promotes actin disassembly from the pointed end. Modified from 
Lee & Dominguez 2010 
 
 
Actin filaments can exhibit different types of organization: branched and crosslinked 
networks, parallel bundles and anti-parallel contractile structures (Blanchoin et al. 2014). The 
Arp2/3 complex (actin related protein 2/3) is responsible for branching of a pre-existing actin 
filament. This complex is activated by the Nucleation Promoting Factors (NPF) WASP 
(Wiskott-Aldrich syndrome protein) or WAVE (WASP-family verprolin-homologous protein), 
which interact with Arp2/3 and actin monomers to create a nucleation core at the side of a 
mother filament (Lee & Dominguez 2010; Achard et al. 2010). The presence of capping 
protein (CP) limits the growth of the filament by binding to the barbed end (Akin & Mullins 
2008). Surprisingly, this CP-mediated termination of filament elongation promotes actin 
network assembly and cell motility (Achard et al. 2010). Whereas the Arp2/3 complex is 
involved in the initiation of actin assembly as well as in the organization of the actin network, 
there are also proteins, which solely connect actin filaments without modulating their 
assembly, e.g. the long crosslinkers alpha-actinin and filamin, and the short crosslinkers 
fimbrin and fascin. Depending on the crosslinking proteins, actin is packed into tight parallel 
or antiparallel bundles or a filament network is built. Branched and crosslinked filaments 
make up the lamellipodium, whereas aligned bundles are the basis for filopodia and stress 
fiber formation (Blanchoin et al. 2014). Alterations in the actin cytoskeleton are associated 
with cancer metastasis and invasion, since the invasion process is characterized by the 
formation of lamellipodia, filopodia and invadopodia (Yamaguchi & Condeelis 2007). 
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During mitosis, the actin cytoskeleton is subjected to dynamic rearrangements. Actin 
filaments localize to the cortical plasma membrane, to retraction fibers and also to the 
contractile ring during late stages of mitosis and cytokinesis (Mitsushima et al. 2010). The 
cortical actin influences spindle positioning, thereby defining the cell´s division axis (Théry et 
al. 2005; Toyoshima & Nishida 2007). Furthermore, an amorphous cluster known as ´actin 
cloud´ was recently described to be present during mitosis (Mitsushima et al. 2010), which 
interacts with astral microtubules, influencing mitotic spindle alignment (Fink et al. 2011). The 
actin cloud forms at the cell cortex early during mitosis, persists until late anaphase and was 
shown to be dependent on the activity of the Arp2/3 complex (Mitsushima et al. 2010). 
 
1.6 Mitotic Spindle Assembly 
The dynamic properties of microtubules along with many proteins that modulate microtubule 
organization and stability are required to set up a bipolar spindle during mitosis to separate 
the sister chromatids (Gadde & Heald 2004). Three sub-populations of microtubules exist 
within a mitotic spindle: kinetochore microtubules connect the chromosomes to spindle poles, 
interpolar microtubules form an overlapping, antiparallel network and astral microtubules 
interact with the cell cortex (Wittmann et al. 2001; Gadde & Heald 2004). The first step 
towards a bipolar spindle is the separation of the centrosomes, which is mediated by motor 
proteins (Wittmann et al. 2001). Motor proteins can be classified into plus-end directed 
motors, known as kinesins, and minus-end directed motors, known as dyneins. Among them, 
the kinesin Eg5 plays an important role during centrosome separation (Whitehead & Rattner 
1998; Tanenbaum et al. 2008). Due to the antiparallel sliding activity of Eg5, the 
centrosomes are pushed to opposing sides (Tanenbaum & Medema 2010). A second 
important player is the minus-end directed motor dynein (Tanenbaum & Medema 2010). 
Dynein localizes to astral microtubules or to the cell cortex (Kardon & Vale 2009). The 
cortical dynein is able to pull on astral microtubules, thereby positioning the mitotic spindle 
(Grill et al. 2003). The main function of the mitotic spindle is the alignment and the 
segregation of the chromosomes. For this, microtubules are attached to kinetochores, which 
involves several kinetochore and microtubule associated proteins. Chromosome alignment 
and segregation requires the function of different kinesins, including chromokinesins. 
Precise spindle positioning is an important process, since it provides the axis of the following 
cell division. Usually, the axis of cell division is oriented along the planar axis, thereby 
ensuring the attachment of the newly formed daughter cells to the substratum (Toyoshima & 
Nishida 2007). The polarization depends on external factors such as the extracellular matrix 
or neighboring cells (Fink et al. 2011). Astral microtubules interact with cortical proteins via 
+TIPs, including EB1, APC (adenomatous poliposis coli) and dynein (Schuyler & Pellman 
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2001). The dynein-dynactin complex binds to NuMA (Nuclear mitotic apparatus protein), that 
is linked to the cell cortex via LGN (GPSM2, G-protein-signaling modulator 2). The minus-
end directed motor activity of dynein-dynactin then provides a pulling force on astral 
microtubules (Bergstralh & St Johnston 2014). 
Furthermore, the actin cytoskeleton is necessary during spindle positioning, since the 
disruption of actin was shown to induce spindle misorientation (Toyoshima & Nishida 2007). 
The actin cytoskeleton provides information about the cell´s shape and adhesion. The 
distribution of adhesions in interphase cells was described to determine the mitotic spindle 
orientation (Théry et al. 2005). Thereby, the actin cytoskeleton is associated with membrane 
ruffles in interphase, which contain microtubule stabilizing proteins such as APC (Etienne-
Manneville & Hall 2003) and motor proteins such as dynein (Busson et al. 1998). These 
proteins remain located in this area during cell division and promote the localization of the 
spindle poles (Dujardin et al. 2003). Additionally, forces generated by retraction fibers lead to 
Arp2/3-based subcortical actin structures in mitotic cells, which exert pulling forces on the 
mitotic spindle (Fink et al. 2011). These actin structures are possibly coupled to 
microtubules, thereby influencing spindle positioning, but its function is largely unknown. 
 
1.7 Chromosomal Instability And Aneuploidy 
Accurate progression of mitosis is pivotal to ensure a correct euploid karyotype. However, 
many human diseases including cancer and neurodegenerative diseases are characterized 
by aneuploidy. A common cause for aneuploidy in human cancer cells is chromosomal 
instability (CIN) (Lengauer et al. 1997). One can distinguish between structural chromosomal 
instability (S-CIN) that describes the susceptibility to structural rearrangements including 
translocations, deletions, inversions and duplications of chromosomal parts (Ricke et al. 
2008; Thompson et al. 2010) and whole chromosomal instability (W-CIN), which is defined 
as the perpetual gain or loss of whole chromosomes during mitosis. In a typical aneuploid 
cancer cell, one chromosome in every one to five cell divisions becomes missegregated 
(Lengauer et al. 1997; Thompson & Compton 2008). It is thought that these low 
missegregation rates allow the acquirement of new cancer phenotypes and the adaptation to 
the environment (Thompson et al. 2010). In contrast, high rates of chromosome 
missegregation induced by a highly deregulated mitosis are lethal (Kops et al. 2004). 
Furthermore, CIN and aneuploidy is of disadvantage for tumor growth, probably caused by 
metabolic changes and proteotoxic stress (Torres et al. 2007; Sheltzer & Amon 2011; Ertych 
et al. 2014). 
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The molecular mechanisms causing CIN in human cancer cells are not well understood, but 
could involve abnormalities during interphase as well as various alterations in mitotic 
progression (Orr & Compton 2013). 
A controversially discussed mechanism is an impaired spindle assembly checkpoint (SAC). 
The SAC senses improper kinetochore-microtubule attachments and maintains genomic 
stability by delaying the metaphase-to-anaphase-transition until all chromosomes are 
amphitelically attached (Fig. 1.5). A defective SAC leads to a premature anaphase onset in 
the presence of faulty kinetochore-microtubule attachments, resulting in chromosome 
missegregation. However, in human cancer cells exhibiting CIN, a weakened SAC due to 
mutations in SAC related genes is rarely found (Tighe et al. 2001; Barber et al. 2008) and the 
complete loss of SAC function was even shown to be lethal (Kops et al. 2004). 
Chromosome missegregation can also result from the presence of supernumerary 
centrosomes, which occur from an aberrant cytokinesis or from defects in centrosome 
biogenesis or centrosome amplification during interphase. In principal, cells containing more 
than two centrosomes can build up a multi-polar spindle resulting in massive chromosome 
missegregation. However, this was shown to be unviable for progenies arising from multi-
polar cell divisions (Ganem et al. 2009). Instead, supernumerary centrosomes often cluster 
to form a pseudo bi-polar spindle (Brinkley 2001). But still, the transient occurrence of a 
multi-polar spindle promotes transient spindle geometry defects, erroneous kinetochore-
microtubule attachments and lagging chromosomes (Ganem et al. 2009), leading to 
chromosome missegregation. 
Lagging chromosomes are widely recognized as a cause for chromosomal instability and 
arise from merotelic kinetochore attachments (Fig. 1.5a). In this case, one kinetochore is 
concomitantly attached to spindle microtubules emanating from the two opposing spindle 
poles (Cimini et al. 2001; Cimini et al. 2002; Thompson & Compton 2008). Normally, sister 
chromatids are attached to opposing poles of the spindle, known as amphitelic attachments. 
During chromosome alignment, one kinetochore becomes attached first and orients towards 
the spindle pole (Rieder & Salmon 1998). This monotelically attached chromosome moves 
poleward until microtubules bind to the unattached kinetochore, resulting in an amphitelic 
attachment and chromosome bi-orientation (Rieder & Salmon 1998; Cimini et al. 2002). But 
errors in kinetochore attachment can occur, including syntelic attachments, where both sister 
chromatids are attached to spindle microtubules emanating from the same spindle pole. In 
addition, merotelic attachments are often detectable in cancer cells (Fig. 1.5a). Merotelic 
attachments support chromosome alignment and the establishment of the metaphase plate, 
but these errors are not detected by the SAC and lead to a chromosome remaining near the 
spindle equator (Cimini et al. 2001) (Fig. 1.5b). During the following cytokinesis, the lagging 
chromosome is distributed onto one of the daughter cells by chance.  
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Figure 1.5: Classification of kinetochore-microtubule attachments. (a) Amphitelic attachments 
describe the state in which both sister kinetochores are attached to spindle microtubules emanating 
from the opposing spindle poles. In case of monotelic attachments, only one kinetochore is attached 
to microtubules emanating from one spindle pole, while syntelic attachments refer to the attachment of 
both sister kinetochores to spindle microtubules emanating from the same spindle pole. Lagging 
chromosomes arise from merotelic attachments, which describes the attachment of sister 
kinetochores to spindle microtubules emanating from the opposing spindle poles, whereby one 
kinetochore is also attached to microtubules from both spindle poles. (b) Merotelic attachments lead to 
the generation of lagging chromosomes during anaphase. The chromatid is randomly segregated onto 
the daughter cells. 
 
 
During progression through mitosis, erroneous attachments can be corrected. Monotelic 
attachments will be sensed by the SAC (Rieder et al. 1995), whereas syntelic attachments 
generate low tension between sister kinetochores (Pinsky & Biggins 2005; Nezi & Musacchio 
2009). Like syntelic attachments, merotelic attachments can be resolved by an error 
correction machinery involving the Aurora B kinase (Cimini et al. 2003; Knowlton et al. 2006; 
Holland et al. 2009). Aurora B is localized to the inner centromere and phosphorylates outer 
kinetochore components like Ndc80 (Cheeseman et al. 2006; DeLuca et al. 2006), Dam1 
(Cheeseman et al. 2002), Ska1 (Chan et al. 2012; Schmidt et al. 2012) and MCAK (Gorbsky 
2004), thereby destabilizing kinetochore-microtubule attachments. However, increased rates 
of the generation of erroneous microtubule-kinetochore attachments might overload the error 
correction machinery leading to the persistence of lagging chromosomes. 
Increased microtubule plus-end assembly rates constitute a novel route to chromosomal 
instability, recently described by our lab (Ertych et al. 2014). MIN/MSI and CIN cell lines were 
analyzed regarding their microtubule plus-end assembly rates during mitosis. These 
analyses revealed elevated rates in all analyzed CIN cell lines. It is assumed, that increased 
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microtubule plus-end assembly rates lead to transient spindle geometry defects, which result 
in hyper-stable kinetochore-microtubule attachments, the occurrence of lagging 
chromosomes and CIN. In turn, restoration of proper microtubule assembly rates by genetic 
means or chemicals suppresses the CIN phenotype. Vice versa, an increase of microtubule 
plus-end assembly rates by genetic means also induced CIN and aneuploidy (Ertych et al. 
2014). 
Furthermore also abnormalities in interphase might contribute to whole CIN. In fact, 
replication stress during S-phase was shown to affect chromosome segregation but this 
observation is still debated (Bakhoum et al. 2014). 
 
1.8 The Ras Homologous (Rho) Family Of Small GTPases  
Small GTPases of the Rho family are intracellular signaling molecules, best known for their 
role in regulating the actin cytoskeleton, in vesicle trafficking, cell cycle regulation and 
transcriptional reprogramming (Cain & Ridley 2009).  
 
                
Fig. 1.6: Regulation of small GTPases of the Rho family. Inactive Rho-GTPases are activated by 
the exchange of GDP for GTP mediated by GEFs. GAPs inactivate Rho-GTPases by catalyzing the 
hydrolysis of GTP to GDP. GDIs bind inactive Rho-GTPases in the cytosol and prevent the nucleotide 
exchange. Modified from Lawson & Burridge 2014 
 
 
Rho GTPases exist in either an inactive GDP-bound form or in an active GTP-bound form 
(Fife et al. 2014). Three different classes of regulatory molecules modulate the activity of the 
Rho-family small GTPases: guanine nucleotide exchange factors (GEFs), GTPase-activating 
Proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs) (Lawson & Burridge 
2014). While GEFs catalyze the exchange of bound GDP for GTP, GAPs stimulate the 
intrinsic GTPase activity, turning the Rho-family proteins into an inactive state. GDIs maintain 
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a cytosolic pool of inactive Rho-family small GTPases. If required, they can be transported to 
cell membranes, where the nucleotide exchange takes place (Leung et al. 1995; Zheng 
2001; Rossman et al. 2005; Bos et al. 2007) (Fig. 1.6). 
Among Rho GTPases, the best-studied members are RhoA, Rac1 and Cdc42 and their role 
during cell motility (Burridge & Wennerberg 2004). For a long time, RhoA was thought to be 
inhibitory for cell migration, since it promotes stress fiber formation and strong adherence 
mediated by focal adhesions (Lawson & Burridge 2014). But RhoA was also found to be 
active at the leading edge of migrating cells, where it is responsible for membrane ruffling 
and the formation of lamellipodia (O’Connor et al. 2000; Machacek et al. 2009; El-sibai et al. 
2009). The switch between stress fiber formation and lamellipodia formation is not well 
understood but might be mediated by two different GEFs, whereby one potentially activates 
Rho at the leading edge and the other one at the rear of the cell (Sadok & Marshall 2014). 
The two homologs RhoA and RhoC were described to have different roles in cell migration 
since they act through different targets (Vega et al. 2011). While RhoC inhibits the 
development of lamellipodia through the formin FMNL3, RhoA promotes tail retraction via its 
effectors mDia (mammalian homolog of Drosophila diaphanous) and ROCK (Rho-associated 
kinase) (Narumiya et al. 2009; Vega et al. 2011). Both are well described regarding their 
roles in stress fiber formation. The activation of mDia and ROCK constitutes the trigger for 
the assembly of actomyosin filaments (Hall 2012). Here, ROCK phosphorylates and 
inactivates the myosin phosphatase and activates myosin light chain, resulting in an 
enhancement of actomyosin contractility (Kimura et al. 1996). Subsequently, contraction 
leads to bundling of actin filaments and clustering of integrins into focal adhesions (Narumiya 
et al. 2009). Actin polymerization itself is then stimulated by mDia. 
During cell motility, RhoA acts in concert with Rac1 and Cdc42 (El-sibai et al. 2009; 
O’Connor et al. 2012). In contrast to RhoA, Rac1 and Cdc42 promote Arp2/3-based actin 
polymerization and branching in the lamellipodium by activating the WAVE or WASP protein 
complexes (Bid et al. 2013; Blanchoin et al. 2014). Effectors of Rac1 and Cdc42 are, among 
others, p21-activated kinase (PAK), WAVE/WASP, IQGAP1 (IQ motif containing GTPase 
activating protein 1) and IQGAP2 (IQ motif containing GTPase activating protein 2) (Kuroda 
et al. 1999). Rac1 activates the p21-activated kinases PAK1, PAK2 and PAK3, which 
themselves activate the actin-binding LIM kinases LIMK1 and LIMK2. These in turn 
phosphorylate the actin binding protein cofilin, thereby inactivating its activity of converting F-
actin into G-actin and allowing actin growth (Ridley 2006; Bid et al. 2013). Rac1 and Cdc42 
were also described to recruit mDia to RhoA, thus facilitating its activity during lamellae 
formation (Kurokawa & Matsuda 2005). 
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Abb 1.7: Rho-family of small GTPases regulating actin remodeling. RhoA promotes actomyosin 
contractility via ROCK. ROCK itself phosphorylates LIMK, thereby leading to inhibition of cofilin. RhoA 
also affects mDIA, which in turn promotes actin polymerization. Rac1 antagonizes RhoA´s function. It 
activates PAK and WAVE. WAVE-dependent activation of Arp2/3 leads to actin polymerization, 
whereas PAK-mediated activation of LIMK results in actin turnover. Cdc42 activates Arp2/3 via 
WASP resulting in actin polymerization. Adapted from Sadok & Marshall 2014. 
 
 
Altered expression or dysregulated activity of the Rho-family of small GTPases is frequently 
associated with tumorigenesis and the development of different cancer types including 
colorectal cancer (Mack et al. 2011). While no mutations for Rho GTPases have been 
described so far, the Rac1-specific GEF TIAM 1 (T-lymphoma invasion and metastasis-
inducing protein-1) and the RhoA-specific GEF RGNEF (p190RhoGEF) were shown to be 
up-regulated in colorectal cancer (Leve & Morgado-Díaz 2012). TIAM 1 was identified as an 
invasion and metastasis gene and shown to be required for the initiation of colon cancer 
growth (Cook et al. 2013). In addition to invasion and metastasis, a mitotic role was also 
suggested for TIAM 1, since it was found to localize to mitotic centrosomes antagonizing the 
function of Eg5 in centrosome separation during prophase (Whalley et al. 2015). In axons, 
TIAM 1 was shown to localize to microtubules via MAP1B (Montenegro-Venegas et al. 
2010). TRIO constitutes another Rac1-GEF with possible functions in mitosis. TRIO was 
identified as a microtubule plus-end binding protein in neurons (Van Haren et al. 2014). In 
these cells, binding is achieved via EB1/Nav1 complexes and requires dynamic 
microtubules. High expression of TRIO is found in different tumor types, including breast and 
lung cancer and glioblastoma and is associated with poor patient prognosis (Schmidt & 
Debant 2014). 
A variety of tumor cells exhibit a deregulated expression or activity of Rho GTPases 
(Boettner & Van Aelst 2002). Especially Rac1 hyperactivation is associated with aggressive 
tumor growth (Bid et al. 2013). Aggressive tumor growth is accompanied by a high migration 
and invasion potential. These processes require the formation of certain cell surface 
extensions like lamellipodia or invadopodia, which emerge from Rac1-mediated 
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reorganization of the actin cytoskeleton (Parri & Chiarugi 2010). Therefore, Rac1 or other 
members of the Rac1 pathway would represent interesting therapeutic targets for anti-cancer 
therapy (Bid et al. 2013).  
 
1.9 Cellular Migration 
The activation of invasion and metastasis represents a hallmark of cancer (Hanahan & 
Weinberg 2011). Upon a migration promoting stimulus the cell starts to polarize and forms 
protrusions into the direction of migration. Thereby, the formation of protrusions is mainly 
driven by actin polymerization, whereas the establishment and maintenance of cell polarity is 
mediated by different factors like Rho-family GTPases, phosphoinositide 3-kinases (PI3Ks), 
vesicular transport and also microtubules (Ridley et al. 2003). Cell migration and invasion 
can be exemplified by a five step model (Lauffenburger & Horwitz 1996; Friedl & Wolf 2003): 
1. Pseudopod protrusion at the leading edge, 2. Formation of a focal contact, 3. Focalized 
proteolysis, 4. Actomyosin contraction, 5. Detachment of the trailing edge (Fig. 1.8). 
Cells can respond to very small differences of chemoattractant concentrations occurring 
between their front and rear. The signaling molecules PtdInst(3,4,5)P3 (PIP3) and 
PtdInst(3,4)P2 (PIP2) rapidly polarize along this gradient, whereby PIP3 is located at the front 
and PIP2 at the rear and the sites of the cell. This leads to the accumulation and activation of 
PI3Ks and PTEN (Phosphatase and Tensin). PTEN is responsible for the cleavage of the 3´ 
phosphate from PIP3 to generate PIP2. Thereby PTEN antagonizes the function of PI3K 
(Yamada & Araki 2001). PI3K accumulates at the leading edge of a cell, whereas PTEN 
localization is confined to the cell´s rear and sides. PIP3 and PIP2 have downstream effects 
on Rac1 and Cdc42 (Yamada & Araki 2001). Several Rac1-GEFs are activated by PI3K 
products. Active Rac1 can then regulate itself via different positive feedback loops. On the 
one hand, active Rac1 is able to recruit and activate PI3Ks at the plasma membrane. On the 
other hand, microtubule polymerization activates Rac1 whereupon Rac1 stabilizes 
microtubules (Waterman-Storer et al. 1999). Both, Cdc42 and Rac1 stimulate actin 
polymerization by activating the Arp2/3 complex via the WASP or WAVE complex, leading to 
the nucleation of a highly branched actin network (Rohatgi et al. 1999; Lawson & Burridge 
2014), thereby inducing pseudopod extension (Nobes & Hall 1995). The growing actin 
filaments bind to a complex consisting of α-actinin, vinculin and paxillin within the cell 
membrane (Calderwood et al. 2000). Continuous actin assembly pushes the cell membrane 
outwards. The growing cell protrusion touches the ECM and transmembrane receptors of the 
integrin family initiate binding to it. Actin filaments are coupled to integrins, which are 
accumulated and clustered at these sides and form a focal contact. These contacts are 
highly dynamic and can therefore stably adhere to or slowly glide along the substratum. 
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Upon binding of integrins, surface proteases like MMP1 (matrix metalloproteinase 1) are 
recruited, which degrade ECM components like collagen, fibronectin and laminins (Ohuchi et 
al. 1997). During invasion, ECM degradation is an important process since it provides space 
for cell expansion and movement 
 
 
Figure 1.8: Model of cell migration. Migration can be divided into five steps: At first, the leading edge 
protrudes due to Arp2/3 mediated actin assembly. Second, a focal contact is formed via clustered 
integrins, whereupon surface proteases cleave ECM components during focalized proteolysis. The 
fourth step involves cell contraction by actomyosin, followed by the detachment of the trailing edge, 
which is mainly driven by focal contact disassembly. Modified from Friedl & Wolf 2013 
 
 
After the initial phase of adhesion, Rac1 activity in the lamellipodium diminishes whereas 
RhoA activity in the rear increases. RhoA promotes the formation of stress fibers and 
mediates the maturation of focal adhesions by activating myosin via Rho kinase (ROCK) 
(O’Connor & Chen 2013; Lawson & Burridge 2014). ROCK inactivates the myosin 
phosphatase by phosphorylating its myosin-binding subunit. Contraction of actin-bound 
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myosin II, leads to bundling of actin fibers (O’Connor & Chen 2013). Actin fibers are 
crosslinked by α-actinin, thereby forming highly regulated actomyosin. Contraction of the 
actomyosin leads to shortening of the cell resulting in an inward tension towards the focal 
contacts (Chew et al. 2002). Cell-substrate-linkages are then resolved preferentially at the 
rear of the cell. Here, the cytoplasmic protease calpain cleaves focal contact components 
(Potter et al. 1997). In contrast, the leading edge stays attached and further elongates (Friedl 
& Wolf 2003). After disassembly of the focal contact, the cell glides forward and detached 
integrins become recycled at the leading edge (Bretscher 1996).  
 
1.10 Microtubules In Cell Migration 
Microtubules are well described for their role in mitotic spindle assembly, but they are not 
only important during cell division, but also required to establish cell polarity during cell 
motility (Bershadsky et al. 1991). Already in 1970, the inhibitory effect of spindle poisons onto 
fibroblasts and their locomotory behavior was reported (Vasiliev et al. 1970). However not 
only a full depolymerization of microtubules but also abolished microtubule dynamics was 
detected to alter cell motility (Liao et al. 1995). Nowadays, it is well established, that 
microtubule dynamics polarize a motile cell in an asymmetric fashion. The main 
characteristic of the polarized microtubule cytoskeleton is its alignment with the cell migration 
axis (Etienne-Manneville 2013). Microtubules predominantly grow towards the leading edge 
and only few of them reach the cell´s rear (Etienne-Manneville 2013). Furthermore, 
polarization is achieved by microtubule stabilization in the leading edge and microtubule 
destabilization at the trailing edge (Kaverina & Straube 2011). At the front of a cell, 
microtubules are captured and stabilized at cortical sides by several +TIPs including CLASP1 
and CLASP2 (Mimori-Kiyosue et al. 2005), CLIP-170 (Fukata et al. 2002) and EB3 (Straube 
& Merdes 2007). Furthermore, leading edge microtubules are also target of Rho-GTPase 
regulation (Wittmann et al. 2003). On the one hand microtubules activate Rac1, thereby 
promoting lamellipodia formation, through delivering GEFs such as TIAM 1, TIAM 2 or TRIO 
(Waterman-Storer et al. 1999; Blangy et al. 2000; Rooney et al. 2010). But in a positive 
feedback loop, this enhanced activity of Rac1 further selectively promotes persistent growth 
of leading edge microtubules (Wittmann et al. 2003). Thereby, activation of Rac1 results in 
PAK1-mediated phosphorylation of the microtubule destabilizing protein Stathmin/Op18 
(Daub et al. 2001). Due to this inactivation, catastrophe events are diminished and 
microtubule growth is promoted (Larsson et al. 1997).  
At the rear of a cell, catastrophes are observed especially at focal adhesion sides 
(Bershadsky et al. 1996; Salaycik et al. 2005; Efimov et al. 2008). In fibroblasts, dynamic 
microtubules target mature focal adhesions. Due to their dynamic instability, microtubules 
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can repeatedly contact a focal adhesion, resulting in its disassembly (Kaverina et al. 1998; 
Krylyshkina et al. 2003). Furthermore, depolymerizing microtubules at the trailing edge result 
in the activation of RhoA via its GEF GEF-H1 (Ren et al. 1999; Waterman-Storer et al. 1999), 
leading to the formation of stress fibers and increased contractility (Bershadsky et al. 1996). 
Thus, microtubules transduce signals to the cell migration machinery depending on their 
dynamic behavior (Kaverina & Straube 2011): GEFs binding to microtubules can either be 
sequestered and inactivated by growing microtubules or released and activated by 
catastrophe events (Nalbant et al. 2010; Chang et al. 2007).  
Hence, changes in microtubule dynamics implies alterations of cell migration (Kaverina & 
Straube 2011). Microtubule associated proteins (MAPs) regulate the dynamic behavior of 
microtubules. EB1 and APC stabilize microtubules at the leading edge in a RhoA-mDia-
mediated fashion (Wen et al. 2004). EB1 and EB3 were described to suppress catastrophes 
but they promote persistent microtubule growth (Komarova et al. 2009). EB1 was also shown 
to increase membrane protrusion and cell migration in melanoma cells (Schober et al. 2009). 
In these cells, depletion of EB1 resulted in a loss of polarized cell morphology. Furthermore, 
APC accumulates at leading edge microtubules, promotes their growth and diminishes 
shrinkage, thus exerting a stabilizing function (Kita et al. 2006). Interestingly, microtubules in 
the leading edge are often post-translationally modified by acetylations or detyrosination 
(Gundersen & Bulinski 1988), resulting in increased stability (Tran et al. 2007) and a 
potentially increased recruitment of MAPs (Etienne-Manneville 2013). 
Additionally, microtubules serve as tracks for directed membrane and organelle transport, 
thereby providing building material for protrusion formation (Nabi 1999) as well as molecular 
motors for focal adhesion turnover (Krylyshkina et al. 2002), which is mediated by integrin 
recycling (Pellinen & Ivaska 2006). Furthermore, endosomes carry membrane-associated 
molecules such as Rac1 and Cdc42, that are delivered to the plasma membrane 
(Palamidessi et al. 2008; Osmani et al. 2010). The traffic is facilitated by the existence of 
long microtubule tracks between the cell center and the periphery (Komarova et al. 2009). 
In cancer, the microtubule-dependent control of cell migration is often impaired (Kaverina & 
Straube 2011). 
 
1.11 Cell Invasion 
The motility of a cell is often studied in 2D, where a cell migrates on a substratum towards a 
chemoattractant forming filopodia and lamellipodia. In contrast, invasion is the process of 
moving into or within a 3D matrix (Fife et al. 2014), which can arise from an aberrant 
regulation of cell migration (Sahai 2005; Yamaguchi et al. 2005). The invasion process 
occurs during cell morphogenesis, wound healing and in malignant cells allowing the 
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metastatic growth into distant organs (Friedl & Wolf 2003). Therefore, tumor cells need to 
detach from the primary tumor, invade the surrounding tissue, intravasate the blood or 
lymphatic vessels, extravasate into distant organs and grow to form secondary tumors 
(Hofmann et al. 2000). For these processes, specialized structures like invadopodia and 
podosomes and the proteolysis of the extracellular matrix (ECM) are required (Friedl & Wolf 
2003). Podosomes are sides of contact to the substratum similar to focal adhesions, but they 
differ in some criteria. In contrast to focal adhesions, podosomes contain actin organizing 
structures like the Arp2/3 complex, N-WASP and fimbrin, which is an actin bundling protein 
(Buccione et al. 2004). Furthermore, they are more dynamic and form from pre-existing 
podosomes and therefore do not require ongoing protein synthesis (Buccione et al. 2004). 
Podosomes continuously probe the substratum and invadopodia are formed by their 
extension (Buccione et al. 2004). Invadopodia are membrane protrusions with ECM 
degradation activity (Buccione et al. 2004) and their formation is dependent on Arp2/3 
activity. The knock down of Arp2/3 was shown suppress the development of these 
membrane protrusions (Yamaguchi et al. 2005). In malignant cells, an excessive cell 
protrusive activity was found, which is mainly driven by aberrant signaling regarding the 
activation of actin rearrangements (Wang et al. 2004). This signature of invasion involved 
deregulated genes in mammary tumors further includes LIMK1 (LIM-kinase 1), CFL1 (cofilin) 
and ACTN3 (actinin) (Wang et al. 2004). 
The degradation and remodeling of the ECM requires matrix-metalloproteinases (MMPs) 
(Coussens & Werb 1996; Chambers & Matrisian 1997). Several MMPs interact with surface 
receptors like integrins or are located to the ECM (Kessenbrock et al. 2010). The up-
regulation of MMPs is often found in human cancers including breast cancer and melanoma 
(Rudolph-Owen et al. 1998; Hofmann et al. 2000). Interestingly, in breast cancer, the 
activation of MMPs was implicated in tumor progression and promotion of EMT (Radisky & 
Radisky 2010). The direct activation of the EMT program is mediated by MMP-3 stimulated 
expression of a constitutively active Rac1 splice variant (Rac1b), which increases reactive 
oxygen species in the cell, resulting in expression of SNAIL and induction of EMT (Radisky et 
al. 2005). Furthermore, MMP-3 is able to cleave E-cadherin, resulting in a bioactive E-
cadherin fragment, which is capable of stimulating cancer cell motility (Lochter et al. 1997; 
Noë et al. 2001). 
 
1.12 Epithelial-Mesenchymal-Transition (EMT) 
Cancer cells invade into tissues by moving as single epithelial or amoeboid cells or as 
clusters. Thereby, the process of invasion accompanies morphological and phenotypical 
changes (Van Zijl et al. 2011). 
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The epithelial-mesenchymal-transition (EMT) is a conserved mechanism occurring during 
embryogenesis, chronic inflammation and fibrosis, but it is also a common process during 
cancer progression and the development of metastasis (Van Zijl et al. 2011). A hallmark of 
EMT is the loss of epithelial characteristics. Instead, the cell gains mesenchymal features 
(Spaderna et al. 2006). As a result, cells destabilize cell-cell-contacts due to the 
downregulation of CDH1, encoding for epithelial E-cadherin (Thiery & Sleeman 2006). E-
cadherin exhibits an extracellular domain, which enables binding to E-cadherins of a 
neighboring cell. Downregulation of CDH1 is mediated by the transcriptional repressors 
Snail/SNAI1, Slug/SNAI2, SIP1/ZEB2 or Twist. The disassembly of adherence junctions 
leads to the translocation of membrane bound β-catenin into the nucleus. There, it affects the 
transcription of genes like c-myc or cyclin D (Van Zijl et al. 2011). Subsequently, 
mesenchymal markers are upregulated. Among them, N-cadherin is responsible for the 
formation of Rho-induced stress fibers and activation of Rac1 and Cdc42, leading to the 
development of filopodia and lamellipodia. Cells, that have undergone EMT, are also able to 
regain epithelial properties. The mesenchymal-epithelial-transition (MET) leads to epithelial 
reorganization resulting in the ability for colonization at secondary sites, which is an 
important process during metastasis (Van Zijl et al. 2011). Thus, EMT can contribute or even 
be a prerequisite for cancer cell migration and invasion. 
 
Scope Of The Study 
Chromosomal instability is a hallmark of most solid tumors (Orr & Compton 2013) and has 
been associated with tumorigenesis and the development of therapy resistance (Bakhoum & 
Compton 2012). CIN enables the development of genetic heterogeneity and thus the 
emergence of novel phenotypes in cancer cells. Among them, cell migration and invasion are 
major characteristics that are acquired during the development of aggressive metastatic 
human tumors (Hanahan & Weinberg 2000). Both, CIN and cancer cell invasion are 
associated with tumor stage and poor patient prognosis. Although both phenotypes often 
appear concomitantly in late tumor stages, little is known about a possible shared link 
between CIN and cancer cell migration and invasion. Thus, the aim of this study was to 
investigate a potential shared mechanistic link between the development of CIN and a highly 
migratory and invasive phenotype. 
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2 Material and Methods 
2.1 Material 
The used working materials including cell culture dishes, pipette tips, disposable syringes 
and reaction tubes were purchased from Sarstedt (Nümbrecht, Germany), Greiner BioOne 




Table 2.1 lists the equipment, which was used for the implementation of this study. 
 
Table 2.1: Equipment 
Equipment Model Company 
CO2 Incubator HERAcell 240 CO2 Incubator 
Thermo Fisher Scientific, Karlsruhe, 
Germany 
Cooling Centrifuge Multifuge X3R 









Power Supply EV231 Peqlab, Erlangen, Germany 
Flow Cytometer BD FACSCanto© II 
Becton Dickinson, San Jose, CA, 
USA 
Gel Documentation Gel iX Imager Intas, Göttingen, Germany 
Heating Block 
Thermomixer Comfort R Eppendorf, Hamburg, Germany 
TDB-120 Dry Block 
Thermostat 




Sub-Cell GT cell 
BioRad Laboratories, München, 
Germany 
Laboratory Scale Sartorius Research R200D Sartorius, Göttingen, Germany 
Magnetic Mixer IKAMAG© RCT IKA Labortechnik, Stauffen, Germany 
Medical X-Ray Film Fuji Super RX 
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Equipment Model Company 
Microscope 
Delta Vision Elite© 
Applied Precision, Chalfont St. Giles, 
UK 
Leica DMI6000B Leica, Wetzlar, Germany 
Zeiss Axio Imager Z1 Zeiss, Göttingen, Germany 
Microscope Camera  
sCMOS camera 
GE Healthcare, Chalfront St. Giles, 
UK 
Leica DFC369 FX Leica, Wetzlar, Germany 
Hamamatsu 1394 ORCA-II 
ER 





Hamamatsu Photonics, Hamamatsu, 
Japan 
Multilabel Reader Victor© X3 PerkinElmer, Rodgau, Germany 
Nitrocellulose 
Membrane 
Protran BA 83 
GE Healthcare, Chalfront St. Giles, 
Great Britain 
Pipettes Pipetman© 
Gilson International, LimburgOffheim, 
Germany 
Pipettor Pipetboy acu 
Integra Biosciences, Fernwald, 
Germany 
PVDF Membrane ImmobilionR-P Merck Millipore, Darmstadt, Germany 
Semidry Western 
Blotting Device 
Perfect Blue© Peqlab, Erlangen, Germany 
Sterile Workbench HERAsafeM 
Thermo Fisher Scientific, Karlsruhe, 
Germany 
Spectrophotometer NanoDrop 2000 
Thermo Fisher Scientific, Karlsruhe, 
Germany 
Tabletop Centrifuge Biofuge pico 










 Own Manufacturing 
Vortex Mixer VORTEX-GENIE© 2 
Scientific Industries inc., Bohemia, 
NY, USA 








The following table lists the software, which was used for data analyses. 
 
Table 2.2: Software 
Software Company 
Hokawo Launcher Hamamatsu Photonics, Hamamatsu, Japan 
ImageJ NIH Image, Bethesda, MD, USA 
Leica Application Suite Leica, Wetzlar, Germany 
Soft Worx© 5.0 Applied Precision Inc., Issaquah, WA, USA 
 
2.1.3 Chemicals 
All used chemicals were purchased from Carl Roth (Karlsruhe, Germany), Sigma-Aldrich 
(Taufkirchen, Germany), VWR International (West Chester, PA, USA), BD Biosciences 
(Heidelberg, Germany), Fermentas (St. Leon-Roth, Germany), Promega (Madison, WI, 
USA), Merck Millipore (Darmstadt, Germany), Roche Diagnostics (Mannheim, Germany), 
Thermo Fisher Scientific (Waltham, MA, USA), Th. Geyer (Renningen, Germany), Enzo Life 
Sciences (New York, NY, USA) AppliChem (Darmstadt, Germany), Amersham Biosciences 
(Buckinghamshire, Great Britain). 
Table 2.3 lists chemicals and inhibitors used in this study and their respective working 
concentration. 
 





Adriamycin 600 nM 
Intercalates into DNA 
and stabilizes 
topoisomerase II 
Th. Geyer, Höxter, Germany 
CK666 20 µM 
Inhibition of actin 
assembly by the Arp2/3 
complex 
Merck Millipore, Darmstadt, 
Germany 
Dimethylenastron 2 µM Inhibition of EG5-kinesin 
Calbiochem, La Jolla, CA, 
USA 
Doxycycline 200 ng/ml 




ITX3 15 µM 
Inhibition of GEF-activity 
of TRIO 
Merck Millipore, Darmstadt, 
Germany 












NSC23766 40 µM Inhibition of Rac1 
Santa Cruz, Dallas, TX, 
USA 
Ponasterone A 5 µmol/l 




Puromycin 1 µg/ml Inhibition of translation 
Sigma-Aldrich Taufkirchen, 
Germany 












Thymidine 2 mM 







Primary antibodies, including their host species, antibody type and the used dilutions are 
listed in Table 2.4. 
 






Used Dilution Company 
α-Tubulin (B-5-1-
2) 
mouse monoclonal IF 1:700 Santa Cruz, Dallas, TX, USA 





mouse monoclonal WB 1:750 Santa Cruz, Dallas, TX, USA 
EB1 
(clone 5) 
mouse monoclonal WB 1:500 




Mouse Monoclonal WB 1:1000 
















human polyclonal IF 1:700 
Europa Bioproducts, Wicken, 
Ely, UK 







Used Dilution Company 
MCAK sheep polyclonal WB 1:250 
Kindly provided by Prof. Linda 
Wordemann (Seattle, WA, 
USA) 
Mep21 mouse polyclonal IHC 1:500 
Kindly provided by Prof. Jörg 
Wilting (Göttingen, Germany) 
p21  
(Ab-1) 
mouse monoclonal WB 1:1000 




mouse monoclonal WB 1:800 




rabbit monoclonal WB 1:1000 GeneTex, Irvine, CA, USA 
Rac1 
(Arc03) 
mouse monoclonal WB 1:500 




goat Polyclonal WB 1:300 Santa Cruz, Dallas, TX, USA 
 
Secondary Antibodies 
Table 2.5 lists the used secondary antibodies including the host species, antibody type, the 
conjugated molecule and the used concentration. 
 





















Anti-Rabbit goat polyclonal 
Alexa-
Fluor594 
IF 1:1000  
Invitrogen, Carlsbad, 
CA, USA 
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2.1.5 Chromosome Enumeration Probes 
The used chromosome enumeration probes including the chromosome region of their 
hybridisation are listed in Table 2.6. 
 
Table 2.6: Chromosome Enumeration Probes 
 
Chromosome Chromosome Region Company 
6 6p11.1-q11.1 Cytocell aquarius, Cambridge, UK 
7 7p11.1-q11.1 Cytocell aquarius, Cambridge, UK 
15 15p11.1-q11.1 Cytocell aquarius, Cambridge, UK 
18 18p11.1-q11.1 Cytocell aquarius, Cambridge, UK 
 
2.1.6 Oligonucleotides 
The oligonucleotids used in this study were synthesized by Sigma-Aldrich (Taufkirchen, 
Germany) and stored at -20°C. 
qRT-PCR Primer 
The qRT-PCR primer used for this study and their respective sequence are listed in Table 
2.7. 
 
Table 2.7: qRT-PCR Primer 
Gene Primer Reference 
36B4 
forward 5´-GATTGGCTACCCAACTGTTG-3´ Kindly provided by Matthias 
Dobbelstein (Göttingen, Germany) reverse 5´-CAGGGGCAGCAGCCACAAA-3´ 
CDKN1A 
forward 5´-TAGGCGGTTGAATGAGAGG-3 Kindly provided by Matthias 














Table 2.8 lists the used siRNAs, their sequence and the corresponding reference. 
 
Table 2.8: siRNAs 
Target Gene Sequence Reference 
CDKN1A 5´-AAUCCCAGCUACUUGGAAGGC-3´ Zhang et al. 2005 
CKAP5 5´-GAGCCCAGAGTGGTCCAAA-3´ De Luca et al. 2008 
EB1 5´-AUUCCAAGCUAAGCUAGAA-3´ Watson & Stephens 2006 
LUCIFERASE 5´-CUUACGCUGAGUACUUCGAUU-3´ Elbashir et al. 2001 
RB 5´-AAGUUUCAUCUGUGGAUGGAG-3´ Guo et al. 2011 
TP53 
5´-GUAAUCUACUGGGACGGAA-3´ Ertych et al. 2014 
5´-GACUCCAGUGGUAAUCUAC-3´ Brummelkamp et al. 2002 
TP73 
5´-CAGGUGACCGACGUCGUGAAA-3´ 










The used plasmids including their purpose and reference are listed in Table 2.9. 
 
Table 2.9: Plasmids 
Vector Purpose Reference 
pcDNA3.1 
CMV-promotor driven 
expression vector for human 
cells  
Invitrogen, Carlsbad, CA, USA 
pcDNA3.1-△Np73 
CMV-promotor driven 
expression of △Np73 in 
human cells 
Kindly provided by Prof. 
Matthias Dobbelstein 
(Göttingen, Germany) 
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Vector Purpose Reference 
pcDNA3.1-E1A 
CMV-promotor driven 
expression of E1A in human 
cells 





expression of E7 in human 
cells 





expression of MCAK in 
human cells 
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA) 
pcDNA3.1-CDKN1A 
CMV-promotor driven 
expression of TP21 in 
human cells 











expression of GFP-tagged 
CKAP5 in human cells 
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA) 
pEGFP-EB3 
CMV-promotor driven 
expression of GFP-tagged 
EB3 in human cells 
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA) 
pEGFP-HMMR 
CMV-promotor driven 
expression of GFP-tagged 
HMMR in human cells 
Kindly provided by Prof. Tony 




tagged EB3 in human cells 
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA) 
pEGFP-Rac1 Q61L 
CMV-promotor driven 
expression of GFP-tagged 
constitutively active Rac1 in 
human cells 
Kindly provided by Prof. Robert 
Grosse (Marburg, Germany) 
pEGFP-Rac1 T17N 
CMV-promotor driven 
expression of GFP-tagged 
dominant negative Rac1 in 
human cells 
Kindly provided by Prof. Robert 
Grosse (Marburg, Germany) 
pInducer 
Doxycycline inducible 
expression vector for human 
cells 
Kindly provided by Prof. 




expression of TAp73α in 
human cells 
Kindly provided by Prof. 
Thorsten Stiewe (Marburg, 
Germany) 
pLOK.1-sh-TP73 
Expression of a TP73 
shRNA in human cells 
Kindly provided by Prof. 
Matthias Dobbelstein 
(Göttingen, Germany) 
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expression of p53 R175H in 
human cells 




2.1.8 Human Cell Lines 
Table 2.10 provides the used human cell lines, their origin and references. 
 
Table 2.10: Human Cell Lines 
Cell Line Origin Reference 
HCT116 colon carcinoma Brattain et al. 1981 
SW48 colon carcinoma Leibovitz et al. 1976 
SW620 colon carcinoma Leibovitz et al. 1976 
SW480 colon carcinoma Leibovitz et al. 1976 
SW837 rectum carcinoma Leibovitz et al. 1976 
CaCo2 colon carcinoma Heinen et al. 1995 
HT29 colon carcinoma Adachi et al. 1987 
LS411N colon carcinoma Suardet et al. 1992 
LS513 colon carcinoma Suardet et al. 1992 
Colo201 colon carcinoma Semple et al. 1978 
LoVo colon carcinoma Drewinko et al. 1976 
HCT116-TP53-/- colon carcinoma Langermann 1998 
HCT116-TP73 shRNA colon carcinoma kindly provided by Dr. Daniela 
Kramer (Göttingen, Germany) 
RKO colon carcinoma Brattain et al. 1984 
RKO CDKN1A inducible colon carcinoma Schmidt et al. 2000 
SK-Mel-19 melanoma Carey et al. 1976 
SK-Mel-28 melanoma Carey et al. 1976 
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Cell Line Origin Reference 
SK-Mel-103 melanoma Gruis et al. 1995 
SK-Mel-147 melanoma Gruis et al. 1995 
 
Generated Human Cell Lines 
The following table lists the cell lines that were generated during this study. 
 
Table 2.11: Generated Human Cell Lines  
Cell line Parental cell line Plasmid 
Selection 
Marker 
HCT116-TP53-/-- ctr HCT116 TP53-/- pRetroSuper-scrambled  Puromycin 
HCT116-TP53-/-- 
TP73 shRNA 
HCT116 TP53-/- pLKO.1-sh-TP73 Puromycin 
HCT116- ctr HCT116 pInducer20 Puromycin 
HCT116- TAp73α HCT116 pInducer20-TAp73α Puromycin 
HCT116-TP53-/- - ctr HCT116 TP53-/- pInducer20 Puromycin 
HCT116-TP53-/- -
TAp73α 
HCT116 TP53-/- pInducer20-TAp73α Puromycin 
HCT116-TP53-/-- 
TP73 shRNA- ctr 
HCT116 TP53-/- pInducer20 Puromycin 
HCT116-TP53-/-- 
TP73 shRNA-TAp73α 
HCT116 TP53-/- pInducer20-TAp73α Puromycin 
HCT116-p53-R175H- 
ctr 
HCT116 p53 R175H pRetroSuper-scrambled  Puromycin 
HCT116-p53-R175H- 
TP73 shRNA 
HCT116 p53 R175H pRcCMV-p53-R175H-72R Puromycin 
 
Cultivation of Human Cells 
Human cells were cultivated at 37°C and 5% CO2. Cells were cultured in RPMI medium 
(Sigma-Aldrich, Taufkirchen, Germany) supplemented with 10% FCS (GE Healthcare, 
Chalfont St. Giles, Great Britain), 100 µg/ml streptomycin and 100 U/ml penicillin (Sigma-
Aldrich, Taufkirchen, Germany). Cells were passaged three times a week. For this, cells 
were washed once with PBS and detached by using trypsin (Sigma-Aldrich, Taufkirchen, 
Germany). A defined amount of cell suspension was transferred to a new cell culture dish. 
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On a long term basis, cells were stored in liquid nitrogen. Therefore, cells were harvested 
and resuspended in freezing medium (70% RPMI, 20% FCS and 10% DMSO), slowly cooled 
to -80°C using a cryo 1°C freezing container and transferred to the vapor phase of liquid 
nitrogen. 
 
2.2 Cell Biological Methods 
2.2.1 Transfection Of Human Cells 
Transfection Using siRNA 
Cells were seeded at 70% density in 6-well plates 24 h prior to transfection. siRNA 
transfections were performed by using INTERFERin reagent (Polyplus, Illkirch, Frankreich). 
60 pmol siRNA were diluted in 189 µl serum free medium. 5 µl INTERFERin were added and 
the mixture was vortexed for 10 s. After incubating for 10 min at room temperature the 
mixture was dropped onto the cells. The medium was changed after 4 h and the knock down 
of respective targets was checked 48 h after transfection. 
 
Plasmid Transfection Using Electroporation 
Cells were harvested by centrifugation at 1000 rpm for 5 min and resuspended in a 
concentration of 5x106 cells/ml in RPMI medium. 10-50 µg of plasmid DNA was added to 400 
µl cell suspension. Electroporation was performed in a 4 mm-cuvette at 300 V and 500 µF 
(HCT116, SW48, RKO, SW480, SW620, CaCo2, HT29), 220 V and 950 µF (SW837, 
LS411N, LS513, Colo201, LoVo) or 200 V and 500 µF (SK-Mel-19, SK-Mel-28, SK-Mel-103, 
SK-Mel-147). Cells were transferred into RPMI medium. After 6 h, cells were washed once 
with PBS and supplemented with fresh RPMI medium. Analyses were performed after 48 h. 
 
Plasmid Transfection Using Polyethylenimin (PEI) 
Cells were seeded at 70% density in 6-well plates 24 h prior to transfection. Before 
transfection, the cells were washed with PBS and supplemented with fresh culture medium. 
For transfection, two solutions were prepared: solution A contained 100 µl PBS mixed with 2-
7 µg plasmid DNA, whereas solution B contained 95 µl PBS mixed with 5 µl PEI (0.0025% 
final concentration). Both solutions were mixed by pipetting and were incubated at room 
temperature for 15 min. The mixture was dropped onto the cells and after 4 h cells were 
washed three times and supplemented with fresh RPMI medium. Analyses were performed 
after 48 h. 
                         Material and Methods 
45 
 
Plasmid Transfection Using METAFECTENE© 
Cells were seeded at 70% density in 6-well plates 24 h prior to transfection. For the 
generation of stable expression cell lines, METAFECTENE© (Biontex Laboratories GmbH, 
Martinsried, Germany) was used. Two solutions were prepared: solution A contained 100 µl 
PBS mixed with 2 µg plasmid DNA, solution B contained 100 µl PBS mixed with 6 µl 
METAFECTENE©. Both solutions were mixed and incubated at room temperature for 15 min. 
Afterwards, the mixture was dropped onto the cells. 6 h after transfection cells were washed 
twice with PBS and supplemented with fresh cell culture medium.  
 
2.2.2 Generation Of Stable Cell Lines 
For the generation of cell lines stably expressing plasmid DNA cells were transfected with 
METAFECTENE©. 24 h after transfection, cells were seeded in different dilutions (1:250, 
1:500, 1:1000, 1:5000) into RPMI medium containing 1 µg/ml puromycin. Puromycin enables 
the selection of successfully transfected cells. Analyses of the single cell clones were 
performed after 30 generations. 
 
2.2.3 Karyotype Analyses 
Chromosome Spreading 
Cells were treated with 150 nM Taxol for 4 h. After centrifugation at 2000 rpm for 5 min, cells 
were resuspended in 2 ml hypotonic solution (40% RPMI medium, 60% aqua dest.) and 
incubated for 20 min at room temperature. Afterwards, cells were fixed with 1 ml ice-cold 
Carnoy´s fixative (75% methanol, 25% glacial acetic acid) and centrifuged for 5 min at 2000 
rpm. The fixation step was repeated three times. Subsequently, cells were resuspended in 
500 µl 100% glacial acetic acid and dropped onto a pre-cooled, wet object slide, which was 
in turn incubated for 5 min at 42°C. Dried slides were stained in 8% Giemsa staining solution 
(Merck, Darmstadt, Germany) in H2O for 25 min. Slides were washed and dried at room 
temperature and embedded in Euparal (Carl Roth, Karlsruhe, Germany). Object slides were 
analyzed using Zeiss Axioscope FS microscope (Zeiss, Oberkochen, Germany) equipped 
with a Hamamatsu C4742-95 camera and the Hokawo Launcher 2.1 software (Hamamatsu 
Photonics, Hamamatsu, Japan) 
 
CEP-FISH 
Asynchronously growing cells were harvested by centrifugation at 2000 rpm for 5 min, 
resuspended in hypotonic solution, fixed by using Carnoy´s fixative and dropped onto 
coverslips as described above. 
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Object slides were incubated in 2x SCC solution (0.3 M sodium chloride, 30 mM trisodium 
citrate, pH 7.0) for 2 min at room temperature. After dehydration in an alcohol series of 70%, 
85% and 100% ethanol for 2 min each, object slides were air dried. 0.6 µl of each probe 
specific for chromosome 7 and chromosome 15 or chromosome 6 and chromosome 18 were 
added to the hybridization solution and pre-warmed for 5 min at 37°C. Cells were covered 
with the probe mixture. Sample and probe were heated for 2 min at 75°C and placed for 2 h 
at 37°C. Afterwards, the cover slip was immersed in 0.25x SSC at 72°C for 4 min (CRC cell 
lines) or 6 min (melanoma cell lines). Thereafter, the cells were incubated in 2x SSC 
containing 0.05% Tween-20 at room temperature for 5 min and stained with Hoechst 33342 
in 2x SSC + 0.05% Tween-20 for 5 min. Object slides were washed three times with 2x SSC 
+ 0.05% Tween-20, dried and embedded in Vectashield (Vector Laboratories, Burlingame, 
CA, USA). Analyses were performed on a DeltaVision Elite microscope. 
 
2.2.4 Synchronization Of Human Cells 
Cell Cycle Synchronization via Double Thymidine Block 
Cell cycle synchronization of human cells at the G1-/S-transition was achieved by a double 
thymidine block. Cells were grown in 2 mM thymidine for 16 h. After washing the cells five 
times with PBS, they were released into fresh culture medium for 8 h. Following, cells were 
seeded in 2 mM thymidine for another 16 h. Cells were washed five times with PBS and 
released into fresh culture medium. For the analysis of lagging chromosomes, cells were 
fixed 8.5 h (CRC cell lines) or 9.5 h (melanoma cell lines) after release from thymidine. 
 
Mitotic Synchronization 
Synchronization of cells in mitosis was achieved by treatment with 2 µM DME for 16 h.  
 
2.2.5 Immunofluorescence Microscopy 
Cells were fixed for immunofluorescence microscopy by using 2% paraformaldehyde in 
PHEM buffer (60 mM PIPES pH 7.0, 27 mM HEPES, 10 mM EGTA, 4 mM MgCl2) for 5 min 
at room temperature followed by 5 min methanol fixation at -20°C. In order to avoid 
unspecific antibody binding, cells were blocked with 5% FCS in PBS for 30 min. Afterwards, 
cells were incubated with primary antibodies in PBS containing 2% FCS for 1.5 h at room 
temperature. Afterwards, cells were washed three times with PBS and incubated with 
fluorescence-labeled secondary antibody for 1.5 h at room temperature. After washing once 
with PBS, cells were incubated in Hoechst33342 (1:15000 in PBS) (Invitrogen, Carlsbad, CA, 
USA) for 5 min and washed three times with PBS. Object slides were dried and embedded 
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using VectaShield (Vector Laboratories, Burlingame, CA, USA). Cells were analyzed using a 
Leica DM600B fluorescence microscope equipped with an ORCA-ER camera. Images were 
taken in a 60x magnification with a z-optical spacing of 0.2 µm. Deconvolution and further 
analyses were performed using the Leica LAS-AF software. Alternatively, a DeltaVision Elite 
microscope (GE Healthcare, Chalfont St. Giles, Great Britain) equipped with a PCO Edge 
sCMOS camera (PCO, Kelheim, Germany) was used. Images were taken with an Olympus 
60x 1.40 NA objective (Olympus, Tokio, Japan) with a z-optical spacing of 0.4 µm, 
deconvolved and further analyzed using the Softworx 5.0 software. 
 
2.2.6 Analyses Of Spindle Orientation 
Asynchronously growing cells were seeded onto fibronectin coated coverslips (BD 
Biosciences, Heidelberg, Germany). Cells were fixed using ice cold methanol for 6 min at  
-20°C, blocked by using 5% FCS in PBS for 20 min and stained for α-tubulin, ɣ-tubulin and 
DNA. Microscopy was performed on a DeltaVision-ELITE microscope (GE Healthcare, 
Chalfont St. Giles, Great Britain) equipped with a PCO Edge sCMOS camera (PCO, 
Kelheim, Germany). Images were acquired with an Olympus 60x 1.40 NA objective 
(Olympus, Tokio, Japan) with a z-optical spacing of 0.4 µm, deconvolved and analyzed using 
SoftWorx 5.0 software (Applied Precision Inc., Issaquah, WA, USA). Determination of spindle 
orientation was calculated using the following formula: spindle axis angle= (number of z-
stacks*0.4 µm / distance of centrosomes) *180/ π. 
 
                          
Fig. 2.1: Schematic illustration for the determination of the spindle axis angle. 
 
2.2.7 Analyses Of Microtubule Plus-End Assembly Rates 
Cells were transfected with 10 µg pEGFP-EB3 plasmid via electroporation 48 h prior to live 
cell analysis. For analysis of microtubule polymerization rates of monopolar spindles, cells 
were treated with 2 µM DME in phenol red free RPMI medium for 1 h (CRC cell lines) -2 h 
(melanoma cell lines). Live cell analyses were performed at 37°C and 5% CO2 using a Delta 
Vision Elite microscope equipped with a PCO edge sCMOS camera. Images of 4 sections 
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with a z-optical spacing of 0.4 µm were taken every 2 sec for 30 sec. Images were 
deconvolved and further analyzed using the Soft WoRX 5.0 software. 
 
2.2.8 Chorion-Allantoic Membrane (CAM) Assay 
Fertilized White Leghorn chick eggs were incubated at 37.8°C and 80% relative humidity. A 
small window was cut into the shell on day three of chick development. Eggs with resealed 
window were further incubated until day 10 of chick development. Two million HCT116 cells 
per CAM were resuspended in a mixture of 50% RPMI1640 medium and 50% matrigel in a 
total volume of 40 µl. After incubation of cell suspensions for 30 min at 37°C and 5% CO2, 




For immunohistological analyses, dissected tumors were fixed in 4% paraformaldehyde for 
20 min, washed three times with PBS and transferred into 10% sucrose for 2 h at 4°C. After 
an overnight incubation in 30% sucrose at 4°C tumors were embedded in tissue freezing 
medium and stored at -80°C. Hardened tumor blocks were cut in 12 µm thick sections using 
a cryotome. Cryosections were transferred onto microscope slides and stored at -20°C. 
For staining of the cryosections, microscope slides were thawed, dried at room temperature 
and blocked using blocking solution (1% BSA, 5% goat serum and 0.2% Triton X-100 in 
PBS) for 30 min. Afterwards, sections were covered with primary antibodies diluted in 
antibody solution (1% BSA and 0.5% Triton X-100 in 0.05 M TBS) over night at 4°C. The 
cryosections were washed two times with PBS. Subsequently, they were covered with 
secondary antibody and DAPI mixed in antibody solution for 1 h at room temperature. 
Specimens were washed three times, mounted in Fluoromount-G (Sigma-Aldrich, 
Taufkirchen, Germany) and analyzed with a Zeiss Axio Imager Z1 microscope (Carl Zeiss, 
Göttingen, Germany). 
 
2.2.10 In Vitro Migration Assay 
Cells were starved for 16 h in medium containing 0.5% FCS. Cells were harvested, counted 
and resuspended in medium containing 0.5% FCS to a final cell concentration of 2*105 cells 
per 200 µl. ThinCert© cell culture inserts (Greiner BioOne, Frickenhausen, Germany) were 
placed in a 24-well plate containing 600 µl culture medium including 10% FCS. The cell 
suspension was added into the cell culture inserts. Cells were incubated for 24 h at 37°C and 
5% CO2 before being detached from the bottom of the cell culture insert by Trypsin/EDTA. 
Detached cells were resuspended in 100 µl PBS and counted.  
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2.2.11 In Vitro Invasion Assay 
Matrigel coated cell culture inserts (BD Bioscience, Bedford, MA, USA) were rehydrated 
according to the manufacturer´s protocol. Meanwhile, cells were harvested, counted and 
resuspended in cell culture medium containing 0.5% FCS to a final concentration of 2*105 
cells per 500 µl. Cell culture inserts were placed in a 24-well containing 750 µm cell culture 
medium. The cell suspension was added into the cell culture inserts and incubated for 48 h 
at 37°C and 5% CO2. Following, non-invasive cells were removed from the upper surface of 
the membrane by scrubbing using a moistened cotton swab. Cells on the lower surface of 
the membrane were fixed using 2% PFA for 5 min at room temperature and methanol for 5 
min at -20°C. Cells were stained using Hoechst33342 for 5 min. After the membrane was 
dried, it was cut from the insert, placed on an object slide and embedded using VectaShield©. 
Invasive cells were analyzed under the microscope at 40x magnification. Ten randomly 
chosen pictures were taken for each assay. Cells were counted using the ImageJ Software. 
 
2.2.12 Rac1-Activation-Assay 
Rac1-Activation-Assay was performed using the RhoA/Rac1/Cdc42 Activation Combo 
Biochem Kit (Cytoskeleton Inc, Denver, CO, USA) according to the manufacturer´s protocol. 
Cell culture plates were placed on ice and the cells were washed once with ice cold PBS. 
Cell lysis was performed on the plate by using 400 µl ice-cold lysis buffer (50 mM Tris pH 
7.5, 10 mM MgCl2, 0.5 M NaCl, 2% Igepal). Cells were harvested and centrifuged for 1 min at 
14800 rpm at 4°C. The supernatant was transferred to a new reaction tube and snap frozen 
in liquid nitrogen. 1500 µg of cell lysate were incubated with 10 µg PAK-PBD-beads for 30 
min at 4°C. Beads were washed once with wash buffer (25 mM Tris pH 7.5, 30 mM MgCl2, 
40 mM NaCl) and resuspended in 15 µl Laemmli sample buffer. Samples were boiled for 5 
min and analyzed by SDS-PAGE and western blot. Rac1 was detected using anti-Rac1 
antibody (Rac1 Arc03, Cytoskeleton Inc., Denver, CO, USA) at 1:500 dilution. 
 
2.2.13 GEF-Assay 
GEF-Assay for TRIO was performed by using Rac1 G15A Agarose Beads (Cell Biolabs Inc., 
San Diego, CA, USA). Cell culture plates were placed on ice and the cells were washed once 
with ice cold PBS. Cell lysis was performed on the plate using 400 µl ice-cold lysis buffer (20 
mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% Triton X-100). Cells were harvested 
and centrifuged for 1 min at 14800 rpm at 4°C. 2000 µg of cell lysate were incubated with 10 
µg Rac1 G15A agarose beads for 1 h at 4°C. Beads were washed three times with HBS 
buffer (20 mM HEPES, pH 7.5, 150 mM NaCl) and resuspended in 15 µl Laemmli sample 
buffer. Samples were boiled for 5 min and analyzed by SDS-PAGE and western blot. TRIO 
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2.3.1 Preparation Of Protein Lysates 
Cells were harvested by centrifugation at 2000 rpm for 5 min and subsequently resuspended 
in 70 µl lysis Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% 
(v/v) Igepal©, 0.1% (w/v) SDS, 0.1% Na-Desoxycholate, 20mM Na3VO4, 25 mM β-
Glycerophosphate, 50 mM NaF, 5 mM Na2MoO4) supplemented with complete protease 
inhibitor cocktail EDTA-free (1:25) (Roche, Switzerland), phosphatase inhibitor (1:10) and 0.5 
µM microcystin-LR (Enzo Life Sciences, Lörrach, Germany). After 10 min incubation on ice, 
cells were centrifuged at 14800 rpm for 20 min at 4°C. The supernatant was transferred to a 
new reaction tube and stored at -20°C. 
 
2.3.2 Protein Determination 
Protein levels were determined by using the Bio-Rad DC Protein assay (BioRad, Hercules, 
CA, USA) following the manufacturer´s protocol. Photometric measurement was performed 
using a VICTOR© X3 microplate reader.  
 
2.3.3 Sodiumdodecylsulfate-Polyacrylamid Gel Electrophoresis (SDS-PAGE) 
A discontinuous SDS-PAGE was used for the separation of proteins according to their 
molecular weight. The SDS-gel composed of a 5% stacking gel (300 nM TRIS-HCl pH 6.8, 
0.1% (w/v) SDS, 5% (v/v) Rotiphorese© Gel 30) and a 6-13% resolving gel (500 mM TRIS-
HCl pH 8.8, 0.1% (w/v) SDS, 6-13% (v/v) Rotiphorese© Gel 30). 5 µl of PageRuler Prestained 
Protein Ladder (Fermentas, St. Leon-Rot, Germany) was used for the determination of the 
molecular weight of the detected proteins. 50 µg protein extract were supplemented with 
SDS sample buffer (15% (w/v) SDS, 15% (v/v) β-mercaptoethanol, 50% glycerol, 0.25% 
(w/v) bromophenol blue). For protein denaturation, samples were heated at 95°C for 5 min. 
Proteins were separated in SDS running buffer (25 mM TRIS-HCl pH 6.8, 192 mM glycine, 





                         Material and Methods 
51 
 
2.3.4 Western Blot 
Semi-dry Blot 
After separation of proteins via SDS-PAGE, they were transferred onto a nitrocellulose 
membrane by semi dry western blot. Transfer was performed in a blotting device at 200 mA 
for 1.5 h using transfer buffer (0.0025% (w/v) SDS, 24.8 mM TRIS-HCl pH 8.0, 170 mM (v/v) 
glycine, 20% methanol). 
 
Tank-Blotting 
Proteins larger than 100 kDa were transferred onto nitrocellulose membrane via tank blotting. 
Transfer was performed in a tank blot device for 3 h at 400 mM by using blotting buffer 
(0.0025% (w/v) SDS, 24.8 mM TRIS-HCl pH 8.0, 170 mM (v/v) glycine, 13% methanol). 
After protein transfer the membrane was blocked for 30 min using 5% milk powder in TBS 
(50mM TRIS-HCl pH 7.2, 160 mM NaCl). The proteins of interest were detected with specific 
primary antibodies diluted in 2% BSA in TBS. The primary antibody was incubated over night 
at 4°. After washing the membrane three times using TBS-T (0.1% Tween in TBS) it was 
incubated with the secondary antibody conjugated to HRP for 1 h at room temperature. 
Subsequently, the membrane was washed three times in TBS-T and once in TBS for 10 min 
each. Proteins were detected by ECL. For this, the membrane was incubated shortly in  
0.1 mM TRIS-HCl pH 8.5 containing 0.4 mM β-coumaric acid, 2.5 mM luminol and 0.03% 
H2O2. Chemoluminescence was detected using Fuji Medical X-Ray Film and the OPTIMAX-
X-Ray Film Processor. 
 
2.4 Molecular Biological Methods 
2.4.1 Escherichia coli cells  
The following E. coli strain was used: 
DH5αF-ϕ80lacZ△M15 △(lacZYA-argF)U169 deoR recA1 hsdR17(  
 ,   
 ) phoA supE44 thi-1 
gyrA96 relA1λ- 
 
2.4.2 Generation Of Competent Escherichia coli Cells 
E. coli DH5α were inoculated in 5 ml Luria Bertani medium (LB medium) (1% peptone 140, 
0.5% yeast extract, 0.5% NaCl) and kept at 37°C overnight on a shaker. The preculture was 
transferred to 400 ml LB medium and grown to a density of OD600= 0.5 at 37°C. The culture 
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was incubated on ice for 5 min. After centrifugation for 5 min at 2000 rpm and resuspending 
in 40 ml cold TfbI buffer (30 mM potassium acetate, 100 mM RbCl, 10 mM CaCl2, 15 % 
glycerol, pH adjusted to 6.0 using 0.2 M acetic acid containing 50 mM of MnCl2) the 
suspension was again incubated on ice for 5 min and centrifuged for 5 min at 2000 rpm. After 
resuspending in 4 ml cold TfbII buffer (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % 
glycerol, pH 6.5) the cells were incubated on ice for 15 min. Aliquots of 100 µl were snap 
frozen in liquid nitrogen and stored at -80°C until usage. 
 
2.4.3 Transformation Of Escherichia coli Cells 
Transformation of E. coli was performed using the heat-shock protocol. 50 µl of competent E. 
coli DH5α cells were mixed with 2 µg plasmid DNA and incubated on ice for 20 min. 
Subsequently, cells were incubated for 40 sec at 42°C followed by an incubation on ice for 2 
min. Cells were supplemented with 600 µl LB medium and incubated for 60 min at 37°C 
while constant shaking. Cells were transferred to 400 ml LB medium containing appropriate 
antibiotics for selection of the plasmid. After overnight incubation at 37°C plasmid DNA was 
isolated from the liquid culture.  
 
2.4.4 Plasmid Isolation 
Plasmid DNA preparation was performed using the NucleoBond© PC 100 X-TRA Midi Kit 
(Macherey Nagel, Düren, Germany) according to the manufacturer´s protocol. 
The DNA concentration was measured using the NanoDrop© 2000 spectro-photometer 
(ThermoFisher, Waltham, MA, USA). 
 
2.4.5 RNA-Isolation 
RNA was isolated using the NucleoSpin© RNA Kit according to the manufacturer´s protocol 
(Macherey Nagel, Düren, Germany). 
RNA was quantified using NanoDrop© 2000 spectrophotometer (ThermoFisher, Waltham, 
MA, USA) and analysed in a 1% agarose gel. 
 
2.4.6 cDNA Synthesis And Quantitative Real Time PCR 
1 µg cDNA was synthesized from RNA using 100 pmol random hexamer primer, dNTPs (0.5 
mM each), 20 U RiboLock RNase inhibitor and 200 U Maxima Reverse Transcriptase 
(ThermoFisher, Waltham, MA, USA). Reaction components were incubated for 10 min at 
25°C followed by 30 min at 50°C. The reaction was terminated by heating at 85°C for 5 min. 
Quantitative real time PCR reactions were performed using gene specific primers, 30 ng 
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cDNA and GoTaq qPCR Master Mix (Promega, Mannheim, Germany) on a Rotor Gene Q 
real time PCR cycler (Qiagen, Hilden, Germany) using the following program (Table 2.12). 
 
Table 2.12: qRT-PCR Program 
 
Denaturation 95°C 5 min  
Denaturation 95°C 5 s 
50x Primer Annealing 60°C 10 s 
Polymerization 60°C 10 s 
 
Transcriptional changes were calculated based on the comparative CT method.  
 
2.4.7 Preparation of Samples For RNA-Sequencing 
HCT116 cells were seeded in 2 mM Thymidine for 16 h, released into the cell cycle for 8 h 
and seeded into 2 mM Thymidine. After 1 h, siRNA transfections were conducted using 60 
pmol LUCIFERASE, TP53 or TP73 siRNA. Medium was changed after 2 h. After 11 h, cells 
were released into the cell cycle for 6.5 h and subsequently harvested. These G2 arrested 
probes were further processed by the Transcriptome and Genome Analysis Laboratory (TAL) 
of the University of Göttingen (Göttingen, Germany). Bioinformatical analyses were 
performed by Silvia von der Heyde (former University of Göttingen, Germany). 




3.1 A Mechanistic Link Between Chromosomal Instability And Tumor Cell 
Migration 
 
3.1.1 Increased Interphase Microtubule Plus-End Assembly Rates Correlate 
With Migration And Invasion 
Aneuploidy is a hallmark of human cancer, which derives from an increased rate of 
chromosome missegregation during mitosis. This process, termed chromosomal instability 
(CIN), contributes to tumorigenesis, tumor progression and therapy resistance (Holland & 
Cleveland 2012). However, the mechanisms behind are not well understood. CIN is often 
associated with late tumor stages, which are associated with larger tumors, high 
invasiveness and infiltration of nearby tissues. Thus, we wanted to investigate a possible link 
between CIN and cancer cell migration and invasion. 
To investigate a potential correlation between these two phenotypes, transwell migration and 
invasion assays were performed. A panel of CRC cells was used, which can be subdivided 
into chromosomally stable, but microsatellite instable (MIN/MSI) cell lines (HCT116, SW48) 
and chromosomally instable (CIN) cell lines (SW480, SW620, SW837, CaCo2, HT29, 
LS411N, LS513, Colo201, LoVo). Intriguingly, only the CIN cell lines Colo201 and LoVo 
exhibited increased migration and invasion (Fig 3.1a-b). In comparison to HCT116 cells, 
Colo201 and LoVo cells displayed an approximal 2-fold increased migration potential as well 
as a nearly 2-fold increased invasion potential. SW620, SW837, CaCo2, HT29, LS411N and 
LS513 exhibited the lowest migration and invasion potentials. Increased microtubule plus-
end assembly rates in mitosis were recently elucidated as a common cause for CIN in 
colorectal cancer (Ertych et al. 2014). Microtubule plus-end assembly rates were measured 
during mitosis in the panel of CRC cell lines. The measurement was performed using the 
GFP-tagged end binding protein EB3, which binds to growing microtubule plus-ends 
(Stepanova et al. 2003). Thus, by using live cell microscopy, the growing microtubule plus-
ends can be tracked over time and microtubule plus-end assembly rates can be determined. 
As shown before (Ertych et al. 2014), all investigated CIN cell lines exhibited increased 
microtubule plus-end assembly rates during mitosis when compared to chromosomally stable 
(MIN/MSI) cell lines HCT116 and SW48 (Fig 3.1c). Microtubule dynamics are known to be 
required for cell migration (Vasiliev et al. 1970). Therefore, interphase microtubule-plus-end 
assembly rates were measured. Interestingly, only the migratory and invasive CIN cell lines 
Colo201 and LoVo displayed significantly increased microtubule plus-end assembly rates 
during interphase compared to the other cell lines (Fig 3.1d).  





These data indicate that only a subset of CIN cells acquired an abnormal increase in 
microtubule plus-end assembly rates in interphase, which correlates with increased cell 
migration and invasion. 
To verify our findings, we used different melanoma cell lines that are well characterized 
regarding their migration and invasion potential. The melanoma cell lines SK-Mel-19 and SK-
Mel-28 are known to be non-invasive, whereas the cell lines SK-Mel-103 and SK-Mel-147 
are described to exhibit a highly invasive phenotype (Alla et al. 2010). The migration and 
invasion potential of these cell lines was validated by transwell migration and invasion 
assays. Transwell migration assays revealed 6,000 migrated SK-Mel-19 cells and 24,500 
 
Figure 3.1: Increased interphase microtubule plus-end assembly rates correlate with a 
migratory and invasive phenotype. (a) Transwell migration assays of a panel of MIN/MSI and CIN 
CRC cell lines. 200,000 cells were seeded and bar graphs show the proportion of migrated cells after 
24 h (mean ± sem, t-test, n=3). (b) Transwell invasion assays for a panel of MIN/MSI and CIN cell 
lines. 200,000 cells were seeded into matrigel coated cell culture inserts and bar graphs show the 
number of invaded cells in each picture of 30 randomly chosen pictures taken at 40x magnification 
from three independent experiments (t-test, mean ± sem, n=3). (c) Measurements of mitotic 
microtubule plus-end assembly rates in a panel of MIN/MSI and CIN CRC cell lines. Cells were treated 
with 2 µM DME for 1 h prior to determination of microtubule plus-end assembly rates. Scatter dot plots 
show the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem,  
t-test, n=30 cells from three independent experiments). (d) Measurements of interphase microtubule 
plus-end assembly rates using a panel of MIN/MSI and CIN CRC cell lines. Scatter dot plots show the 
average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 
cells from three independent experiments). 
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migrated SK-Mel-28, whereas for SK-Mel-103 and SK-Mel-147 migrated cells in a range from 
97,000 to 100,500 were detected (Fig. 3.2a). Using transwell invasion assays, 53 and 80 
invaded cells per field were observed for SK-Mel-19 and SK-Mel-28, while the highly invasive 
cell lines SK-Mel-103 and SK-Mel-147 exhibited 366 and 323 invaded cells per field (Fig 
3.2b). These four melanoma cell lines were further analyzed with respect to their microtubule 
plus-end assembly rates during mitosis and interphase by EB3 tracking experiments. 
Interestingly, the highly migratory and invasive cell lines SK-Mel-103 and SK-Mel-147 
exhibited increased microtubule plus-end assembly rates during interphase when compared 
to the non-invasive cell lines SK-Mel-19 and SK-Mel-28 (Fig 3.2c). Microtubule plus-end 
assembly rates in interphase were increased from 17.9 µm/min and 18.3 µm/min in SK-Mel-
19 and SK-Mel-28, respectively, to 21.2 µm/min in both SK-Mel-103 and SK-Mel-147 cells. 
Apart from that, SK-Mel-19, SK-Mel-28, SK-Mel-103 and SK-Mel-147 displayed increased 
microtubule plus-end assembly rates during mitosis of 18.7 µm/min, 19.7 µm/min, 19.4 
µm/min and 19.6 µm/min (Fig. 3.2c), when compared to chromosomal stable CRC cell lines 
HCT116 and SW48 (Fig. 3.1a). 
 
 
Figure 3.2: Highly migratory and invasive melanoma cell lines SK-Mel-103 and SK-Mel-147 
exhibit increased interphase microtubule plus-end assembly rates. (a) Transwell migration 
assays using a panel of melanoma cell lines. Bar graphs show the proportion of migrated cells from 
200,000 seeded cells after 24 h (mean ± sem, t-test, n=3). (b) Transwell invasion assays using a 
panel of four melanoma cell lines. 200,000 cells were seeded and bar graphs show the number of 
invaded cells in each picture of 30 randomly chosen pictures taken at 40x magnification from three 
independent experiments (mean ± sem, t-test, n=3). (c) Measurements of mitotic and interphase 
microtubule plus-end assembly rates in a panel of melanoma cell lines. Cells were treated with 2 µM 
DME 2 h prior to EB3 tracking experiments. Scatter dot plots show the average microtubule plus-end 




In summary, a subset of the analyzed CRC and melanoma cell lines display increased 
microtubule plus-end assembly rates in interphase. Additionally, migration and invasion 
seem to be associated with CIN, but CIN is not per se associated with a high migration and 
invasion potential. 
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3.1.2 Alterations In Microtubule Plus-End Assembly Rates, But Not A CIN 
Phenotype Affect Migration And Invasion 
To examine a potential interplay between increased microtubule plus-end assembly rates 
during interphase and increased cell migration and invasion, enhanced microtubule plus-end 
assembly rates were restored to normal levels by treatment with the microtubule-binding 
drug Taxol. Taxol inhibits dynamic microtubule properties and hence stabilizes microtubules 
(Jordan and Wilson  2004). 2 h prior to EB3 tracking experiments, cells were treated with  
0.2 - 0.5 nM Taxol, which was previously shown to be sufficient to restore proper microtubule 
plus-end assembly rates in CIN cells (Ertych et al. 2014). 
Indeed, at these sub-nanomolar concentrations, Taxol significantly suppressed increased 
microtubule plus-end assembly rates during mitosis as well as during interphase in both 
Colo201 and LoVo cells (Fig 3.3a). During mitosis, the microtubule plus-end assembly rates 
in Colo201 cells were reduced from 20.4 µm/min to 16.9 µm/min and in LoVo cells from 20.2 
µm/min to 17.9 µm/min. During interphase, the microtubule plus-end assembly rates in 
Colo201 cells were decreased from 21.0 µm/min to 16.6 µm/min and in LoVo cells from 20.3 
µm/min to 17.7 µm/min. These measured values are comparable to microtubule plus-end 
assembly rates typically seen in chromosomally stable and non-migratory HCT116 cells  
(Fig. 3.3a).  
 
 
Figure 3.3: Restoration of microtubule plus-end assembly rates suppresses cell migration in 
CRC cell lines. (a) Measurements of mitotic and interphase microtubule plus-end assembly rates in 
CRC cell lines. Cells were treated with DMSO or 0.2 nM Taxol for 2 h. 1-2 h prior to EB3 tracking 
experiment, cells were treated with 2 µM DME. Scatter dot plots show the average microtubule plus-
end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three 
independent experiments). (b) Transwell migration assays of CRC cell lines. Cells were treated with 
DMSO or 0.2 nM Taxol. Bar graphs show the proportion of migrated cells from 200,000 seeded cells 
after 24 h (mean ± sem, t-test, n=3). 
 
 
Furthermore, transwell migration assays were performed with Taxol treated cells. The 
migration potential of Colo201 and LoVo cells was significantly decreased upon Taxol 
treatment in comparison to control DMSO treated cells (Fig 3.3b). In Colo201 cells, the 
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number of migrated cells was reduced by approximately 45% from 86,667 cells upon DMSO 
treatment to 47,667 cells upon Taxol treatment, whereas for LoVo cells the amount of 
migrated cells was decreased from 78,667 cells to 37,333 cells on average. In HCT116 cells, 
Taxol treatment did not have a significant influence on the migration potential. These results 
indicate an important role of microtubule plus-end assembly rates for cell migration in CRC 
cell lines. To further substantiate this finding, the melanoma cell lines SK-Mel-19, SK-Mel-28, 
SK-Mel-103 and SK Mel-147 cells were evaluated regarding their response to Taxol. EB3 
tracking experiments were performed with these cell lines. 2 h prior to determination of 
microtubule plus-end assembly rates, cells were treated with 0.5 nM Taxol. EB3 tracking 
experiments revealed a significant decrease in microtubule plus-end assembly rates during 
both, mitosis and interphase, upon low dose Taxol treatment in all investigated cell lines  
(Fig 3.4a). Taxol treatment reduced the microtubule plus-end assembly rates in SK-Mel-103 
and SK-Mel-147 cells to values comparable to microtubule plus-end assembly rates 
measured in SK-Mel-19 and SK-Mel-28 cells.  
 
         
Figure 3.4: Restoration of microtubule plus-end assembly rates suppresses the invasive 
phenotype in melanoma cells. (a) Measurements of mitotic and interphase microtubule plus-end 
assembly rates in melanoma cell lines. The indicated cells were treated with DMSO or 0.5 nM Taxol 
for 2 h. 2 h prior to EB3 tracking experiments, cells were treated with 2 µM DME. Scatter dot plots 
show the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-
test, n=30 cells from three independent experiments). (b) Transwell invasion assays of the indicated 
melanoma cell lines. Cells were treated with DMSO or 0.5 nM Taxol. 200,000 cells were seeded and 
the amount of invaded cells after 48 h in each picture of 30 randomly chosen pictures taken with 40x 
magnification from three independent experiments was determined and illustrated as bar graphs 
(mean ± sem, t-test, n=3). 
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To further investigate the impact of Taxol on the invasion potential of the melanoma cells, 
transwell invasion assays were performed. Here, low-dose Taxol treatment significantly 
decreased the invasive phenotype of SK-Mel-103 and SK-Mel-147 cells. DMSO treated SK-
Mel-103 and SK-Mel-147cells exhibited 366 and 323 invaded cells per field, respectively. 
Taxol treatment reduced the invaded cells per field to 69 cells in SK-Mel-103 and 100 cells in 
SK-Mel-147 (Fig 3.4b). 
Increased microtubule plus-end assembly rates cause transient spindle geometry defects, 
which lead to merotelic microtubule-kinetochore attachments (Ertych et al. 2014). Merotelic 
attachments are erroneous microtubule-kinetochore attachments, which occur, when one 
kinetochore is attached to microtubules emanating from the two opposing spindle poles. 
Since the spindle assembly checkpoint does not detect these malattachments, cells can 
progress into anaphase and display so called lagging chromosomes (Cimini et al. 2001).  
To investigate whether increases in microtubule plus-end assembly rates results in the 
generation of lagging chromosomes in CRC and melanoma cells, cells were synchronized at 
G1/S transition by double thymidine block and released into the cell cycle and thereby treated 
with either DMSO or 0.2 - 0.5 nM Taxol for 8.5 h (CRC cell lines) - 9.5 h (melanoma cell 
lines). Cells were fixed and stained for immunofluorescence microscopy and the occurrence 
of lagging chromosomes during anaphase was analyzed.  
 
      
Figure 3.5: Restoration of microtubule plus-end assembly rates by low dose Taxol treatment 
suppresses the generation of lagging chromosomes. (a) Quantification of cells showing lagging 
chromosomes during anaphase. CRC cells were synchronized at G1/S transition by a double 
thymidine block and released into the cell cycle thereby treating with DMSO or 0.2 nM Taxol. After 
8.5 h cells were fixed and stained for immunofluorescence microscopy and the occurrence of lagging 
chromosomes was analyzed. Bar graphs show proportion of cells displaying at least one CREST-
positive chromatid (mean ± sem, t-test, n=3 with a total of 300 anaphase cells). (b) Quantification of 
cells with lagging chromosomes during anaphase using melanoma cell lines. Cells were 
synchronized at G1/S transition by a double thymidine block and released into the cell cycle thereby 
treating with DMSO or 0.5 nM Taxol. After 9.5 h cells were fixed and stained for immunofluorescence 
microscopy and the occurrence of lagging chromosomes was analyzed. Bar graphs show 
quantification of cells displaying at least one CREST-positive chromatid (mean ± sem, t-test, n=3 
with a total of 300 anaphase cells). 
 
 
The proportion of cells exhibiting lagging chromosomes in Colo201 and LoVo cells was 
significantly decreased after low dose Taxol treatment in comparison to DMSO treated cells. 
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On average 6% of DMSO treated Colo201 cells exhibited lagging chromosomes. This 
proportion was reduced to 3.6% upon Taxol treatment. Also in LoVo cells, the occurrence of 
lagging chromosomes was reduced from 6% to 2%. However, Taxol treatment had no 
significant influence onto the generation of lagging chromosomes in HCT116 cells (Fig 3.5a).  
The melanoma cell lines investigated here have not been characterized regarding the 
generation of lagging chromosomes. But the increased microtubule plus-end assembly rates 
during mitosis (Fig 3.2c) hint to a chromosomally instable phenotype. DMSO treated 
melanoma cells exhibited lagging chromosomes in a range from 3% to 5%. This proportion 
was reduced to 1% to 2% upon low dose Taxol treatment. Thus, also in melanoma cell lines, 
increased microtubule plus-end assembly rates are associated with the generation of lagging 
chromosomes, albeit at lower frequency when compared to the CRC cell lines. 
Hence, Taxol treatment decreased microtubule plus-end assembly rates in mitotic and 
interphase cells and reduced both the occurrence of lagging chromosomes and the migratory 
and invasive phenotype in CRC and melanoma cell lines. Since the generation of lagging 
chromosomes is tightly associated with CIN, the question arose, whether a CIN phenotype 
per se might be responsible for the increased migration and invasion potential.  
The occurrence of lagging chromosomes can be specifically suppressed in the presence of 
increased microtubule plus-end assembly rates by overexpression of the mitotic centromere-
associated kinesin MCAK (Ertych et al. 2014). MCAK is a microtubule depolymerase, which 
destabilizes kinetochore microtubules at the metaphase to anaphase transition, thus 
resolving erroneous kinetochore-microtubule-attachments (Maney et al. 1998; Bakhoum et 
al. 2009). 
MCAK was overexpressed in the CRC cell lines HCT116 and Colo201, as well as in the 
melanoma cell line SK-Mel-103. The overexpression of MCAK was verified by western blot 
analyses (Fig 3.6a). Cells were synchronized at G1/S transition, released into the cell cycle 
for 8.5 h (CRC cell lines) - 9.5 h (melanoma cell line) and fixed and stained for 
immunofluorescence microscopy. MCAK overexpression decreased the number of cells with 
lagging chromosomes in all cell lines in comparison to control vector transfected cells (Fig 
3.6b). In Colo201 cells, the amount of lagging chromosomes was reduced from 6.3% to 
1.6%, whereas in SK-Mel-103 cells the amount was reduced from 4% to 1.6% on average. 
These reductions in the occurrence of lagging chromosomes are comparable to those 
obtained by Taxol treatment (Fig 3.5a-b), but EB3 tracking experiments revealed no 









To investigate a potential link between CIN and migration, transwell migration assays were 
performed. These experiments revealed no influence of MCAK overexpression on the 
               
Figure 3.6: CIN does not trigger cell migration per se. (a) Representative western blot of HCT116, 
Colo201 and SK-Mel-103 cells detecting MCAK after overexpression of MCAK. ɣ-tubulin served as 
loading control. (b) The occurrence of anaphase cells with lagging chromosomes was analyzed in 
HCT116, Colo201 and SK-Mel-103 cells after overexpression of MCAK. Cells were synchronized at 
G1/S transition by double thymidine block, released into the cell cycle for 8.5 h (HCT116, Colo201) or 
9.5 h (SK-Mel-103) and fixed and stained for immunofluorescence microscopy. Bar graphs show 
proportion of cells exhibiting at least one CREST-positive chromatid (mean ± sem, t-test, n=3 with a 
total of 300 anaphase cells). (c) Measurements of microtubule plus-end assembly rates during 
mitosis and interphase after overexpression of MCAK. Scatter dot plots show the average 
microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from 
three independent experiments). (d) Transwell migration assays of HCT116, Colo201 and  
SK-Mel-103 cells were performed with or without overexpression of MCAK. 200,000 cells were 
seeded and bar graphs show the amount of migrated cells after 24 h (mean ± sem, t-test, n=3). (e) 
Transwell migration assay of HCT116 and HCT116 MAD2
+/-
. 200,000 cells were seeded and bar 
graphs show the amount of migrated cells after 24 h (mean ± sem, t-test, n=3). 
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migration potential of Colo201 and SK-Mel-103 cells (Fig 3.6d). Additionally HCT116-MAD2+/- 
cells were analyzed regarding their migration potential. These cells have a mitotic checkpoint 
defect and frequently missegregate chromosomes. But the HCT116-MAD2+/- cells did not 
show increased cell migration compared to parental HCT116 cells (Fig. 3.6e). Thus the 
occurrence of lagging chromosomes per se did not influence the migration potential of the 
highly migratory cell lines Colo201 and SK-Mel-103. Instead, abnormally increased 
microtubule plus-end assembly rates in mitosis and interphase are associated with the 
generation of lagging chromosomes and increased cell migration, respectively. 
Microtubule plus-end assembly is mediated by the microtubule polymerase ch-TOG 
(encoded by the CKAP5 gene) (Gard & Kirschner 1987; Brouhard et al. 2008). In order to 
further investigate the influence of increased microtubule plus-end assembly rates during 
migration and invasion and also to exclude unspecific effects of the Taxol treatment, CKAP5 
was repressed by siRNA in SK-Mel-103 and Colo201 cells. HCT116 was used as a control 
cell line. The repression of CKAP5 was verified by western blot analyses (Fig 3.7a). Live cell 
microscopy experiments revealed a significant decrease of microtubule plus-end assembly 
rates in SK-Mel-103 and Colo201 cells to normal levels during both, mitosis and interphase, 
upon siRNA-mediated repression of CKAP5 in comparison to LUCIFERASE siRNA 
transfected cells (Fig 3.7b). In HCT116 cells, microtubule plus-end assembly rates were not 
significantly influenced upon CKAP5 repression (Fig. 3.7b).  
Furthermore, repression of CKAP5 also led to a significant decrease in the amount of cells 
exhibiting lagging chromosomes in Colo201 and SK-Mel-103 cells compared to 
LUCIFERASE siRNA transfected cells. In Colo201 cells, the number of cells showing lagging 
chromosomes was reduced from 6.7% to 3.6%, whereas in SK-Mel-103 cells the amount 
was reduced by 50% from 4% to 2%. (Fig 3.7c).  
Following that, transwell migration and invasion assays were performed. Here, SK-Mel-103 
and Colo201 cells displayed a significantly decreased migration and invasion potential after 
CKAP5 repression in comparison to control transfected cells (Fig 3.7d-e). Upon 
LUCIFERASE siRNA transfection, Colo201 and SK-Mel-103 exhibited on average 78,333 
migrated cells and 94,250 migrated cells, respectively, which were reduced to 53,417 cells 
and 72,250 cells upon CKAP5 repression. Transwell invasion assays revealed on average 
92 invaded Colo201 cells, which were reduced to 37 invaded cells per field upon CKAP5 
repression, and 353 invaded SK-Mel-103 cells, which were decreased to 254 cells per field 
after CKAP5 repression. 
The data upon repression of CKAP5 substantiates the findings obtained upon low dose Taxol 
treatment: A decrease in microtubule plus-end assembly rates also decreased the migratory 
and invasive phenotype. 
 




Figure 3.7: Inhibition of increased microtubule plus-end assembly rates suppresses 
migration and invasion. (a) Representative western blot detecting ch-TOG using HCT116, 
Colo201 and SK-Mel-103 cells transfected with 60 pmol LUCIFERASE or CKAP5 siRNA. ɣ-tubulin 
served as loading control. (b) Measurements of mitotic and interphase microtubule plus-end 
assembly rates after repression of CKAP5. HCT116, Colo201 and SK-Mel-103 cells were 
transfected with 60 pmol LUCIFERASE or CKAP5 siRNA. 1 h - 2 h prior to EB3 tracking 
experiments, cells were treated with 2 µM DME. Scatter dot plots show the average microtubule 
plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three 
independent experiments). (c) Quantification of cells exhibiting lagging chromosomes after CKAP5 
or LUCIFERASE siRNA transfection as described in (a). Cells were synchronized at G1/S transition 
by double thymidine block, released into the cell cycle for 8.5 - 9.5 h and fixed and stained for 
immunofluorescence microscopy. Cells displaying at least one CREST-positive chromatid were 
counted as positive. Bar graphs show proportion of cells with lagging chromosomes (mean ± sem, 
t-test, n=3 with a total of 300 anaphase cells). (d) Transwell migration assays after CKAP5 or 
LUCIFERASE siRNA transfection as described in (a). 200,000 cells were seeded into cell culture 
inserts and bar graphs show the number of migrated cells after 24 h. (mean ± sem, t-test, n=3)  
(e) Transwell invasion assays after CKAP5 or LUCIFERASE siRNA transfection as described in (a). 
200,000 cells were seeded into cell culture inserts. After 48 h, the number of invaded cells in each 
picture of 30 randomly chosen pictures was determined. Pictures were taken with  




Furthermore, it was of interest to investigate, whether an increase in microtubule plus-end 
assembly rates per se induces a migratory and invasive phenotype. To address this 
question, the microtubule polymerase ch-TOG/CKAP5 or a control vector were 
overexpressed or cells were treated with low doses of Nocodazole. Our group showed 
recently that low concentrations of the microtubule destabilizing drug Nocodazole increased 
microtubule plus-end assembly rates (Ertych et al. 2014). HCT116 and SK-Mel-28 cells, 
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which neither exhibit increased microtubule plus-end assembly rates nor a migratory and 
invasive phenotype, were used for this approach.  
The overexpression of CKAP5 was verified by western blot analyses (Fig. 3.8a). EB3 
tracking experiments were performed and revealed a significant increase in microtubule plus-
end assembly rates during both, interphase and mitosis, upon CKAP5 overexpression in 
comparison to control vector (Fig 3.8b). During mitosis, microtubule pus-end assembly rates 
were increased on average from 16.9 µm/min to 20.3 µm/min in HCT116 cells and 18.3 
µm/min to 20.7 µm/min in SK-Mel-28 cells. During interphase, microtubule pus-end assembly 
rates were increased on average from 17.3 µm/min to 20.3 µm/min in HCT116 cells and from 
17.9 µm/min to 20.6 µm/min in SK-Mel-28 cells. Under these conditions, transwell migration 
and invasion assays were performed to analyze the migratory and invasive phenotype after 
CKAP5 overexpression (Fig 3.8c-d). Both, the migration and invasion potentials, of HCT116 
and SK-Mel-28 cells were significantly increased after CKAP5 overexpression. The migration 
potential was increased from 37,083 migrated HCT116 cells and 34,000 migrated SK-Mel-28 
cells to 69,417 and 71,583 migrated cells, respectively. In HCT116 cells, the transwell 
invasion assays revealed on average 55 invaded cells per field after control vector 
transfection and 143 invaded cells upon CKAP5 overexpression. In SK-Mel-28 cells, the 
number of invaded cells was increased from 66 invaded cells to 169 invaded cells upon 
CKAP5 overexpression. As hypothesized from the induction of increased microtubule plus-
end assembly rates during mitosis, HCT116 and SK-Mel-28 cells exhibited increased 
numbers of cells exhibiting lagging chromosomes after overexpression of CKAP5 (Fig 3.8e). 
In HCT116 cells the proportion was increased from 1.6% to 4% and in SK-Mel-28 cells from 
2% to 4.6% upon CKAP5 overexpression. 
In addition to CKAP5 overexpression, cells were treated with 2 nM Nocodazole 2 h prior to 
the determination of microtubule plus-end assembly rates. Indeed, after Nocodazole 
treatment, cells exhibited increased microtubule plus-end assembly rates that were 
comparable to microtubule plus-end assembly rates measured upon CKAP5 overexpression 
(Fig 3.8b). Transwell migration and invasion assays revealed a significantly increased 
migration and invasion potential (Fig 3.8bc-d), which was also comparable to the effects 
obtained upon CKAP5 overexpression. Analyses of cells displaying lagging chromosomes 
revealed a slight increase in their occurrenc. In HCT116 cells, low dose Nocodazole 
treatment increased the number of lagging chromosomes from 1.5% to 3.25% on average, 
whereas in SK-Mel-28 cells this amount was increased from 1.6% to 3.3% in comparison to 
DMSO treated cells (Fig. 3.8e). 
 




Figure 3.8: Induction of increased microtubule plus-end assembly rates triggers migration and 
invasion. (a) Representative western blot of HCT116 and SK-Mel-28 cells after overexpression of 
CKAP5. ɣ-tubulin served as loading control. (b) Measurements of mitotic and interphase microtubule 
plus-end assembly rates after overexpression of CKAP5 or treatment with 2 nM Nocodazole for 2 h. 
Cells were treated with 2 µM DME 1 h - 2 h prior to EB3 tracking experiments. Scatter dot plots show 
the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, 
n=30 cells from three independent experiments). (c) Transwell migration assays after overexpression 
of CKAP5 or treatment with 2 nM Nocodazole. 200,000 cells were seeded into cell culture inserts. Bar 
graphs show number of migrated cells after 24 h (mean ± sem, t-test, n=3) (d) Transwell invasion 
assays after overexpression of CKAP5 or treatment with 2 nM Nocodazole. 200,000 cells were 
seeded into cell culture inserts. Bar graphs show the number of invaded cells in every picture of  
30 randomly chosen pictures from three independent experiments (mean ± sem, t-test, n=3). (e) 
Quantification of cells with lagging chromosomes after over expression of CKAP5 or treatment with  
2 nM Nocodazole. Cells were synchronized at G1-S-transition by double thymidine block, released into 
the cell cycle for 8.5 h - 9.5 h and fixed and stained for immunofluorescence microscopy. Cells 
displaying at least one CREST-positive chromatid were quantified. Bar graphs show the proportion of 
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3.1.3 Metastasis Associated Alterations In Human Cancer Induce Increased 
Microtubule Plus-End Assembly Rates 
In human cancers, various alterations in gene expression are associated with a highly 
migratory and invasive phenotype. To address the question, whether the correlation between 
migration and invasion and altered microtubule dynamics can be detected also in cancer 
associated settings different gene alterations with prognostic significance were tested for 
their influence on microtubule dynamics. Thereby, inactivation of the retinoblastoma protein 
Rb is associated with the development of invasive cancers (Labrecque et al. 2016). In 
addition, overexpression of E1A and E7 leads to inactivation of Rb. Furthermore, the 
overexpression of the receptor for hyaluronan-mediated motility (Rhamm/HMMR) is known to 
promote cellular motility and invasion (Maxwell et al. 2008; Crainie et al. 1999). Additionally, 
increased TGF-β signaling is highly correlated with metastasis in several cancer entities  and 
known to induce EMT and to increase cell migration (Dalal et al. 1993; Meulmeester & Ten 
Dijke 2010). 
HCT116 and SK-Mel-28 cells were used for siRNA-mediated repression of RB, for 
overexpression of E7, E1A and HMMR or for treatment with TGF-β. Transwell migration and 
invasion assays were conducted and confirmed the highly migratory and invasive potential 
after these treatments (Fig. 3.9a-b). Interestingly, in EB3 tracking experiments, RB 
repression, E7, E1A and HMMR overexpression or treatment with 10 ng/ml TGF-β for 3 h 
significantly increased microtubule plus-end assembly rates in mitosis and interphase in both 
cell lines (Fig. 3.9c-d). In HCT116 cells, the indicated treatments increased microtubule plus-
end assembly rates in mitosis from 16.7-16.8 µm/min in control cells to 19.5-20.2 µm/min and 
in interphase from a range of 16.7-16.8 µm/min to 20.2-20.3 µm/min. In mitotic SK-Mel-28 
cells, elevated microtubule polymerization rates of 19.5-20.5 µm/min were measured 
compared to 18.4-19.3 µm/min on average in control cells. During interphase, the indicated 
treatments increased microtubule plus-end assembly rates from 18.3-18.4 µm/min to 
polymerization rates ranging from 20.3-20.6 µm/min.  
Thus, cancer relevant alterations, which are described to be associated with a highly invasive 
phenotype are accompanied by increased mitotic and interphase microtubule plus-end 
assembly rates. 
 




Figure 3.9: Invasion-associated alterations in cancer correlate with increased microtubule plus-
end assembly rates. (a) Transwell migration assays of HCT116 and SK-Mel-28 cells after 
transfection with 60 pmol LUCIFERASE or RB siRNA, or overexpression of E7, E1A or HMMR, or 
after treatment with 10 ng/ml TGF-β. 200,000 cells were seeded and bar graphs show the amount of 
migrated cells after 24 h (mean ± sem, t-test, n=3). (b) Transwell invasion assays of HCT116 and SK-
Mel-28 cells after the indicated treatments. 200,000 cells were seeded. Bar graphs show the number 
of invaded cells in every picture of 30 randomly chosen pictures from three independent experiments 
(mean ± sem, t-test, n=3). (c) EB3 tacking experiments of HCT116 and SK-Mel-28 cells in mitosis 
after the indicated treatments. Scatter dot plots show the average microtubule plus-end assembly 
rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent 
experiments). (d) EB3 tracking experiment of HCT116 and SK-Mel-28 cells in interphase after the 
indicated treatments. Scatter dot plots show the average microtubule plus-end assembly rates of  
20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent experiments). 
 
 
3.1.4 The Microtubule Plus-End Binding Protein EB1 Is Important For 
Microtubule-Dependent Signaling 
The previous observations indicate a strong correlation between abnormally increased 
microtubule plus-end assembly rates and a migratory and invasive phenotype. Migration and 
invasion is mainly driven by different actin filament structures and their remodeling. But also 
microtubules are described to play a role during cell motility (Waterman-Storer & Salmon 
1999). Still the question arises, how changes in microtubule dynamics affect cellular motility. 
An interesting hypothesis is that microtubule plus-ends might form moving signaling 
platforms, in which the end-binding protein EB1 plays an important role. Thus, it was of 
interest to investigate, whether the repression of EB1 in human cancer cells would affect CIN 
and cell migration. Therefore, EB1 was partially repressed by the use of siRNA in SW620 
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and SK-Mel-103 cells. Repression of EB1 was verified by western blot analyses (Fig. 3.10a). 
Interestingly, EB1 knock down did not affect microtubule plus-end assembly rates neither in 
mitosis nor in interphase (Fig 3.10b). However, the occurrence of cells with lagging 
chromosomes was significantly decreased (Fig 3.10c). Moreover, SK-Mel-103 cells showed 
a significant decreased migration potential upon EB1 repression in transwell migration 
assays (Fig. 3.10d). 
 
                
Figure 3.10: Repression of EB1 reduces the migratory and CIN phenotype while having no 
impact on microtubule plus-end assembly rates. (a) Representative western blot of SW620 and 
SK-Mel-103 cells after repression of EB1. Cells were transfected with 80 pmol LUCIFERASE or EB1 
siRNA. ɣ-tubulin served as loading control (b) Measurements of microtubule plus-end assembly rates 
in mitosis and interphase after repression of EB1. SW620 and SK-Mel-103 cells were transfected with 
80 pmol LUCIFERASE or EB1 siRNA. Scatter dot plots show the average microtubule plus-end 
assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent 
experiments). (c) Quantification of cells exhibiting lagging chromosomes after repression of EB1. 
Cells were synchronized at G1/S transition by double thymidine block, released into the cell cycle for 
8.5 h - 9.5 h and fixed and stained for immunofluorescence microscopy. Cells displaying at least one 
CREST-positive chromatid were counted as positive. Bar graphs show the proportion of cells 
displaying lagging chromosomes (mean ± sem, t-test, n=3 with a total of 300 anaphase cells).  
(d) Transwell migration assays after repression of EB1. 200,000 cells were seeded and bar graphs 
show the number of migrated cells after 24 h (mean ± sem, t-test, n=3).. 
 
 
These results revealed that EB1 is involved in triggering enhanced migration and CIN in  
SK-Mel-103 and SW620 cells in response to increased microtubule plus-end assembly rates. 
Since partial EB1 repression did not alter the microtubule plus-end assembly rates itself, the 
results suggest, that EB1 acts downstream of microtubules.  
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3.1.5 SW620 And SK-Mel-103 Cells Exhibit Elevated Levels Of Active TRIO 
The repression of EB1 seems to disrupt a signaling pathway, which is important for migration 
and invasion downstream of microtubule dynamics. Therefore, it was of utmost interest to 
investigate, how EB1-derived signaling affect cellular motility. Recently, the binding of EB1 to 
TRIO was described (Van Haren et al. 2014). TRIO is a guanine nucleotide exchange factor 
(GEF) for Rac1 and is part of a gene signature of genes implicated in cell migration (referred 
to as HCCS24) as well as of the HET70 signature of genes associated with aneuploidy 
(Kohn et al. 2012, Sheltzer 2013;). Therefore, TRIO represents an interesting candidate that 
may link microtubule dynamics to CIN and cell migration. 
To test for an involvement of TRIO in CIN and migration, GEF assays were performed to 
analyze TRIO activity in chromosomally instable SW620 and highly migratory SK-Mel-103 
cells. For this, an agarose bead coupled nucleotide-free Rac1 mutant (Rac1 G15A) that 
binds to activated GEFs with increased affinity was used to pull down active TRIO. 
TRIO activity in chromosomal instable SW620 cells was compared to chromosomal stable 
HCT116 cells during mitosis. Cells were arrested in mitosis by treatment with 2 µM DME for 
16 h. Additionally, cells were treated with DMSO or 0.2 nM Taxol. Treatment with the TRIO 
specific inhibitor ITX3 (Bouquier et al. 2009) served as a control. Western blot analyses 
revealed similar levels of endogenous TRIO in HCT116 and SW620 cells, which were not 
altered upon Taxol or ITX3 treatment (depicted as input) (Fig 3.11a). However, an increased 
proportion of active TRIO was immunoprecipitated using the GST-Rac1 G15A agarose 
beads in DMSO treated SW620 cells compared to DMSO treated HCT116 cells. Importantly, 
the amount of active TRIO was reduced upon low dose Taxol treatment. ITX3 treated cells 
exhibited the lowest proportion of active TRIO, demonstrating a significant inhibition of TRIO 
activity (Fig 3.11a). 
GEF-assays were also performed using the melanoma cell lines SK-Mel-28 and SK-Mel-103. 
Here, it was distinguished between mitotic and interphase cells. Mitotic cells were obtained 
by treatment with 2 µM DME for 16 h. Additionally, cells were treated with DMSO, 0.5 nM 
Taxol or 15 µM ITX3. Interestingly, SK-Mel-103 cells displayed elevated levels of 
endogenous TRIO in comparison to SK-Mel-28 (depicted as input). These increased levels of 
endogenous TRIO were not altered upon Taxol or ITX3 treatment (Fig 3.11b). After 
immunoprecipitation using GST-Rac1 G15A agarose beads a higher proportion of active 
TRIO was detected in DMSO treated SK-Mel-103 when compared to DMSO treated  
SK-Mel-28 cells. This increased level of active TRIO was reduced by treatment with 0.5 nM 
Taxol. ITX3 treated cells exhibited very low proportions of active TRIO (Fig 3.11b). 
 




Figure 3.11: Elevated levels of active TRIO in SW620 and SK-Mel-103 cells depend on 
increased microtubule plus-end assembly rates. (a) HCT116 cells and SW620 cells were treated 
with 2 µM DME for 16 h in combination with DMSO, 0.2 nM Taxol or 15 µM ITX3. GEF assays were 
performed using 2 mg lysate and 10 µg GST-Rac1 G15A agarose beads for 1 h at 4°C.  
A representative western blot detecting TRIO is shown and quantifications of relative TRIO protein 
levels from three independent experiments are given. Bar graphs show amounts of active TRIO 
normalized to control treated cells (mean ± sem, t-test, n=3). (b) SK-Mel-28 and SK-Mel-103 cells 
were treated with 2 µM DME for 16 h in combination with DMSO, 0.5 nM Taxol or 15 µM ITX3. GEF 
assays were performed with 2 mg lysate and 10 µg GST-Rac1 G15A agarose beads for 1 h at 4°C.  
A representative western blot detecting TRIO is shown and quantifications of relative TRIO protein 
levels from three independent experiments are given. Bar graphs show amounts of active TRIO 
normalized to control treated cells (mean ± sem, t-test, n=3). (c) Asynchronously growing SK-Mel-28 
and SK-Mel-103 cells were treated with DMSO, 0.5 nM Taxol or 15 µM ITX3 for 16 h. GEF assays 
were performed using 2 mg lysate and 10 µg GST-Rac1 G15A agarose beads for 1 h at 4°C.  
A representative western blot detecting TRIO is shown and quantifications of relative TRIO protein 
levels from three independent experiments are given. Bar graphs show proportions of active TRIO 
normalized to control treated cells (mean ± sem, t-test, n=3). 
 
 
SK-Mel-103 and SK-Mel-28 cells were also analyzed during interphase. Asynchronously 
growing cells were treated with DMSO, 0.5 nM Taxol or 15 µM ITX3 for 16 h. Also during 
interphase, SK-Mel-103 cells exhibited increased proportions of endogenous TRIO as 
opposed to SK-Mel-28 cells (depicted as input) (Fig 3.11c). Higher proportions of active 
TRIO were immunoprecipitated using GST-Rac1 G15A agarose beads in DMSO treated SK-
Mel-103 as opposed to DMSO treated SK-Mel-28 cells. These elevated proportions were 
reduced upon low dose Taxol and ITX3 treatment.  
In summary, GEF assays revealed elevated levels of active TRIO in the CIN cell line SW620 
during mitosis as well as in the highly migratory and invasive and cell line SK-Mel-103 in 
interphase and mitosis. GEF activity depended on increased microtubule plus-end assembly 
rates, since Taxol treatment decreased the proportion of active TRIO.  
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TRIO was shown to bind to microtubule plus-ends via Nav1/EB1-complex or directly via EB1 
(Van Haren et al. 2014). Therefore, it was tested, whether GEF activity of TRIO depends on 
its microtubule plus-end localization via EB1. SW620 and SK-Mel-103 cells were transfected 
with 80 pmol LUCIFERASE or EB1 siRNA. To investigate active TRIO levels in mitotic 
SW620 cells, cells were treated with 2 µM DME for 16 h. GEF assays were performed and 
revealed decreased proportions of active TRIO upon EB1 repression in comparison to cells 
transfected with LUCIFEARSE siRNA (Fig. 3.12a). SK-Mel-103 cells were analyzed during 
mitosis and interphase. Mitotic cells were obtained by treatment with 2 µM DME for 16 h. 
During both, mitosis and interphase, SK-Mel-103 cells exhibited decreased proportions of 
active TRIO upon repression of EB1 (Fig. 3.12b-c), revealing an EB1-dependent activation of 
TRIO. 
 
            
Figure 3.12: TRIO activity depends on its microtubule plus-end localization via EB1. (a) SW620 
cells were transfected with 80 pmol LUCIFERASE or EB1 siRNA. Cells were treated with 2 µM DME 
for 16 h. GEF assays were performed using 2 mg lysate and 10 µg GST-Rac1 G15A agarose beads 
for 1 h at 4°C. A representative western blot and quantifications of active TRIO protein levels are 
given. Bar graphs show proportions of active TRIO normalized to LUCIFERASE transfected cells 
(mean ± sem, t-test, n=3). (b) SK-Mel-103 cells were transfected with 80 pmol LUCIFERASE or EB1 
siRNA. Cells were treated with 2 µM DME for 16 h. GEF assays were performed using 2 mg lysate 
and 10 µg GST-Rac1 G15A agarose beads for 1 h at 4°C. A representative western blot and 
quantifications of active TRIO protein levels are given. Bar graphs show proportions of active TRIO 
normalized to LUCIFERASE transfected cells (mean ± sem, t-test, n=3). (c) SK-Mel-103 cells were 
transfected with 80 pmol LUCIFERASE or EB1 siRNA. GEF assays were performed using  
2 mg lysate and 10 µg GST-Rac1 G15A agarose beads for 1 h at 4°C. A representative western blot 
and quantifications of active TRIO protein levels are shown. Bar graphs show proportions of active 
TRIO normalized to LUCIFERASE transfected cells (mean ± sem, t-test, n=3). 
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3.1.6 Inhibition Of TRIO Decreases CIN And Migration in SW620 and  
SK-Mel-103 Cells 
In order to analyze whether increased TRIO activity as detected in the GEF assays influence 
the migratory and the CIN phenotype, SK-Mel-103 and SW620 cells were treated with the 
TRIO specific inhibitor ITX3. ITX3 treatment did not alter the microtubule plus-end assembly 
rates during mitosis and interphase in neither SW620 nor SK-Mel-103 cells (Fig. 3.13a).  
 
 
Figure 3.13: Inhibition of TRIO suppresses the generation of lagging chromosomes and inhibits 
cell migration. (a) Measurements of mitotic and interphase microtubule plus-end assembly rates in 
SW620 and SK-Mel-103 cells treated with DMSO or 15 µM ITX3. Scatter dot plots show the average 
microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from 
three independent experiments). (b) Quantification of cells exhibiting lagging chromosomes during 
anaphase. SW620 and SK-Mel-103 cells were treated with DMSO or 15 µM ITX3. Cells were 
synchronized at the G1/S transition by double thymidine block and released into the cell cycle. After 
8.5 h - 9.5 h cells were fixed and stained for immunofluorescence microscopy. Bar graphs show 
quantification of cells showing at least one CREST-positive chromatid (mean values ± sem, t-test, n=4 
with a total of 400 anaphase cells ). (c) Transwell migration assays of SK-Mel-103 cells. Cells were 
treated with DMSO or 15 µM ITX3. 200,000 cells were seeded into cell culture inserts. Bar graphs 
show the number of migrated cells after 24 h (mean ± sem, t-test, n=3). (d) Measurements of mitotic 
and interphase microtubule plus-end assembly rates in SW620 and SK-Mel-103 cells transfected with 
60 pmol LUCIFERASE or TRIO siRNA. Scatter dot plots show the average microtubule plus-end 
assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent 
experiments). (e) Quantification of cells showing lagging chromosomes during anaphase. SW620 and 
SK-Mel-103 cells were transfected with 60 pmol LUCIFERASE or TRIO siRNA. Cells were 
synchronized at the G1/S transition and released into the cell cycle. After 8.5 h - 9.5 h cells were fixed 
and stained for immunofluorescence microscopy and the occurrence of lagging chromosomes was 
analyzed. Bar graphs show the amount of cells exhibiting at least one CREST-positive chromatid 
(mean values ± sem, t-test, n=4 with a total of 400 anaphase cells). (f) Transwell migration assays of 
SK-Mel-103 cells. Cells were transfected with 60 pmol LUCIFERASE or TRIO siRNA. 200,000 cells 
were seeded and bar graphs show the proportion of migrated cells after 24 h (mean ± sem, t-test, 
n=3).  
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However, the proportion of cells showing lagging chromosomes was significantly reduced in 
both cell lines. In SW620 cells, the occurrence of lagging chromosomes was reduced from 
6.25% to 4.25% on average, whereas in SK-Mel-103 cells the amount was decreased from 
3.5% to 1.75% on average (Fig. 3.13b). Transwell migration assays of SK-Mel-103 cells also 
revealed a decreased cell migration activity. Upon ITX3 treatment, the number of migrated 
cells was reduced from 98,333 cells to 53,333 cells (Fig. 3.13c). 
To exclude unspecific effects of the TRIO inhibitor, siRNA-mediated repression of TRIO was 
conducted. These experiments confirmed the results obtained by ITX3 treatment. Although 
the microtubule plus-end assembly rates were not significantly altered during mitosis and 
interphase (Fig. 3.13d), a significant decrease in the occurrence of lagging chromosomes 
was detected in both SW620 and SK-Mel-103 cells upon TRIO repression. SW620 cells 
exhibited on average 4.75% lagging chromosomes, whereas LUCIFERASE transfected cells 
exhibited 7%. In SK-Mel-103 cells, the amount of cells displaying lagging chromosomes was 
reduced from 3.5% to 2% on average (Fig. 3.13e). In addition, SK-Mel-103 cells exhibited a 
reduced migration behavior upon TRIO repression compared to LUCIFERASE transfected 
cells. The amount of migrated cells was reduced from 91,333 cells to 46,667 cells  
(Fig. 3.13f). These results might indicate that increased TRIO activity can account for the 
induction of lagging chromosomes and increased cell migration. 
 
 
3.1.7 Elevated Rac1 Activity Affects CIN And Migration In SW620 And  
SK-Mel-103 Cells 
The previous experiments revealed an increased level of active TRIO in the CIN cell line 
SW620 during mitosis and in the highly migratory and invasive cell line SK-Mel-103. Since 
TRIO functions as a GEF for Rac1 (Blangy et al. 2000; Cannet et al. 2014), it was of interest 
to investigate whether Rac1 activity was increased in these cells. To test this, PAK-PBD 
agarose beads were used for pull down assays to isolate GTP-bound Rac1 from cell lysates 
derived from mitotic HCT116 and SW620 cells and from mitotic and interphase SK-Mel-28 
and SK-Mel-103 cells. 
HCT116 and SW620 cells were synchronized in mitosis by treatment with 2 µM DME for  
16 h. The treatment was combined with DMSO, 0.2 nM Taxol, 15 µM ITX3 or 40 µM of the 
Rac1 inhibitor NSC23766. While the overall Rac1 levels did not vary significantly between 
the two cell lines, DMSO treated SW620 cells displayed nearly 1.5 fold higher levels of active 
Rac1 as opposed to DMSO treated HCT116 cells. Importantly, Taxol treatment of SW620 
cells reduced Rac1 activity to levels similar to HCT116 cells. The inhibition of Rac1 by using 
its specific inhibitor NSC23766 served as a control and revealed a significant inhibition of 
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Rac1, whereas treatment with the TRIO inhibitor ITX3 revealed the dependency of Rac1 on 
TRIO (Fig. 3.14a). 
Rac1 pull down assays were also performed with mitotic and interphase SK-Mel-28 and  
SK-Mel-103 cells. To obtain mitotic lysates, SK-Mel-28 and SK-Mel-103 cells were treated 
with 2 µM DME for 16 h in combination with DMSO, 0.5 nM Taxol, 40 µM NSC23766 or 15 
µM ITX3. Rac1 activity assays using mitotic cell lysates revealed nearly 1.5-fold increased 
levels of active Rac1 in DMSO treated SK-Mel-103 cells compared to DMSO treated  
SK-Mel-28 cells, whereas the overall Rac1 levels did not vary between the two cell lines. 
Similar to the experiment using SW620 cells, treatment with low doses Taxol, NSC23766 
and ITX3 reduced the proportion of active Rac1 also in the melanoma cells (Fig. 3.14b). 
 
 
Figure 3.14: Elevated levels of active Rac1 are dependent on increased microtubule plus-end 
assembly rates. (a) HCT116 cells were treated with DMSO and SW620 cells were treated with 
DMSO, 0.2 nM Taxol, 40 µM NSC23766 or 15 µM ITX3 for 16 h combined with 2 µM DME to 
synchronize cells in mitosis. 1.5 mg of cell lysates were incubated with 10 µg PAK-PBD agarose 
beads for 30 min at 4°C and active Rac1 was precipitated and detected on western blot using Rac1 
specific antibodies. A representative western blot is shown. Western blot quantifications of active Rac1 
protein levels normalized to DMSO treated control cells are represented as bar graphs (mean ± sem, 
t-test, n=3). (b) SK-Mel-28 and SK-Mel-103 cells were treated with 2 µM for 16 h combined with 
DMSO, 0.5 nM Taxol, 40 µM NSC23766 or 15 µM ITX3 and processed as HCT116 and SW620 
described in (a). A representative western blot is shown. Western blot quantifications of active Rac1 
protein levels normalized to DMSO treated control cells are represented as bar graphs (mean ± sem, 
t-test, n=3). (c) Asynchronously growing SK-Mel-28 cells were treated with DMSO and SK-Mel-103 
cells were treated with DMSO, 0.5 nM Taxol, 40 µM NSC23766 or 15 µM ITX3 for 16 h. Interphase 
cell lysates were processed as described in (a). A representative western blot is shown. Western blot 
quantifications of active Rac1 protein levels normalized to DMSO treated control cells are represented 
as bar graphs (mean ± sem, t-test, n=3). 
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SK-Mel-28 and SK-Mel-103 cells were also analyzed regarding their proportions of active 
Rac1 during interphase. Similar to mitotic cells, DMSO treated interphase SK-Mel-103 cells 
exhibited higher levels of active Rac1 as opposed to DMSO treated SK-Mel-28 cells. Here, 
the level of active Rac1 was increased approximately 1.75-fold. Also in interphase, these 
elevated Rac1 levels could be reduced by Taxol, as well as by NSC23766 and ITX3 
treatment (Fig 3.14c). 
Active Rac1 pull-down assays revealed elevated levels of active Rac1 in SW620 cells during 
mitosis and in SK-Mel-103 cells during both, mitosis and interphase. Since ITX3 treatment 
reduced the levels of active Rac1, Rac1 was verified as a downstream target of TRIO. 
In order to further evaluate the relevance of active Rac1 for the migrating and invasive 
phenotype as well as for the generation of lagging chromosomes, a constitutively active 
mutant of Rac1 (Rac1 Q61L) was overexpressed in HCT116 cells. HCT116 cells exhibit 
neither a migratory phenotype nor elevated amounts of cells with lagging chromosomes. 
However, after overexpression of Rac1 Q61L, the migration potential of HCT116 cells was 
enhanced from 35,667 cells to 69,000 cells on average. Treatment with the Rac1 inhibitor 
NSC23766 reduced cell migration observed upon Rac Q61L overexpression to a level 
comparable to the control transfected cells, showing the specificity of the Rac1 Q61L 
overexpression (Fig. 3.15a).  
 
           
Figure 3.15: Overexpression of a constitutively active Rac1 mutant protein induces migration 
and the generation of lagging chromosomes. (a) Transwell migration assays of HCT116 cells 
transfected with a constitutively active mutant of Rac1 (Rac1 Q61L).10 µg Rac1 Q61L were 
overexpressed and cells were treated with H2O or 40 µM NSC23766. 200,000 cells were seeded for 
the migration assay. Bar graphs show the number of migrated cells after 24 h (mean ± sem, t-test, 
n=3). (b) Measurements of mitotic and interphase microtubule plus-end assembly rates in HCT116 
cells with an overexpression of Rac1 Q61L. 1 h prior to EB3 tracking experiments, cells were treated 
with 2 µM DME. Scatter dot plots show the average microtubule plus-end assembly rates of  
20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent experiments).  
(c) Quantification of HCT116 cells displaying lagging chromosomes during anaphase after 
overexpression of Rac1 Q61L. Cells were synchronized at G1/S transition by double thymidine block 
and released into the cell cycle. After 8.5 h cells were fixed and stained for immunofluorescence 
microscopy and cells with lagging chromosomes were quantified. Bar graphs show the amount of 
HCT116 cells exhibiting at least one CREST-positive chromatid (mean values ± sem, t-test, n=3 with 
a total of 300 anaphase cells).  
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Interestingly, EB3 tracking experiments revealed that the overexpression of Rac1 Q61L did 
not affect microtubule plus-end assembly rates (Fig. 3.15b). However, the quantification of 
cells with lagging chromosomes during anaphase showed increased amounts from 2.3% in 
control vector transfected cells to 3.6% in Rac1 Q61L expressing cells (Fig. 3.15c). 
Since the overexpression of a constitutively active Rac1 mutant induced a migratory 
phenotype and the generation of lagging chromosomes, the question arose whether a 
dominant negative mutant of Rac1 would reduce migration and the amount of cells showing 
lagging chromosomes in migratory and CIN cells. To test this, a dominant negative mutant of 
Rac1 (Rac1 T17N), which is described to inhibit Rac1´s function (Ridley et al. 1992), was 
overexpressed in SK-Mel-103 and SW620 cells. In transwell migration assays, the 
overexpression of Rac1 T17N indeed led to a decrease of the migration potential. Upon 
control vector transfection, 95,417 migrating cells were detected on average, which were 
reduced to 51,667 cells upon overexpression of Rac1 T17N (Fig. 3.16a). While having no 
significant influence onto the microtubule plus-end assembly rates of SW620 and  
SK-Mel-103 cells (Fig. 3.16b), the amount of cells exhibiting lagging chromosomes was 
significantly decreased (Fig. 3.16c). Control transfected SK-Mel-103 cells exhibited 4% 
lagging chromosomes on average, which were reduced to 2.25% upon overexpression of 
Rac1 T17N. In SW620 cells, the occurrence of lagging chromosomes was reduced from 
6.7% to 3.3%. 
 
 
Figure 3.16: Overexpression of a dominant negative mutant protein of Rac1 reduces migration 
and the generation of lagging chromosomes in SW620 and SK-Mel-103 cells. (a) Transwell 
migration assays of SK-Mel-103 cells transfected with Rac1 T17N.10 µg Rac1 T17N or control vector 
were overexpressed. 200,000 cells were seeded in cell culture inserts for migration assay. Bar graphs 
show the amount of migrated cells after 24 h (mean ± sem, t-test, n=3). (b) Measurements of mitotic 
and interphase microtubule plus-end assembly rates in SW620 and SK-Mel-103 cells with an 
overexpression of Rac1 T17N. 1 h - 2 h prior to EB3 tracking experiments, cells were treated with  
2 µM DME. Scatter dot plots show the average microtubule plus-end assembly rates of 20 
microtubules per cell (mean ± sem, t-test, n=30 cells from three independent experiments).  
(c) Quantification of cells showing lagging chromosomes during anaphase in SW620 and SK-Mel-103 
cells with an overexpression of Rac1 T17N. Cells were synchronized at G1/S transition by double 
thymidine block and released into the cell cycle. After 8.5 h - 9.5 h cells were fixed and stained for 
immunofluorescence microscopy. Bar graphs show the amount of cells exhibiting at least one  
CREST-positive signal (mean ± sem, t-test, n=3 (SW620) - 4 (SK-Mel-103) with a total of 300-400 
anaphase cells).  
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To further substantiate the role of Rac1 in cell migration and in the generation of lagging 
chromosomes, Rac1 activity was inhibited in SW620 and SK-Mel-103 cells by treatment with 
the Rac1 specific inhibitor NSC23766. In transwell migration assays, NSC23766 treatment 
led to a significant decrease of migrating SK-Mel-103 cells. In comparison to control treated 
cells, the amount of migrated cells was reduced from 93,250 cells to 44,333 cells on average 
upon NSC23766 treatment (Fig. 3.17a). In addition, analyses of lagging chromosomes in 
SW620 and SK-Mel-103 cells revealed a decreased number of cells displaying lagging 
chromosomes after treatment with NSC23766. The occurrence of lagging chromosomes was 
reduced from 6.3% to 3.3% and 4.3% to 2% in SW620 and SK-Mel-103 cells, respectively 
(Fig. 3.17b). However, microtubule plus-end assembly rates were neither altered in 
interphase nor in mitosis in both cell lines (Fig. 3.17c). 
 
 
Figure 3.17: Inhibition of Rac1 by its specific inhibitor decreases migration and the generation 
of lagging chromosomes. (a) Transwell migration assays of SK-Mel-103 cells treated with H2O or  
40 µM NSC23766. 200,000 cells were seeded for the migration assay. Bar graphs show the number of 
migrated cells after 24 h (mean ± sem, t-test, n=3). (b) Quantification of cells showing lagging 
chromosomes during anaphase in SW620 and SK-Mel-103 cells treated with H2O or 40 µM 
NSC23766. Cells were synchronized by double thymidine block and released into the cell cycle. After 
8.5 h - 9.5 h, cells were fixed and stained for immunofluorescence microscopy. Bar graphs show the 
proportion of cells exhibiting at least one CREST-positive chromatid (mean ± sem, t-test, n=3 with a 
total of 300 anaphase cells). (c) Measurements of mitotic and interphase microtubule plus-end 
assembly rates in SW620 and SK-Mel-103 cells. Cells were treated with H2O or 40 µM NSC23766 for 
2 h. 1-2 h prior to EB3 tracking experiments, cells were treated with 2 µM DME. Scatter dot plots show 
the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, 
n=30 cells from three independent experiments). 
 
 
These results substantiate the hypothesis, that elevated levels of Rac1 contribute to both, a 




                              Results 
78 
 
3.1.8 The Arp2/3 Complex Acts Downstream Of Rac1 During Migration And The 
Development Of CIN 
Rac1 is well described for its role in lamellipodia formation during cell motility. In the 
lamellipodium, actin branching is achieved by Rac1-mediated activation of the Arp2/3 
complex (Ridley et al. 2003). Therefore, it was of interest to investigate whether the Arp2/3 
complex acts as a downstream effector of Rac1 during migration and chromosome 
segregation. 
To address this, inhibition of Arp2/3 was achieved by using the specific Arp2/3 inhibitor 
CK666 in SW620 and SK-Mel-103 cells. Transwell migration assays using SK-Mel-103 cells 
were performed and revealed a significantly decreased amount of migrated cells upon 
CK666 treatment. The number of migrated SK-Mel-103 cells was reduced from 89,667 cells 
on average in control experiments to 58,167 migrated cells upon CK666 treatment  
(Fig. 3.18a). Analyses of cells displaying lagging chromosomes revealed a significant 
decrease of chromosome missegregation in both cell lines. In CK666 treated SW620 cells, 
the amount of cells showing lagging chromosomes was reduced from 6% to 3.6% on 
average, whereas CK666 treatment in SK-Mel-103 cells decreased the number from 4.3% to 
2.3% (Fig. 3.18b). Similar to treatments with NSC23766 and ITX3, CK666 treatment had no 
significant influence on the microtubule plus-end assembly rates during mitosis and 
interphase in SW620 and SK-Mel-103 cells (Fig. 3.18c). 
 
 
Figure 3.18: Inhibition of the Arp2/3 complex decreases migration and the generation of 
lagging chromosomes. (a) Transwell migration assays of SK-Mel-103 cells treated with H2O or  
20 µM CK666. 200,000 cells were seeded in cell culture inserts for the migration assay. Bar graphs 
show the number of migrated cells after 24 h (mean ± sem, t-test, n=3). (b) Quantification of cells 
exhibiting lagging chromosomes during anaphase in SW620 and SK-Mel-103 cells treated with H2O or 
20 µM CK666. Cells were synchronized by double thymidine block and released into the cell cycle. 
After 8.5 h - 9.5 h, cells were fixed and stained for immunofluorescence microscopy. Bar graphs show 
the proportion of cells exhibiting at least one CREST-positive chromatid (mean ± sem, t-test, n=3 with 
a total of 300 anaphase cells). (c) Measurements of mitotic and interphase microtubule plus-end 
assembly rates in SW620 and SK-Mel-103 cells. Cells were treated with DMSO or 20 µM CK666 for  
2 h. 1-2 h prior to EB3 tracking experiments, cells were treated with 2 µM DME. Scatter dot plots show 
the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, 
n=30 cells from three independent experiments). 
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Since the inhibition of the Arp2/3 complex revealed similar results as previously obtained by 
Rac1 and TRIO inhibition, it seems likely, that TRIO, Rac1 and the Arp2/3 complex act in the 
same pathway. All three proteins seem to be important players for the development of a 
highly migratory phenotype and for the generation of lagging chromosomes. On the other 
hand, inhibition of any component of the TRIO-Rac1-Arp2/3 pathway resulted in decreased 
migration and decreased chromosome missegregation in highly migratory and invasive 
cancer cells exhibiting CIN. 
 
3.1.9 Inhibition Of TRIO, Rac1 And The Arp2/3 Complex Affects Spindle 
Orientation In SW620 Cells 
Ertych et al. described the phenotype of increased microtubule plus-end assembly rates and 
showed that these increased microtubule plus-end assembly rates are associated with 
transient mitotic spindle orientation defects, which, in turn, result in the induction of lagging 
chromosomes (Ertych et al. 2014). Since inhibition of TRIO, Rac1 and the Arp2/3 complex 
reduced the amounts of lagging chromosomes, I investigated, whether spindle orientation is 
influenced by the TRIO-Rac1-Arp2/3 pathway. To address this question, SW620 cells were 
seeded onto fibronectin coated slides and treated with DMSO, 0.2 nM Taxol, 15 µM ITX3,  
40 µM NSC23766 or 20 µM CK666 for 16 h. Afterwards, cells were fixed for immuno-
fluorescence microscopy and the spindle axis angle was determined. Staining for α-tubulin, 
ɣ-tubulin and DAPI marked the mitotic spindle and the centrosomes and allowed the 
discrimination between cells in prometaphase and cells in metaphase due to positioning of 
the centrosomes with respect to the chromosomes (Fig. 3.19a). Images with a z-optical 
spacing of 0.4 µm were taken and the spindle axis angle was determined by the formula: 
spindle axis angle= (number of z-stacks*0.4 µm / distance of centrosomes) *180/ π  
(Fig. 3.19b). 
During prometaphase, DMSO treated SW620 cells exhibited a mean spindle axis angle of 
22.8°, which was significantly reduced to 9.2° upon treatment with 0.2 nM Taxol. Similarly, 
inhibition of TRIO, Rac1 or the Arp2/3 complex significantly decreased the spindle axis 
angle. Upon drug treatment, mean spindle axis angles were reduced to values ranging from 
10.1° to 10.9° (Fig. 3.19c). During metaphase, the spindle axis angle in DMSO treated 
SW620 cells was not as variable as observed in prometaphase cells. While prometaphase 
cells exhibited 22.8°, the analyses of metaphase cells revealed a mean spindle axis angle of 
8.5°. However, a reduction of the mean spindle axis angle in metaphases was also detected 
upon inhibitor treatment. Taxol treatment reduced the angle in metaphase to 4.6°. Upon 
ITX3, NSC23766 and CK666 treatment, the spindle axis angles were reduced to 4.4°, 5.4° 
and 4.2°, respectively (Fig. 3.19d). 
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Figure 3.19: Analyses of spindle orientation in SW620 cells during prometaphase or 
metaphase. (a) Representative immunofluorescence images of DMSO or Taxol treated 
prometaphase or metaphase SW620 cells. Cells were stained for α-tubulin, ɣ-tubulin and DAPI.  
A maximum intensity projection as well as pictures with focused centrosomes are shown. Z refers to 
the respective z-stack with focused centrosome. Scale bar 10 µM. (b) Schematic illustration for the 
determination of the spindle axis angle. (c) Measurements of spindle axis angle in prometaphase. 
SW620 cells were seeded onto fibronectin coated slides and treated with DMSO, 0.2 nM Taxol,  
15 µM ITX3, 40 µM NSC23766 or 20 µM CK666 for 16 h. Afterwards, cells were fixed and stained for 
immunofluorescence microscopy. Pictures of cells in prometaphase were taken and the angle 
between centrosomes and substratum was analyzed. The box and whisker plots show the range, 
median and quartile of the measurements (t-test, n= 60 cells from three independent experiments). 
Additionally, mean values are given. (d) Measurements of spindle axis angle in metaphase. SW620 
cells were treated as described in (a). Pictures of cells in metaphase were taken and the angle 
between centrosomes and substratum was determined. The box and whisker plots show the range, 
mean and quartile of the measurements (t-test, n= 60 cells from three independent experiments). 
Additionally, mean values are given.  
 
 
These results indicate an important role for TRIO, Rac1 and the Arp2/3 complex in spindle 
positioning during mitosis, in addition to their well established role in cell motility. 
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3.1.10 Inhibition Of TRIO, Rac1 Or The Arp2/3 Complex Suppresses CIN In 
SW620 And SK-Mel-103 Cells 
SK-Mel-103 and SW620 cells exhibited an increased amount of cells displaying lagging 
chromosomes, which were reduced by treatment with the TRIO inhibitor ITX3, the Rac1 
inhibitor NSC23766 and the Arp2/3 complex inhibitor CK666. Since the occurrence of lagging 
chromosomes is a widely recognized mechanism for the appearance of CIN (Cimini et al. 
2001), it was of interest to investigate whether the inhibition of TRIO, Rac1 and the Arp2/3 
complex would also affect the CIN phenotype present in SK-Mel-103 and SW620 cells. To 
evaluate CIN, single cell clones of both cell lines were generated in the presence or absence 
of the different inhibitors. As a control, cells were treated with low doses of Taxol, because 
Taxol was already proven to suppress CIN (Ertych et al. 2014). Cell clones were grown for 
30 generations and their chromosome number deviation was analyzed by chromosome 
counting in metaphase spreads and by CEP-FISH analyses. SW620 cell clones were 
analyzed by individual chromosome counting. Upon Taxol treatment, the amount of cells with 
a chromosome numbers deviating from modal was highly decreased (Fig. 3.20a). 
 
                            
Figure 3.20: Inhibition of TRIO, Rac1 or the Arp2/3 complex suppresses CIN in SW620 cells.  
(a) Karyotype analyses by chromosome counting in metaphase spreads of single cell clones derived 
from SW620 cells treated with DMSO or 0.2 nM Taxol for 30 generations. The percentage of cells 
with a chromosome number deviating from modal was determined (n=100 cells). (b) Karyotype 
analyses by chromosome counting in metaphase spreads of single cell clones derived from SW620 
cells treated with DMSO or 15 µM ITX3 for 30 generations. The percentage of cells with  
a chromosome number deviating from modal was determined (n=100 cells). (c) Karyotype analyses 
by chromosome counting in metaphase spreads of single cell clones treated with H2O or 40 µM 
NSC23766 for 30 generations. The percentage of cells with a chromosome number deviating from 
modal was determined (n=100 cells). (d) Karyotype analyses by chromosome counting in metaphase 
spreads of single cell clones derived from SW620 cells treated with H2O or 20 µM CK666 for  
30 generations. The percentage of cells with a chromosome number deviating from modal was 
determined (n=100 cells). 
                              Results 
82 
 
Also ITX3, NSC23677 and CK666 treated single cell clones showed decreased numbers of 
aneuploid cells when compared to the respective control treated cells (Fig. 3.20b-d). 
Thereby, inhibition of TRIO by ITX3 revealed the strongest reduction in cells with 
chromosome numbers deviating from modal. 
SW620 single cell clones were further studied by CEP-FISH analyses. Therefore, α-satellite 
probes specific for chromosome 7 and chromosome 15 were used. 
 
                          
Fig. 3.21: CEP-FISH analyses of SW620 derived single cell clones treated with TRIO, Rac1 or 
Arp2/3 complex inhibitor. (a) CEP-FISH analyses detecting chromosome 7 and chromosome 15 in 
single cell clones derived from SW620 cells treated with DMSO or 0.2 nM Taxol for 30 generations. 
The percentage of cells with a chromosome number deviating from modal was calculated (n=100 
cells). (b) CEP-FISH analyses of single cell clones derived from SW620 cells treated with DMSO or 
15 µM ITX3 for 30 generations. The percentage of cells with a chromosome number deviating from 
modal was calculated (n=100 cells). (c) CEP-FISH analyses of single cell clones derived from SW620 
cells treated with H2O or 40 µM NSC23766 for 30 generations. The percentage of cells with  
a chromosome number deviating from modal was calculated (n=100 cells). (d) CEP-FISH analyses of 
single cell clones derived from SW620 cells treated with H2O or 20 µM CK666 for 30 generations. 




In order to verify the results obtained in SW620 cells, also SK-Mel-103 cells were analyzed 
after treatment with the different inhibitors by CEP-FISH analyses. Here, α-satellite probes 
specific for chromosome 6 and chromosome 18 were used. Also in this cell line, the different 
treatments reduced the amount of cells with chromosome numbers deviating from modal. 
Treatment with Taxol, ITX3 and NSC23766 had a stronger effect than treatment with CK666. 
Whereas upon Taxol, ITX3 and NSC23766 treatment the amount of aneuploid cells was 
reduced by 18-24%, CK666 treatment led to a reduction in aneuploid cells by 9-11% in the 
different single cell clones (Fig. 3.22a-d). 
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Figure 3.22: Inhibition of TRIO, Rac1 and Arp2/3 complex suppresses CIN in SK-Mel-103 cells. 
(a) CEP-FISH analyses detecting chromosome 6 and chromosome 18 in single cell clones derived 
from SK-Mel-103 cells treated with DMSO or 0.5 nM Taxol for 30 generations. The percentage of 
cells with a chromosome number deviating from modal was calculated (n=100 cells). (b) CEP-FISH 
analyses of single cell clones derived from SK-Mel-103 cells treated with DMSO or 15 µM ITX3 for  
30 generations. The percentage of cells with a chromosome number deviating from modal was 
calculated (n=100 cells). (c) CEP-FISH analyses of single cell clones derived from SK-Mel-103 cells 
treated with H2O or 40 µM NSC23766 for 30 generations. The percentage of cells with a 
chromosome number deviating from modal was calculated (n=100 cells). (d) CEP-FISH analyses of 
single cell clones derived from SK-Mel-103 cells treated with H2O or 20 µM CK666 for  
30 generations. The percentage of cells with a chromosome number deviating from modal was 
calculated (n=100 cells). 
 
 
In order to test whether long-term treatment of cells with the different inhibitors has an effect 
on cell migration and microtubule plus-end assembly rates, one single cell clone derived from 
Taxol, ITX3, NSC23766 and CK666 treated SW620 or SK-Mel-103 cells was analyzed. As 
expected, Taxol treatment reduced the microtubule plus-end assembly rates during mitosis 
and interphase in single cell clones (Fig. 3.23a). In contrast, treatment with ITX3, NSC23766 
or CK666 did not alter microtubule plus-end assembly rates. Transwell migration assays 
were performed with a single cell clone derived from SK-Mel-103 cells treated with  
0.5 nM Taxol, 15 µM ITX3, 40 µM NSC23766 or 20 µM CK666. Here, prolonged treatment 
with the different inhibitors reduced cell migration robustly (Fig. 3.23b). 
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Figure 3.23: Single cell clones treated with inhibitor of TRIO, Rac1 or the Arp2/3 complex show 
no alterations in microtubule plus-end assembly rates but a reduce migratory phenotype.  
(a) Measurements of microtubule plus-end assembly rates during mitosis and interphase. Single cell 
clone 1 of SW620 (Fig. 3.20, Fig 3.21) and clone 1 of SK-Mel-103 (Fig. 3.22) generated over 30 
generations in the presence of DMSO, 0.2 nM (SW620) or 0.5 nM (SK-Mel-103) Taxol, 15 µM ITX3, 
40 µM NSC23766 and 20 µM CK666 were treated with 2 µM DME for 1 h - 2 h prior to EB3 tracking 
experiments. Scatter dot plots show the average microtubule plus-end assembly rates of  
20 microtubules per cell (mean ± sem, t-test, n=10 cells). (b) Transwell migration assays of  
SK-Mel-103 single cell clones treated as described in (a). 200,000 cells were seeded in cell culture 
inserts. Bar graphs show the number of migrated cells after 24 h (mean ± sem, t-test, n=3). 
 
 
To further verify that the observed reduction in aneuploidy depends on the used drugs, the 
generated single cell clones were cultivated for further 30 generations in the absence of 
drugs. Afterwards, the chromosome numbers were determined by CEP-FISH analyses and 
compared to the chromosome copy numbers obtained before removal of the drug. These 
analyses revealed an increase in aneuploid cells in all SW620 and SK-Mel-103 cell clones 
after removal of the different drugs (Fig. 3.24a-b). Thus, CIN is re-introduced after re-
activation of the TRIO-Rac1-Arp2/3 pathway. 
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Figure 3.24: Drug removal re-induces CIN. (a) CEP-FISH analyses of SW620 cells before and after 
drug removal. After treatment with Taxol, ITX3, NSC23766 and CK666 for 30 generations, SW620 
derived single cell clones were treated with DMSO for additional 30 generations. The percentage of 
cells with a chromosome number deviating from modal was determined (n=100 cells). (b) CEP-FISH 
analyses of SK-Mel-103 cells before and after drug removal. After treatment with Taxol, ITX3, 
NSC23766 and CK666 for 30 generations, SK-Mel-103 derived single cell clones were treated with 
DMSO for additional 30 generations. The proportion of cells with a chromosome number deviating 
from modal was calculated (n=100 cells). 
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3.2 The Role Of p53 And p73 In Chromosomal Instability And Migration 
 
3.2.1 Loss Of TP53 And TP73 Increases Microtubule Plus-End Assembly Rates 
And Induces CIN 
A frequent lesion in the vast majority of human cancer types is a loss of function of the tumor 
suppressor p53. However, the loss of TP53 is not sufficient to induce aneuploidy in human 
cells (Bunz et al. 2002). The p53 homolog TP73 is located on chromosome arm 1p36, which 
is frequently deleted in various cancer types. This loss was shown to be associated with 
cancer (Kaghad et al. 1997). Furthermore, p73 suppresses polyploidy in the absence of p53 
(Talos et al. 2007). Therefore, we were interested to investigate whether p53 and p73 might 
cooperate to suppress CIN in cancer cells. 
To address this hypothesis, TP53 and TP73 were either separately or concomitantly 
repressed by siRNA in the chromosomal stable cell line HCT116 and microtubule plus-end 
assembly rates were measured. The knock down efficiency of TP53 and TP73 was 
confirmed by western blot (Fig. 3.25a).  
 
 
Figure 3.25: Concomitant repression of TP53 and TP73 leads to increased microtubule plus-
end assembly rates and induces the generation of lagging chromosomes. (a) Representative 
western blot showing the downregulation of TP53 and TP73 in response to siRNA transfection. β-actin 
was used as loading control. (b) Determination of microtubule plus-end assembly rates after 
repression of TP53, TP73 or both concomitantly. HCT116 cells were transfected with 60 pmol TP53, 
TP73 or LUCIFEARSE siRNA. For EB3 tracking experiments, cells were treated with 2 µM DME for  
1 h. Scatter dot plots show the average microtubule plus-end assembly rates of 20 microtubules per 
cell (mean ± sem, t-test, n=30 cells from three independent experiments). (c) Quantification of cells 
showing lagging chromosomes during anaphase in HCT116 cells after separate or concomitant 
repression of TP53 and TP73. Cells were synchronized at G1/S by double thymidine block and 
released into the cell cycle for 8.5 h. Cells were fixed and stained for immunofluorescence 
microscopy. Bar graphs show the number of cells exhibiting at least one CREST-positive chromatid 
(mean ± sem, t-test, n=3 with a total of 300 anaphase cells). (d) Quantification of cells exhibiting 
chromatin bridges. Cells were processed as described in (c). Bar graphs show the number of cells 
displaying chromatin bridges (mean ± sem, t-test, n=3 with a total of 300 anaphase cells). 
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The knock down of either TP53 or TP73 revealed only a slight increase in microtubule plus-
end assembly rates, whereas the simultaneous repression of both transcription factors 
greatly increased the microtubule plus-end assembly rates during mitosis and interphase 
when compared to LUCIFERASE siRNA transfected cells (Fig. 3.25b). During mitosis, the 
microtubule plus-end assembly rates were increased from 16.0 µm/min upon LUCIFERASE 
siRNA to 19.7 µm/min upon repression of both TP53 and TP73. During interphase, 
microtubule plus-end assembly rates were enhanced from 16.4 µm/min to 19.7 µm/min. 
Since increased microtubule plus-end assembly rates cause the generation of lagging 
chromosomes, the role of p53 and p73 during chromosome segregation was investigated. 
Cells were synchronized at G1/S transition by a double thymidine block and released into the 
cell cycle. Cells were fixed and stained after 8.5 h and cells in anaphase displaying lagging 
chromosomes were quantified. Importantly, the concomitant repression of TP53 and TP73 in 
chromosomal stable HCT116 cells induced the appearance of cells exhibiting lagging 
chromosomes from 1.6% to 4.3%. The repression of either TP53 or TP73 alone did not 
significantly increase the proportion of cells with lagging chromosomes (Fig. 3.25c). Apart 
from the occurrence of lagging chromosomes, depletion of TP53 and TP73 led to highly 
increased numbers of cells showing chromatin bridges during anaphase (Fig. 3.25d). 
Lagging chromosomes underlie CIN in cancer cells (Cimini et al. 2001). In order to further 
evaluate the impact of TP53 and TP73 on chromosomal stability, HCT116-TP53-/- cells were 
used for the generation of stable single cell clones repressed of TP73 by using a TP73 
shRNA expression plasmid. Furthermore, HCT116-TP53-/- cells were transfected with a 
control shRNA expression plasmid. HCT116-TP73 shRNA expression cells were available in 
our lab. TP73 repression was verified by western blot analyses (Fig. 3.26a). Stable cell 
clones with a significant repression of TP73 (TP73sh clones) were further analyzed regarding 
their microtubule plus-end assembly rates by EB3 tracking experiments. Here, cells with a 
repression of both transcription factors showed significantly increased microtubule plus-end 
assembly rates in mitosis and in interphase when compared to the single knock down cells 
HCT116-TP53-/- and HCT116-TP73sh (Fig. 3.26b). The increased microtubule plus-end 
assembly rates also correlated with elevated amounts of cells with lagging chromosomes. 
Upon repression of both transcription factors, the amount of cells displaying lagging 
chromosomes was increased more than 3-fold compared to single knock down cells  
(Fig. 3.26c). Karyotype analyses of three individual single cell clones by individual 
chromosome counting in metaphase spreads revealed an increased amount of cells with 
chromosome numbers deviating from modal number of 45 after concomitant loss of TP53 
and TP73 (Fig. 3.26d). The amount of aneuploid cells was increased from 12% in both 
control transfected HCT116-TP53-/- cell clones to 32%-44% in the three cell clones repressed 
of both transcription factors, indicating a chromosomal instability phenotype. 
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Figure 3.26: The concomitant repression of TP53 and TP73 leads to CIN. (a) HCT116-TP53
-/-
 
cells were stably transfected with a TP73 shRNA or a control shRNA expression plasmid and single 
cell clones were isolated. Knock down of TP73 was verified by western blot, whereby β-actin served 
as loading control. (b) EB3 tracking experiments of cells in mitosis and interphase. The indicated 
single cell clones were treated with 2 µM DME 1 h prior to EB3 tracking experiments. Scatter dot 
plots show the average microtubule plus-end assembly rates of 20 microtubules per cell  
(mean ± sem, t-test, n=20 cells from two independent experiments). (c) Quantification of cells 
showing lagging chromosomes during anaphase. The indicated single cell clones were synchronized 
at G1/S transition by a double thymidine block and released into the cell cycle. Bar graphs show the 
proportion of cells exhibiting at least one CREST-positive chromatid (mean ± sem, t-test, n=3 with a 
total of 300 anaphase cells). (d) Induction of CIN after repression of TP53 and TP73. Karyotype 
analyses of single cell clones were performed by chromosome counting in metaphase spreads. The 
percentage of cells with a chromosome number deviating from modal was calculated (n=100 cells). 
 
 
These results showed that separate repression of TP53 or TP73 is not sufficient to induce 
chromosomal instability and aneuploidy in HCT116 cells. However, the concomitant 
repression of TP53 and TP73 induces CIN.  
To test whether the occurrence of lagging chromosomes and CIN depends on the increased 
microtubule plus-end assembly rates (Fig. 3.25b), single cell clones repressed of TP53 and 
TP73 were treated with 0.2 nM Taxol over 30 generations followed by drug removal for 
additional 30 generations. Upon low dose Taxol treatment, cells with low expression of TP53 
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and TP73 showed decreased microtubule plus-end assembly rates, that were again 
increased after Taxol removal (Fig. 3.27a). Corresponding to that observation, the proportion 
of cells displaying lagging chromosomes increased after Taxol removal by about 3-4 fold 
(Fig. 3.27b). Karyotype analyses by counting individual chromosomes in metaphase spreads 
revealed between 20% and 25% of cells with a chromosome number deviating from modal 
upon Taxol treatment. After Taxol removal, the amount of aneuploid cells increased to 40% 
to 50% in the three different cell clones (Fig. 3.27c). 
 
     
Figure 3.27: The CIN phenotype induced by loss of TP53 and TP73 in HCT116 cells can be 
suppressed by Taxol treatment. (a) Measurements of microtubule plus-end assembly rates in 
HCT116-TP53
-/-
 with a stable repression of TP73. Single cell clones were treated with 0.2 nM Taxol for 
30 generations, following removal of Taxol and cultivation in DMSO for additional 30 generations. 
Cells were treated with 2 µM DME 1 h prior to EB3 tracking experiments. Scatter dot plots show the 
average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=10 
cells). (b) Quantification of the amount of cells exhibiting lagging chromosomes during anaphase. 
Single cell clones were generated as described in (a). Cells were synchronized at G1/S transition by 
double thymidine block, released into the cell cycle for 8.5 h and fixed and stained for 
immunofluorescence microscopy. Bar graphs show the proportion of cells displaying at least one 
CREST-positive chromatid (n= 100 anaphase cells counted). (c) Karyotype analyses of single cell 
clones. Single cell clones were generated as described in (a). The proportion of cells with a 
chromosome number deviating from modal was calculated (n=100 cells). 
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These results indicate a causal role for increased microtubule plus-end assembly rates 
induced by loss of p53 and p73 for the development of CIN. 
To exclude unspecific effects of the TP73 shRNA construct, TAp73 was re-expressed in 
HCT116-TP53-/-/TP73sh cells. Furthermore, TAp73 was re-expressed in HCT116 and 
HCT116-TP53-/-  cells, which served as control cell lines. Stable cell clones were generated 
by the use of a doxycycline inducible TAp73 expression vector. The re-expression of TAp73 
in individual single cell clones was confirmed by western blot analyses (Fig. 3.28a).  
 
 
Figure 3.28: The re-expression of TAp73 suppresses CIN in HCT116-TP53
-/-
/TP73sh cells. (a) 




 /TP73sh cells and 
single cell clones were isolated. The re-expression of TAp73 was verified by western blot. β-actin 
served as a loading control (b) Measurements of microtubule plus-end assembly rates in single cell 
clones, that are shown in (a). Cells were treated with 2 µM DME 1 h prior to EB3 tracking 
experiments. Scatter dot plots show the average microtubule plus-end assembly rates of  
20 microtubules per cell (mean ± sem, t-test, n=10 cells). (c) Quantification of the proportion of cells 
showing lagging chromosomes in single cell clones, that are shown in (a). Cells were synchronized at 
G1/S transition by double thymidine block, released into the cell cycle and fixed and stained for 
immunofluorescence microscopy after 8.5 h. Bar graphs show the quantification of cells exhibiting at 
least one CREST-positive chromatid (mean ± sem, t-test, n=3 with a total of 300 anaphase cells).  
(d) Karyotype analyses of the indicated single cell clones. The proportion of cells with a chromosome 
number deviating from modal was determined by chromosome counting in metaphase spreads 
(n=100 cells). 
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EB3 tracking experiments were performed to investigate the microtubule plus-end assembly 
rates. The control cells (HCT116-TAp73 and HCT116-TP53-/--TAp73) were not altered in 
their microtubule plus-end assembly rates, revealing that overexpression of TAp73 does not 
affect microtubule dynamics. However, re-expression of TAp73 in HCT116-TP53-/-/TP73sh 
cells decreased the microtubule plus-end assembly rates during interphase and mitosis 
comparable to control transfected HCT116-TP53-/-/TP73sh cells (Fig. 3.28b). Consequently, 
the amount of cells showing lagging chromosomes was decreased approximately 3-fold upon 
re-expression of TAp73 in HCT116-TP53-/-/TP73sh cells, whereas the generation of lagging 
chromosomes was not affected in HCT116 and HCT116-TP53-/- cells (Fig. 3.28c). Karyotype 
analyses by chromosome counting from metaphase spreads revealed a decreased amount 
of cells with a chromosome number deviating from modal in HCT116-TP53-/-/TP73sh cells 
exhibiting a stable re-expression of TAp73 compared to control transfected  
HCT116-TP53-/-/TP73sh cells (Fig. 3.28d). These results support the hypothesis that p53 and 
p73 cooperate in maintaining both, proper microtubule plus-end assembly rates in mitosis 
and chromosomal stability. 
So far, cells with a knock out of TP53 were used. However, this situation is not a common 
feature of cancer cells. Instead, human cancer cells rather exhibit a loss of function of p53 
due to mutations. Different hot spot mutations were described including a most frequent p53 
R175H mutation (Muller & Vousden 2013). HCT116 cells expressing a TP53 R175H mutant 
where used to further evaluate the importance of both p53´s and p73´s function for the 
maintenance of chromosomal stability. HCT116-p53-R175H single cell clones stably 
transfected with control shRNA or TP73 shRNA expression plasmids were isolated and the 
knock down of TP73 was verified by western blot analyses (Fig. 3.29a). Subsequently, 
microtubule plus-end assembly rates were determined. While the p53 mutation alone did not 
affect microtubule plus-end assembly rates, the stable repression of TP73 in HCT116-p53-
R175H cells resulted in an increase in microtubule plus-end assembly rates. Furthermore, 
the cell clones were treated with 0.2 nM Taxol 2 h prior to EB3 tracking experiments. The low 
dose Taxol treatment led to a decrease in microtubule plus-end assembly rates to levels 
similarly observed in the control transfected HCT116-p53-R175H cell clone 1 (Fig. 3.29b). 
Analyses of HCT116-p53-R175H cells with low TP73 expression revealed an increased 
proportion of cells displaying lagging chromosomes in comparison to control transfected 
HCT116-p53-R175H cells. While the proportion of control cells exhibiting lagging 
chromosomes was in a range from 1%-2%, on average 5%-5.6% of the single cell clones 
derived from HCT116-p53-R175H repressed of TP73 showed lagging chromosomes  
(Fig. 3.29c). Subsequently, karyotype analyses by chromosome counting from metaphase 
spreads were conducted. Importantly, HCT116-p53-R175H cell clones with low TP73 
expression also displayed a higher amount of cells with a chromosome number deviating 
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from modal. This number was increased from 20%-26% in control transfected HCT116-p53-
R175H cells to 43%-46% in the three HCT116-p53-R175H cell clones repressed of TP73 
(Fig. 3.29d), indicating that the TP53 mutation in combination with loss of TP73 induced CIN. 
 
           
Figure 3.29: Repression of TP73 in HCT116 cells expressing a mutant form of p53 induces 
CIN. (a) TP73 was stably repressed in HCT116 cells expressing mutant TP53 (p53-R175H) by 
shRNA and single cell clones were generated. The repression of TP73 was verified by western blot. 
β-actin served as loading control. (b) Measurements of microtubule plus-end assembly rates in the 
single cell clones shown in (a). Cells were treated with 2 µM DME 1 h prior to EB3 tracking. Scatter 
dot plots show the average microtubule plus-end assembly rates of 20 microtubules per cell (mean ± 
sem, t-test, n=10 cells). (c) Quantification of proportion of cells with lagging chromosomes in the 
single cell clones shown in (a). Cells were synchronized by double thymidine block, released into the 
cell cycle and fixed for immunofluorescence microscopy after 8.5 h. Bar graphs show quantification of 
cells exhibiting at least one CREST-positive chromatid (mean ± sem, t-test, n=3 with a total of 300 
anaphase cells). (d) Karyotype analyses of the indicated single cell clones by individual chromosome 
counting from metaphase spreads. The percentage of cells with a chromosome number deviating 
from modal was determined (n=100 cells). 
 
 
Another common genetic alteration of cancer cells is the overexpression of a truncated form 
of p73, which is ∆Np73. ∆Np73 is described to inhibit both, p53´s and p73´s function and 
might act in a dominant negative manner (Zaika et al. 2002). To investigate the influence of 
∆Np73 expression on microtubule plus-end assembly rates, ∆Np73 was overexpressed in 
HCT116 cells. To verify the inhibition of p53´s function by ∆Np73, cells were treated with  
600 nM adriamycin for 16h to induce DNA damage and the activation of p53. Western blot 
analyses were performed and the protein level of the p53 target p21 was examined. While 
the overexpression of ∆Np73 did not alter the protein level of p53 itself, the p53-mediated 
induction of p21 was greatly decreased suggesting that p53 function is inhibited (Fig. 3.30a). 
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Furthermore, EB3 tracking experiments were performed. The overexpression of ∆Np73 in 
HCT116 cells also increased the microtubule plus-end assembly rates during both, mitosis 
and interphase in comparison to control transfected cells (Fig. 3.30b). Moreover, in the same 
cells, the proportion of cells with lagging chromosomes was also increased (Fig. 3.30c). 
 
          
Figure 3.30: The expression of ∆Np73 increases microtubule plus-end assembly rates and 
induces the occurrence of lagging chromosomes. (a) △Np73 was transiently overexpressed in 
HCT116 cells. Cells were treated with 600 nM adriamycin for 16 h and p21 protein levels were 
detected on western blot. β-actin was used as a loading control. (b) Measurements of microtubule 
plus-end assembly rates after overexpression of △Np73. Cells were treated with 2 µM DME 1 h prior 
to EB3 tracking experiments. Scatter dot plots show the average microtubule plus-end assembly 
rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent 
experiments). (c) Quantification of cells with lagging chromosomes during anaphase in HCT116 cells 
after transient overexpression of △Np73. Cell cycle synchronization at G1/S transition was achieved 
by a double thymidine block. Cells were released into the cell cycle for 8.5 h and fixed and stained for 
immunofluorescence microscopy. Bar graphs show the proportion of cells displaying at least one 
CREST-positive chromatid (mean ± sem, t-test, n=3 with a total of 300 anaphase cells). 
 
 
These results indicate that expression of ∆Np73 is sufficient to functionally inactivate both, 
p53 and p73 and to mediate an increase of microtubule plus-end assembly rates and 
chromosome segregation defects. 
 
3.2.2 Abnormal Microtubule Dynamics Induced By Loss Of TP53 And TP73 Are 
Mediated By p21 
Since p53 and p73 are transcription factors it is likely that upon loss of both various genes 
might not be transactivated. In collaboration with the Transcriptome and Genome Analysis 
Laboratory (TAL) of the University Göttingen RNA sequencing of HCT116 cells synchronized 
in G2 was performed. For this, HCT116 cells were separately or concomitantly depleted of 
TP53 and TP73by siRNA. Analyses of the data were performed by Dr. Silvia von der Heyde 
(former University of Göttingen, Göttingen, Germany). The following table shows an extract 
of genes, which were deregulated upon separate or concomitant loss of TP53 and TP73. 
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Table 3.1: Extract of deregulated genes after single or concomitant loss of TP53 and TP73. FC: fold 
change  
TP53 siRNA  
vs  
LUC siRNA 






gene FC gene FC gene FC 
TP53 0.21 TP73 0.46 TP53 0.22 
CDKN1A 0.39 CDKN1A 0.92 TP73 0.43 
TP53INP1 0.28 RMRP 0.27 CDKN1A 0.31 
MDM2 0.50 RPPH1 0.34 TP53INP1 0.31 
BAX 0.65 GATA3 0.46 MDM2 0.48 
SESN1 0.46 SNORA21 0.48 BAX 0.60 
DNALI1 2.21 AKAP5 2.00 IQGAP2 2.02 
CDH4 2.26 SH2D3C 2.03 TGFBI 3.96 
 
Among the deregulated genes, the CDK-inhibitor p21 (encoded by the CDKN1A gene) was 
found, which is a key target gene of p53 (El-Deiry et al. 1993). To verify the RNA sequencing 
results, qRT-PCR analyses were performed to investigate the relative CDKN1A mRNA levels 
in cells repressed of either TP53, TP73 or both concomitantly. The analyses verified low 
expression of CDKN1A in HCT116-TP53-/- cells compared to parental HCT116 cells. 
Repression of TP73 alone also decreased CDKN1A mRNA level, but not as strong as 
observed upon repression of TP53. In cells repressed of both TP53 and TP73, the CDKN1A 
mRNA levels were even more decreased compared to HCT116-TP53-/- cells (Fig. 3.31a). 
 
          
Figure 3.31: Repression of CDKN1A induces increased microtubule plus-end assembly rates 
and lagging chromosomes. (a) qRT-PCR analyses to quantify CDKN1A expression in cells 
repressed of TP53 and TP73. RNA was extracted from asynchronously growing cells and cDNA was 
synthesized. qRT-PCR was performed with gene specific primers. CDKN1A mRNA levels were 
normalized to the housekeeping gene 36B4. Bar graphs show relative mRNA expression levels 
(mean ± sem, t-test, n=3) (b) Measurements of microtubule plus-end assembly rates in HCT116 cells 
after transfection with 60 pmol LUCIFERASE or CDKN1A siRNA. Scatter dot plots show the average 
microtubule plus-end assembly rates of 20 microtubules per cell (mean ± sem, t-test, n=20 cells from 
two independent experiments). (c) Quantification of cells with lagging chromosomes after siRNA-
mediated repression of CDKN1A in HCT116 cells. Cells were synchronized at G1/S transition by 
double thymidine block and released into the cell cycle. After 8.5 h cells were fixed and stained for 
immunofluorescence microscopy. Bar graphs show proportion of cells exhibiting at least one CREST-
positive chromatid (mean ± sem, t-test, n=3 with a total of 300 anaphase cells). 
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Subsequently, CDKN1A was repressed in HCT116 cells by siRNA. EB3 tracking experiments 
showed significantly increased microtubule plus-end assembly rates upon CDKN1A 
repression compared to LUCIFERASE siRNA transfected cells (Fig. 3.31b). Furthermore, the 
occurrence of lagging chromosomes was analyzed. While LUCIFERASE siRNA transfected 
cells exhibited 1.6% lagging chromosomes, this proportion was increased to 4.6% on 
average in CDKN1A siRNA transfected cells (Fig. 3.31c). 
To elucidate the relevance of p21 for increased microtubule plus-end assembly rates in 
HCT116 cells induced by concomitant repression of TP53 and TP73, CDKN1A was  
re-expressed in these cells. The overexpression of CDKN1A was verified by western blot 
analyses (Fig. 3.32a).  
 
         
Figure 3.32: The re-expression of CDKN1A restores increased microtubule plus-end assembly 
rates observed upon repression of TP53 and TP73 in HCT116 and RKO cells. (a) Representative 
western blot verifying CDKN1A expression in HCT116 cells. β-actin was used as loading control. (b) 
Measurements of microtubule plus-end assembly rates in HCT116 and HCT116-TP53
-/-
/TP73shRNA 
upon re-expression of CDKN1A. Scatter dot plots show the average microtubule plus-end assembly 
rates of 20 microtubules per cell (mean ± sem, t-test, n=30 cells from three independent 
experiments). (c) Representative western blot showing CDKN1A induction upon ponasterone A 
treatment in RKO cells. β-actin was used as loading control. (d) Measurements of interphase 
microtubule plus-end assembly rates in RKO cells, expressing CDKN1A upon ponasterone A (Pon) 
treatment. Cells were transfected with 60 pmol siRNA and treated with 5 µmol/l ponasterone A for 
CDKN1A induction. Scatter dot plots show the average microtubule plus-end assembly rates of  
20 microtubules per cell (mean ± sem, t-test, n=20 cells from two independent experiments).  
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Subsequently, the microtubule plus-end assembly rates were examined. Since the 
overexpression of CDKN1A led to a cell cycle arrest in G1-phase, the microtubule plus-end 
assembly rates could solely be measured in interphase cells. The re-expression of CDKN1A 
resulted in a decrease in microtubule plus-end assembly rates in comparison to control 
vector transfected HCT116-TP53-/-/TP73sh cells (Fig. 3.32b). The microtubule plus-end 
assembly rates measured upon CDKN1A re-expression were comparable to those measured 
in control HCT116 cells.  
To further strengthen these findings, RKO cells harboring a ponasterone A inducible 
CDKN1A expression plasmid were used (Schmidt et al. 2000). Also here, the induction of 
CDKN1A via ponasterone A treatment arrested the cells in G1-phase and microtubule plus-
end assembly rates were only measured in interphase. Cells were repressed of either TP53 
or TP73 or both concomitantly by siRNA transfection and the ponasterone A inducible 
CDKN1A expression plasmid was overexpressed. Treatment with 5 µmol/l ponasterone A led 
to the induction of CDKN1A expression, which was verified by western blot analyses  
(Fig. 3.32c). EB3 tracking experiments revealed, that also in RKO cells, the loss of both 
TP53 and TP73 resulted in an increase in microtubule plus-end assembly rates during 
interphase, which was reduced upon re-expression of CDKN1A (Fig. 3.32d). Therefore, it is 
possible that p21 acts as an important effector of both, p53 and p73, for regulating 
microtubule plus-end assembly rates in these cells. 
 
3.2.3 Loss of TP53 And TP73 Causes An Invasive Phenotype In HCT116 Cells 
Interestingly, loss of TP53 and TP73 induced not only increased microtubule plus-end 
assembly rates during mitosis but also in interphase. As shown in the first part of this thesis, 
increased microtubule plus-end assembly rates in interphase are associated with increased 
cell migration and invasion. Therefore, transwell invasion assays for cells with loss of TP53 
and TP73 were performed. HCT116, HCT116-TP53-/-, HCT116-TP73shRNA cells and three 
individual cell clones of HCT116-TP53-/- cells with a stable repression of TP73 were used. 
Furthermore, one HCT116 TP53-/-/TP73sh cell clone, which was generated in the presence 
of low dose Taxol (Fig. 3.27), was analyzed to examine the influence of microtubule plus-end 
assembly rates on invasion (Fig. 3.33a). Transwell invasion assays revealed a significantly 
increased number of invasive cells after concomitant repression of TP53 and TP73 in 
HCT116 cells (Fig. 3.33a). The repression of either TP53 or TP73 alone did not alter the 
invasion potential in comparison to control HCT116 cells. Importantly, low dose Taxol 
treatment reduced the amount of invading cells to levels comparable to parental HCT116 
cells, suggesting that also in cells with loss of TP53 and TP73 the invasive phenotype is 
mediated by increased microtubule plus-end assembly rates. 




Figure 3.33: Loss of TP53 and TP73 induces invasion. (a) Transwell invasion assays using 
HCT116, HCT116-TP53
-/-
, HCT116-TP73shRNA cells, three individual cell clones of HCT116-TP53
-/-
 
cells with a stable repression of TP73 and one Taxol treated cell clone. Bar graphs show the amount 
of invaded cells in 30 randomly chosen pictures from three independent experiments (t-test,  
mean ± sem, n=3). (b) Transwell invasion assays of HCT116 and SK-Mel-28 cells after 
overexpression of 50 µg △Np73. Bar graphs show the amount of invaded cells in 30 randomly chosen 
pictures from three independent experiments (t-test, mean ± sem, n=3). (c) Western blot analysis of 
E-cadherin protein level after transient repression of TP53, TP73 or both concomitantly. Cells were 
transfected with 60 pmol siRNA and analysis was performed after 48 h. E-cadherin was detected and 
β-actin was used as a loading control. 
 
 
This result was also obtained after expression of △Np73 in HCT116 and in non-invasive  
SK-Mel-28 cells (Fig. 3.33b). As a marker for high motility and invasion, the protein levels of 
E-cadherin were determined after transient repression of TP53 and TP73. Western blot 
analysis revealed a strong decrease in E-cadherin protein level after simultaneous 
repression of TP53 and TP73 but not after sole loss of TP53 or TP73 (Fig. 3.33c).  
 
3.2.4 In Vivo Analyses Of Invasiveness Of HCT116 Cells After Loss Of TP53 And TP73 
In order to study the invasive phenotype of the HCT116-TP53-/-/TP73sh cells in vivo, chorion 
allantoic membrane (CAM) assays were performed. CAM assays are an established animal 
model for cancer research and are widely used to study angiogenesis as well as tumor cell 
migration and invasion (Deryugina & Quigley 2009). Briefly, fertilized chicken eggs are 
opened and the CAM becomes accessible. Cells are applied onto the CAM and can be 
analyzed regarding their growth behavior on and through the membrane. 
HCT116 control shRNA, HCT116-TP53-/-, HCT116-TP73sh and HCT116-TP53-/-/TP73sh 
cells were applied onto the CAM and the grown tumors including the CAM were isolated after 
seven days. Tumors were fixed and analyzed regarding their overall growth characteristics. 
Here, the tumors derived from HCT116-TP53-/-/TP73sh macroscopically differed from the 
tumors derived from the single knock down cells. Whereas the control shRNA transfected 
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HCT116 cells and the cells repressed of either TP53 or TP73 exhibited a polypoid 
cauliflower-like growth, the cells repressed of both TP53 and TP73 exhibited an ulcerative 
invasive phenotype (Fig. 3.34a), which is often found in invasive carcinoma of the colon. 
 
    
Figure 3.34: Loss of TP53 and TP73 causes ulcerative invasive tumor growth in vivo. (a) CAM 
assays of HCT116 control shRNA, HCT116-TP53
-/-
 control shRNA, HCT116-TP73shRNA and 
HCT116-TP53
-/-
/TP73shRNA cells. Two million cells were applied on the CAM on day ten of chicken 
development. After additional seven days, tumors were isolated and macroscopically analyzed. Two 
representative tumors derived from each cell line are shown from the top and from the bottom view. 
Scale bar 200 µm. (b) Dissected tumors derived from HCT116 control cells and HCT116-TP53
-/-
/TP73sh cells were sliced into 12 µM sections and stained for Mep21 and DAPI. Arrows indicate the 
CAM. Scale bar 100 µm 
 
 
Immunofluorescence microscopy of cryo-sections of HCT116 control shRNA cells and 
HCT116-TP53-/-/TP73sh cells gave more insights into the tumor phenotypes. Dissected 
tumors were sliced into 12 µM sections and stained for Mep21 and DAPI. Staining for Mep21 
allowed the discrimination between tumor and blood vessels of the CAM, since Mep21 is a 
marker for blood endothelial cells of the chicken. Analyses of the tumors derived from 
HCT116 control cells confirmed the exophytic appearance. The CAM was mainly preserved, 
but still, the tumor protrudes into the CAM in some sections. Furthermore, the tumor 
exhibited a very compact and dense structure. In contrast, tumors derived from  
HCT116-TP53-/-/TP73sh cells showed a mostly destroyed CAM and highly invasive tumor 
growth. Also, the tumor appeared to be very porous.  
These in vivo tumor growth analyses confirmed a highly invasive phenotype induced by the 
loss of both TP53 and TP73. 




4.1 Increased Activity Of TRIO-Rac1-Arp2/3 Pathway As A Trigger For Migration 
And CIN 
The development of genomic instability is a hallmark of human cancers, which enables the 
development of certain cancer hallmarks like insensitivity to anti-growth signals, deregulated 
apoptotic signaling or tissue invasion and metastasis (Hanahan & Weinberg 2000; Hanahan 
& Weinberg 2011). These newly obtained phenotypes are thought to be acquired by 
mutations, structural alterations of the genome or chromosomal instability. Thus CIN is 
associated with tumor progression and an aggressive tumor behavior, which is also 
characterized by infiltration of nearby tissues and metastases. However, the underlying 
mechanisms are still largely unknown and a clear link between CIN and cancer cell invasion 
and metastases is missing so far. 
In this thesis, the migration and invasion potential of a panel of MIN/MSI and CIN CRC cell 
lines and of a panel of melanoma cell lines was examined. Interestingly, not all analyzed CIN 
cell lines exhibited a migratory and invasive phenotype, but vice versa the migratory and 
invasive cell lines were CIN (Fig. 3.1, Fig. 3.2, Fig. 3.5). Importantly, the migration and 
invasion potentials of CRC and melanoma cell lines were strongly associated with increased 
interphase microtubule plus-end assembly rates (Fig. 3.1, Fig. 3.2). Recently, our group 
established increased microtubule plus-end assembly rates during mitosis as a common 
cause for CIN (Ertych et al. 2014), but the role of increased interphase microtubule plus-end 
assembly rates has not been investigated yet. This apparent new relationship between 
microtubule plus-end dynamics in interphase and cell migration was surprising. Therefore, it 
was of great interest to investigate how enhanced microtubule dynamics contribute to the 
regulation of cell motility.  
In this study, a hyperactive TRIO-Rac1-Arp2/3 pathway was identified as a trigger for the 
development of a highly migratory and a chromosomally instable phenotype. Furthermore, 
the studies revealed increased microtubule plus-end assembly rates as an activator of this 
pathway. During interphase, the hyperactivation of TRIO-Rac1-Arp2/3 due to elevated 
microtubule plus-end assembly rates presumably results in highly branched actin filaments, 
which are required for lamellipodia and invadopodia formation during cellular migration and 
tissue invasion. On the other hand, during mitosis, the microtubule-dependent 
hyperactivation of TRIO-Rac1-Arp2/3 induces spindle misorientation, the generation of 
lagging chromosomes and CIN. Therefore, increased microtubule plus-end assembly rates 
promote the development of a highly aggressive and invasive phenotype. 
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Fig. 4.1: Model showing the microtubule-dependent hyperactivity of the TRIO-Rac1-Arp2/3 
pathway that affects both mitosis and interphase. During interphase, in cells exhibiting increased 
microtubule plus-end assembly rates, TRIO binds to microtubules via EB1 and becomes 
hyperactivated. TRIO activates Rac1, which subsequently leads to Arp2/3-mediated reorganization of 
the actin cytoskeleton and the formation of lamellipodia thus facilitating migration and invasion. 
During mitosis, the microtubule dependent increased activity of the Arp2/3 complex leads to spindle 
misorientation due to enhanced formation of actin clouds. The spindle misorientation causes lagging 
chromosomes and CIN. 
 
 
During cell migration, the activation of Rho family GTPases is mediated by GEFs. At least 20 
GEFs are known to regulate the activation of Rac1 by catalyzing the exchange of GDP for 
GTP (Marei & Malliri 2016). Upon them TIAM1, TIAM2, GEF-:H1, ASEF and TRIO are well 
characterized (Kawasaki et al. 2000; Blangy et al. 2000; Krendel et al. 2002; Rooney et al. 
2010). TRIO was identified as a microtubule plus-end binding protein in HeLa and neurite 
cells, whereby binding to microtubules is mediated by the +TIP EB1 (Van Haren et al. 2014). 
EB1 was described to be an important protein in the development of a signaling platform at 
the microtubule plus-end (Vaughan 2005; Tamura & Draviam 2012), which includes binding 
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of CLIP-170 (Lantz & Miller 1998), APC, CLASP1 and CLASP2 (Tsvetkov et al. 2007). 
Interestingly, EB1 is overexpressed in different tumor types and is associated with increased 
tumor formation (Wang et al. 2005). Repression of EB1 interfered with formation of 
lamellipodia protrusions in mouse melanoma cells and deregulated Arp2/3 activity during 
interphase (Schober et al. 2009). The binding of TRIO to EB1 enhances its activity. 
Therefore, the question arises, how binding of TRIO and other GEFs to microtubule plus-
ends leads to their activation. In HeLa and neurite cells it was shown, that TRIO binds to 
microtubules via the navigator complex Nav1 and EB1. Thereby, the GEF activity of TRIO 
and subsequent neurite outgrowth were enhanced. It is hypothesized, that due to binding of 
TRIO to Nav1 and EB1, the GEF domain of TRIO becomes exposed and the interaction 
between TRIO and its target GTPase is stabilized (Van Haren et al. 2014). Further, the 
binding of TRIO to microtubules via EB1 might lead to a spatial regulated intracellular 
signaling, which is needed for Rac1-mediated lamellipodia formation at the leading edge of a 
migrating cell. Microtubule polymerization sequesters and inactivates GEFs whereas 
microtubule depolymerization releases GEFs (Chang et al. 2007). These processes mainly 
occur at the microtubule plus-ends. During cell motility, the centrosome and the majority of 
microtubules are oriented towards the leading edge of the cell (Wittmann & Waterman-Storer 
2001). Furthermore, microtubule plus-ends, which are oriented towards the leading edge, 
grow more persistently compared to microtubules oriented towards the rear of a cell 
(Waterman-Storer & Salmon 1997; Ballestrem et al. 2000). However, microtubules usually do 
not enter the lamellipodium except some so called ´pioneer microtubules´ (Wittmann et al. 
2003). It seems possible that TRIO might be bound to microtubule plus-ends via EB1 and is 
mainly transported towards the leading edge. Here, microtubule depolymerization would lead 
to a release of TRIO, which would then in turn be able to activate membrane bound Rac1 in 
the leading edge, resulting in Arp2/3-activation and actin branching within the lamellipodium. 
It remains unclear, whether TRIO directly activates Rac1 or whether also another Rho-family 
small GTPase, RhoG, which is also a target of TRIO´s GEF activity (Blangy et al. 2000), is 
involved. RhoG is able to activate both Rac1 and Cdc42 in the lamellipodium in a 
microtubule dependent manner (Gauthier-Rouviere et al. 1998), resulting in elevated levels 
of active Rac1 and active Cdc42. Active Rac1 and Cdc42, in turn, lead to WAVE/WASP-
mediated activation of the Arp2/3 complex. The Arp2/3 complex is a well established 
complex in the formation of branched actin in the lamellipodium, thereby providing a 
protrusive force (Zheng et al. 2008). The hyperactivity of the Arp2/3 complex contributed to 
growth and invasiveness of gastric carcinoma (Zheng et al. 2008), whereas silencing 
interfered with cell migration in pancreatic cancer (Rauhala et al. 2013). Therefore, the 
hyperactivation of Arp2/3 mediated by the TRIO-Rac1 axis constitutes a greatly important 
step in tumor cell migration and invasion.  
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Because only few microtubules reach into the lamellipodium it is questionable whether they 
are sufficient to transport enough TRIO molecules for the activation of either Rac1 or RhoG 
to the side of protrusion. Therefore, an amplification of the signaling cascade might be 
necessary. Rac1 activity can also be stimulated through the Ras GTPase activating like 
protein IQGAP1, which stabilizes and increases active Rac1 and Cdc42 levels (Briggs & 
Sacks 2003). IQGAP1 binds to the +TIP CLIP-170, which was detected at microtubules in 
the leading edge (Fukata et al. 2002; Watanabe et al. 2004). Furthermore, IQGAP1 is also 
localized at the cell cortex. A positive feedback loop between IQGAP1 and Rac1 is 
described: cortical IQGAP1 stimulates Rac1, which in turn promotes microtubule-dependent 
stabilization of IQGAP1 (Siegrist & Doe 2007). Further, not only TRIO but also other GEFs, 
like GEF-H1 and ASEF might be delivered to the leading edge. Therefore, different GEF 
activities and IQGAP1 might contribute to the microtubule-dependent activation of Rac1 in 
the leading edge and an amplified signaling (Fig. 4.2). 
 
      
Fig. 4.2: Possible modes of induction of microtubule dependent actin assembly at the leading 
edge. Microtubule-dependent transport of TRIO to the leading edge might directly activate membrane 
bound Rac1. But Rac1 activation may also happen due to RhoG activation. Furthermore, IQGAP1 
could be transported to Rac1, where a positive feedback loop between Rac1 and IQGAP1 would 
result in highly active Rac1. Additionally, microtubules could also deliver Rac1-GEFs other than TRIO 
to the leading edge. These different modes might cooperate to mediate actin assembly through the 
activation of the Arp2/3 complex. 
 
 
Recently, also microtubules themselves were described to be capable of actin polymerization 
(Henty-Ridilla et al. 2016). Also here, the +TIP CLIP-170 is involved. It binds to formins, 
which accelerate actin polymerization by binding to the growing barbed end (Evangelista et 
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al. 2003). Therefore, also TRIO-independent mechanisms could contribute to actin assembly 
at the leading edge to promote migration. 
Interestingly, recent studies linked the amplification of centrosomes with the hyperactivation 
of Rac1 and an invasive phenotype (Godinho et al. 2014). Thereby, an increased number of 
centrosomes is thought to nucleate increased amounts of microtubules that activate Rac1 by 
an unknown mechanism. In conformity with my results, an increased microtubule polymer 
mass might also expose more microtubule plus-ends with, where binding of TRIO can occur. 
Therefore, more TRIO could be transported towards Rac1 at the invasive front. Whether 
increased microtubule plus-end assembly rates, which constitute the trigger of increased 
Rac1-activity in my studies, also lead to increased microtubule polymer mass is not clear and 
remains to be studied. 
In contrast to interphase, the role of TRIO, Rac1 and the Arp2/3 complex in mitotic 
chromosome segregation is not established, but some reports hint to mitotic roles of different 
GEFs. The Rac1-GEF TIAM1 was described to play a role during centrosome separation 
(Woodcock et al. 2010). Its depletion resulted in increased centrosome separation and 
chromosome congression failures (Woodcock et al. 2010). Also TRIO was identified as a 
mitotic Rac1-GEF, acting during cytokinesis at the cleavage furrow (Cannet et al. 2014). 
Unpublished data from our group showed that TRIO is localized to microtubule plus-ends 
during interphase and mitosis in an EB1-dependent fashion. At the cell cortex, TRIO might 
be able to activate Rac1 with subsequent actin polymerization triggered by the Arp2/3 
complex. During mitosis, a dynamic, revolving cluster of actin filaments was described to be 
present from prometaphase to anaphase (Mitsushima et al. 2010). This cluster, referred to as 
´actin clouds´, is located at the cell cortex, extends into the cytoplasm and depends on 
Arp2/3 activity (Mitsushima et al. 2010). Actin clouds might exert pulling forces on 
centrosomes towards retraction fibers, thus polarizing the cell and orientating the mitotic 
spindle at the longest cell axis (Fink et al. 2011). Unpublished data from our group indeed 
revealed a decreased formation of actin clouds upon treatment with TRIO-, Rac1- or Arp2/3-
inhibitors. Thus, the appearance of a hyperactive TRIO-Rac1-Arp2/3 pathway during mitosis 
might result in an enhanced branched actin polymerization, leading to the accumulation of 
dense actin clouds. However, it remains unclear, how actin clouds affect spindle positioning. 
First hints towards this question were provided recently by the Pellman Group (Kwon et al. 
2015). Their studies suggest that the actin cloud might exert pulling forces via the 
microtubule binding myosin Myo10, which was shown to link actin and microtubules and 
move the spindle poles towards actin clouds and retraction fibers (Weber et al. 2004; 
Woolner et al. 2008; Kwon et al. 2015). Myo10 was described to exhibit overlapping 
functions with dynein in mammalian cells. Dynein is mainly involved in anchoring the mitotic 
spindle at the cell cortex via a complex of Gαi-LGN-NuMA and a loss of dynein causes 
                            Discussion 
104 
 
misorientated mitotic spindles (Kiyomitsu & Cheeseman 2012). But the cortical distribution of 
dynein is also affected by external stimuli (Morin & Bellaïche 2011). Therefore, it is not clear, 
whether actin clouds influence the localization of dynein or whether dynein affects the 
orientation of actin clouds. 
Our unpublished data showed that the mitotic localization of TRIO is not restricted to astral 
microtubules, which grow towards the cell cortex and could possibly interact with membrane 
bound Rac1. Therefore, TRIO might not only function at the cortex but also at centrosomes, 
since its localization depends on EB1, which was shown to localize also to centrosomes 
(Morrison et al. 1998; Berrueta et al. 1998; Mimori-Kiyosue et al. 2000). Furthermore, Rac1 
was also described to localize to centrosomal regions in early mitosis (Woodcock et al. 
2010). Here, it was shown, that the Rac1-GEF TIAM1 facilitates bipolar spindle assembly 
(Woodcock et al. 2010). Therefore, also TRIO might interact with Rac1 at centrosomes thus 
triggering actin cloud assembly. Besides microtubules, also actin is important for centrosome 
separation, since depolymerization of actin inhibits splitting of centrosomes (Uzbekov et al. 
2002). Tyrosine-phosphorylated cortactin (p-cortactin) was identified as a trigger for 
centrosome separation (Wang et al. 2008). Actin filaments can attach to p-cortactin and exert 
forces to push the centrosomes apart (Wang et al. 2008). During interphase, the 
phosphorylation of cortactin requires Rac1 activity (Head et al. 2003). Therefore, also during 
mitosis, active Rac1 might be important in facilitating cortactin phosphorylation. An abnormal 
regulated cortactin phosphorylation due to Rac1 hyperactivity might further be associated 
with deregulated spindle formation and chromosome missegregation. 
The overexpression and increased activity of TRIO, Rac1 and Arp2/3 is linked to several 
tumor types. TRIO overexpression, which comes along with hyperactive TRIO, is observed in 
different cancer types and can be found in the most aggressive forms of malignant 
glioblastoma, where it is associated with poor patient survival (Schmidt & Debant 2014). 
Additionally, our unpublished results revealed a correlation of high TRIO expression in 
metastases of colon cancers exhibiting CIN. Thus, TRIO is highly associated with both, 
invasiveness and aneuploidy in late stage colon tumors. Furthermore, deregulated Rac1-
activity is common in cancer. Rac1 overexpression can be found in breast carcinoma, non-
small cell lung carcinoma and gastric carcinoma and results in accelerated tumor 
progression and high mortality rates (Espina et al. 2008). Rac1-signaling modulates cell 
migration and invasion by mediating lamellipodia formation and MMP expression, thereby 
leading to tumor metastases (Mack et al. 2011) but a role of hyperactive Rac1 is not directly 
associated with CIN so far. Downstream of Rac1, also overexpression of the Arp2/3 complex 
is associated with highly invasive tumors. In gastric carcinoma, increased activity of the 
Arp2/3 complex is involved in pathogenesis and progression (Zheng et al. 2008). However it 
remains to be shown whether TRIO, Rac1 or Arp2/3 overexpressing tumors also display 
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increased actin cloud formation during mitosis and thus, spindle misorientation and CIN. Still, 
this shared trigger for the development of CIN and cancer cell migration and invasion may 
constitute an interesting target in cancer therapies. The Rac1 inhibitor NSC23766 was 
already used in treatment of different breast cancers, where it induced cell cycle arrest and 
apoptosis (Yoshida et al. 2010). However, the efficacy of NSC23766 was not sufficient for its 
substantial clinical use (Bid et al. 2013). But the development of a drug that targets the TRIO-
Rac1-Arp2/3 pathway might possibly suppress CIN and cancer cell migration and invasion 
and thus the two highly relevant phenotypes, which are detected in aggressive cancer. 
 
4.2 p53 And p73 Act As Regulators Of Chromosomal Stability And Cell Invasion 
In human cancer, the TP53 gene encoding for the tumor suppressor p53 is the most 
frequently mutated gene. Mutations in TP53 occur late during cancer progression (Baker et 
al. 1990). p53 has two homologs, p63 and p73. Interestingly, the chromosome region coding 
for p73 is lost in a wide array of tumors, including neuroblastoma (Kaghad et al. 1997), 
melanoma (Dracopoli et al. 1989) and hepatocellular carcinoma (Yeh et al. 1994). p73 was 
shown to inhibit aneuploidy in the absence of p53 in mice (Talos et al. 2007). Furthermore, a 
dominant negative form of p73, △Np73, which inhibits p53´s and p73´s function, is often 
overexpressed in tumors and is associated with a highly metastatic phenotype (Steder et al. 
2013). Thus, we wanted to elucidate how p53 and p73 cooperate in maintaining genomic 
stability and suppressing invasion. 
In this study, p53 and p73 were identified as important regulators of chromosomal stability 
and cellular migration and invasion. Importantly, the concomitant loss of TP53 and TP73 
induced aneuploidy (Fig. 3.26d). A complete loss of TP53 is not common in cancer, but 
several hot spot mutations of p53 are described (Goldstein et al. 2011; Muller & Vousden 
2013). These mutants were shown to interact with p73, thereby inhibiting its transcriptional 
activity (Gaiddon et al. 2001). But during my studies, an effect of mutant p53 (p53 R175H) 
onto chromosomal stability was not detected. However, in combination with TP73 repression, 
the development of CIN was observed (Fig. 3.29). A dominant negative form of p73, △Np73, 
was described to negatively regulate both, p53 and p73 function (Grob et al. 2001). In my 
studies, △Np73 overexpression indeed caused increased amounts of cells displaying lagging 
chromosomes (Fig. 3.30), which constitute a prerequisite for the development of CIN 
suggesting that concurrent loss of p53 and p73 function is required to induce CIN.  
The loss of function of p53 in human colon carcinoma cells is not sufficient to induce 
aneuploidy (Bunz et al. 2002). However, in colorectal cancer CIN is often associated with 
p53 loss. Since p53 and p73 exhibit functional and structural similarities, such as a highly 
conserved DNA-binding domain (Levrero et al. 2000), they might be able to fulfill redundant 
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functions and partially transactivate the same genes. Therefore, upon loss of either p53 or 
p73, the remaining protein might be able to substitute for the other. This is in agreement with 
findings from Talos et al., who showed that p73 suppresses polyploidy in the absence of 
functional p53 in mouse embryonic fibroblasts (MEFs) (Talos et al. 2007). But while these 
MEFs developed polyploidy, in my studies the used colorectal cancer cells developed 
aneuploidy. Thus, on the one hand the maintenance of chromosomal stability seems to be 
regulated by p53 and p73 but on the other hand different mechanism might account for that 
in mice and human.  
Further, the absence of p53 was shown to correlate with centrosome amplification in mice 
(Tarapore & Fukasawa 2002). Additionally, in mouse models, a relationship between mutant 
p53 and p73 was described causing overduplication of centrosomes. In these studies, p53 
R172H derived tumors were highly aneuploid due to inhibition of p73 and subsequent 
centrosome amplification (Murphy et al. 2000). Supernumerary centrosomes generate 
lagging chromosomes, due to transient spindle geometry defects occurring during the 
assembly of multipolar spindles, that are clustered into a spindle pole. Also human tumors 
show a strong association between mutant p53 and supernumerary centrosomes, including 
breast tumors (Carroll et al. 1999). However, it was also shown, that loss of p53 alone 
neither lead to centrosome amplification nor to CIN (Lengauer et al. 1997; Bunz et al. 2002).  
In addition to deregulated mitotic functions, also erroneous replication might result from 
simultaneous loss of function of p53 and p73. An aberrant activation of CDK-cyclin 
complexes during S-phase was indeed detected in mice upon loss of p53 and p73 (Talos et 
al. 2007). This resulted in aneuploidy due to a delayed S-phase and re-replication. Indicative 
for erroneous pre-mitotic defects is the occurrence of acentric chromosomes or chromosome 
bridges (Burrell et al. 2013). Since in my studies, cells concomitantly depleted of TP53 and 
TP73 exhibited high amounts of cells displaying anaphase bridges (Fig 3.25d), it might be 
possible that replication stress leads also to structural chromosome aberrations (S-CIN) in 
these cells. Thus, depletion of TP53 and TP73 might cause replication stress, which affects 
the following mitosis (Wilhelm et al. 2013; Gelot et al. 2015). Recently, an impaired 
replication fork progression was detected in the absence of p53 (Yeo et al. 2016). Thereby, 
p53 was discovered to prevent conflicts between transcription and replication in S-phase. 
Upon loss of p53, the timely progression of replication was disturbed by secondary DNA 
structures, leading to replication fork stalling and collapse (Yeo et al. 2016). This in turn 
results in DNA double strand breaks, which may underlie deletion in mitosis. 
My studies showed that the repression of both, TP53 and TP73 or the overexpression of 
△Np73 resulted in an invasive phenotype. Furthermore, the loss of both transcription factors 
led to a strong reduction in the E-cadherin protein level (Fig. 3.32b), which might be a marker 
for EMT. Interestingly, in vivo studies of HCT116 cells repressed of both TP53 and TP73 by 
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using CAM assays revealed a clinical relevant phenotype: while tumors derived from control 
shRNA transfected HCT116 cells exhibited a polypoid cauliflower-like phenotype, tumors 
derived from TP73 shRNA transfected HCT116-TP53-/- cells exhibited an ulcerative invasive 
tumor growth (Fig. 3.34).  
Wild-type p53 was found to inhibit EMT, cancer cell invasion and metastases by Mdm2-
mediated degradation of the transcriptional repressor Slug, which leads to enhanced CDH1 
(encoding for E-cadherin) expression (Wang et al. 2009). But p53´s function is opposed by 
another transcription factor, Twist, which is able to hinder DNA binding of p53 (Shiota et al. 
2008; Smit & Peeper 2008). Therefore, upon loss of TP53, both Slug and Twist can drive the 
repression of CDH1 and promote EMT. Furthermore, Slug and Twist were described to be 
increased upon TP73 repression in MCF-10A cells leading to a highly migratory phenotype of 
this cell line (Zhang et al. 2012). This indicates a regulation of Slug and Twist by both p53 
and p73. Thus, the loss of function of p53 and p73 downregulates CDH1 expression, which 
is frequently observed in cancer and strongly associated with metastases in mouse models 
(Derksen et al. 2006). 
During invasion, the formation of podosomes and invadopodia is an important step. These 
membrane protrusions are involved in adhesion and invasion and are capable of secretion of 
matrix-metalloproteinases (MMPs). The formation of podosomes is mediated by Src kinase 
activity, which is counteracted by p53. Hence, wild-type p53 is involved in suppressing the 
formation of invadopodia and podosomes. This is mediated by up-regulating PTEN and 
caldesmon. PTEN antagonizes phosphatidylinositol-3,4,5-trisphosphate (PIP3) and 
phosphatidylinositol-4,5-bisphosphate (PIP2) formation during cell polarization, whereas 
caldesmon inhibits Arp2/3 induced actin polymerization and also stabilizes actin stress fibers 
(Yamakita et al. 2003; Yoshio et al. 2007).  
The loss of function of p53 and p73 can also occur due to overexpression of △Np73. This 
overexpression results in the gain of highly aggressive traits in cancer (Engelmann et al. 
2014). △Np73 inhibits p53 and p73 and therefore might work antagonistically to both (Pützer 
2013). △Np73 overexpression is found in several cancers including lung cancer (Uramoto et 
al. 2004), neuroblastoma (Douc-Rasy et al. 2002) and prostate carcinoma (Guan & Chen 
2005). The △Np73 isoform is a regulator of EMT by up-regulating N-cadherin and vimentin 
as well as Slug, which represses CHD1, and was found highly expressed in metastases of 
skin cancer patients (Engelmann et al. 2014). Vice versa, the knock down of △Np73 in 
metastatic cell lines suppressed their invasion potential (Steder et al. 2013). Thus △Np73 
plays an important role in metastasis induction potentially by inhibiting the repressive 
functions of p53 and p73. The loss of function of p53 and p73 were accompanied by 
increased mitotic and interphase microtubule plus-end assembly rates. Based on the findings 
represented in this thesis, repression of TP53 and TP73 might hyperactivate the TRIO-Rac1-
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Arp2/3 pathway, which in turn leads to a highly invasive phenotype. Thus, the increased 
microtubule plus-end assembly rates in mitosis and interphase detected after depletion of 
TP53 and TP73 or overexpression of △Np73 might support the hyperactivation of TRIO and 
the respective downstream signaling. This might be in line with the observation that the loss 
of TP53 alone is not sufficient to induce migration and invasion (Sablina et al. 2003; Guo & 
Zheng 2004) (Fig. 3.32a), since depletion of TP53 alone did not induce increased 
microtubule plus-end assembly rates (Fig. 3.25b). In mice, TP53 deletion was described to 
result in elevated activities of the PI3K-Rac1-Akt signaling pathway without altering their 
protein expression (Guo et al. 2003). This suggests that cells exhibit enhanced capability of 
cell migration upon loss of function of p53 but nevertheless also other stimuli are necessary 
for the development of a migratory and invasive phenotype. These additionally required 
stimuli could involve various alterations, which affect and enhance microtubule plus-end 
assembly rates. This may include mutations of TP53. Mutations of TP53 can result in gain of 
functions, which predispose cells to cancer invasion and metastasis (Oren & Rotter 2010). In 
mouse models, mutant p53 increases the capability of metastatic carcinomas (Lang et al. 
2004; Heinlein et al. 2008). 
RNA-sequencing revealed a pronounced repressed expression of CDKN1A upon depletion 
of TP53 and TP73, which was confirmed by qRT-PCR analyses (Table 3.1, Fig. 3.31a). 
Furthermore, the re-expression of CDKN1A suppressed microtubule plus-end assembly 
rates in interphase detected upon loss of p53 and p73 (Fig. 3.32b, d). Thus it might be 
possible, that the observed phenotypes are mediated by p21. p21 acts as a CDK inhibitor, 
and therefore the loss of function of p21 would lead to an increased CDK activity. Known p21 
targets are CDK2 in interphase and CDK1 in mitosis. Whereas CDK2 functions mainly during 
G1-S-phase, CDK1 is active during mitosis. A function of CDKs in the regulation of 
microtubule dynamics is not known, but a few reports have shown a localization of CDKs at 
centrosomes. For instance, the mitotic CDK1 is transported to the centrosome by the 
centrosomal protein Cep63 (Löffler et al. 2011) and becomes activated there in early mitosis 
(Jackman et al. 2003). Further, CP110 is a target of CDK2, which is involved in centrosome 
duplication. Loss of CDK-phosphorylation on CP110 led to polyploidy (Chen et al. 2002). 
Also the spindle checkpoint kinase Mps1 is phosphorylated by CDK2 (Fisk & Winey 2001). 
Moreover, hyperactivation of CDK2 correlates with centrosome amplification (Adon et al. 
2010). Thus, a relationship between deregulated CDK activity and dysfunction might exist. 
Therefore, loss of p21 might affect centrosome-mediated microtubule dynamics through 
increased CDK activity. Whether p21 indeed exerts its microtubule dynamic regulating 
function via its CDK-inhibiting activity needs to be further analyzed in future studies. 
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